data_2jr7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jr7 _Structure_validation_residue.Date_analyzed 2017-03-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.531 0.205 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.3 -50.26 0.93 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.368 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 m -127.99 111.52 24.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.036 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 60.23 175.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.372 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -91.01 -63.51 1.26 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.486 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -170.51 137.28 1.37 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.681 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -85.47 132.66 34.17 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.506 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.6 t -131.33 141.43 45.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.832 0.348 . . . . 0.0 111.25 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -67.0 139.99 57.7 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.253 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -56.69 -29.06 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.612 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -59.01 -32.64 69.89 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.675 0.274 . . . . 0.0 110.682 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -73.07 -33.04 65.41 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.413 ' CE1' HG13 ' A' ' 57' ' ' VAL . 8.3 m-85 -61.61 172.35 1.25 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.431 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.45 107.65 16.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.91 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -65.26 134.6 53.99 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.703 0.287 . . . . 0.0 110.636 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -110.56 98.54 7.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.493 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.04 -26.58 64.7 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.755 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -48.68 -50.95 30.96 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.3 t -149.11 32.75 0.74 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.41 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 50.25 73.49 0.26 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.936 0.398 . . . . 0.0 111.726 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.9 m -138.21 145.26 41.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.747 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -113.15 140.25 48.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.554 0.216 . . . . 0.0 110.645 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -129.31 151.69 49.68 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.62 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CD1' ' HD2' ' A' ' 25' ' ' PRO . 15.5 t80 -127.71 136.93 29.72 Favored Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.252 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 42.8 Cg_endo -67.89 124.07 11.43 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.56 2.173 . . . . 0.0 112.576 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.26 142.06 24.08 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.31 -17.08 44.6 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.649 2.233 . . . . 0.0 112.833 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.7 p -69.38 -32.01 70.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.518 0.199 . . . . 0.0 111.208 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.37 -39.77 1.28 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.738 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.08 -170.17 2.58 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.687 0.279 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 4.1 m120 -134.68 137.0 43.19 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.012 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -60.14 164.33 4.18 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.734 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -147.0 139.12 24.56 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.773 0.32 . . . . 0.0 111.691 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.3 tt -152.08 124.8 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.895 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -72.12 150.39 43.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.464 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -59.93 -38.23 81.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.837 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.94 -37.8 83.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.6 -47.83 81.09 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.622 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 mt -64.79 -36.22 83.61 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -65.49 -28.82 69.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.43 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -91.7 -35.21 14.3 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.31 -13.52 2.77 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.683 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -67.85 79.22 0.21 Allowed 'General case' 0 C--N 1.34 0.184 0 CA-C-O 120.995 0.426 . . . . 0.0 110.616 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -96.34 39.39 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.565 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.6 p -126.82 133.62 68.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.143 0.497 . . . . 0.0 111.447 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.87 135.71 53.32 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.407 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.37 132.21 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -87.71 137.32 32.0 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.644 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.29 -5.0 16.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.573 2.182 . . . . 0.0 113.145 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.6 m -109.84 -68.03 0.95 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.914 -0.13 . . . . 0.0 111.111 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 30.3 p -73.85 -27.29 61.01 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.0 m 65.04 40.72 4.98 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.873 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mt -93.55 -179.53 5.06 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.737 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.6 pt -129.5 143.26 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.02 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 pt -143.69 143.62 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -91.42 135.99 33.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.361 0.601 . . . . 0.0 111.547 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.413 HG13 ' CE1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -109.58 114.53 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.869 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.1 mm -92.79 135.36 27.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.706 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -157.3 177.93 10.9 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.124 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.417 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 5.3 t0 -90.79 104.33 16.93 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -60.29 -32.09 70.87 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.788 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.04 -35.16 80.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.661 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 1.7 mm100 -79.63 -47.0 16.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -63.52 -42.76 98.44 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.345 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.5 t -84.53 83.05 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.918 0.389 . . . . 0.0 110.218 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -113.51 93.73 4.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.89 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.01 -61.91 3.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.822 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -124.63 35.54 4.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 111.347 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.7 m -140.2 103.35 4.58 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.753 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -86.2 116.08 64.45 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.123 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.9 174.83 1.13 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.01 2.473 . . . . 0.0 112.812 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.73 155.84 62.62 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.043 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.08 154.26 62.48 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.238 2.625 . . . . 0.0 112.848 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 m -148.25 90.76 1.84 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 62.35 -179.72 0.13 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.629 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -133.59 154.89 50.52 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.114 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.48 127.44 37.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.127 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -132.67 85.02 2.19 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.67 33.79 3.73 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.99 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.86 82.59 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.973 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -141.86 35.11 1.58 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.989 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tt -92.64 99.41 12.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.97 141.4 36.24 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.6 p80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.907 179.784 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.52 -58.6 1.25 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.525 0.203 . . . . 0.0 111.513 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.8 m -64.1 140.06 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 111.408 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -76.36 139.82 41.15 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -62.86 -67.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.711 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -161.4 141.38 10.61 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.702 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -87.51 135.12 33.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.572 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.464 HG12 ' CE1' ' A' ' 24' ' ' TYR . 21.2 t -129.97 141.54 46.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.288 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.81 139.92 57.8 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.9 tp -56.92 -28.26 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.468 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.02 -33.74 69.29 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.617 0.246 . . . . 0.0 110.797 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.62 -29.55 62.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.042 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 13.9 m-85 -64.31 173.99 1.82 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.186 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -116.0 111.85 20.96 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.771 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -65.71 122.08 16.45 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.846 0.355 . . . . 0.0 110.647 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -100.19 92.08 5.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.94 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.23 -27.29 54.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.675 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -47.15 -52.2 16.13 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.488 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.8 m -142.87 27.73 1.62 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.692 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 52.29 67.8 0.92 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.882 0.373 . . . . 0.0 111.473 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.8 m -138.27 150.05 46.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.563 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -114.46 139.3 49.64 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.619 0.247 . . . . 0.0 110.655 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -126.6 153.93 44.62 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.549 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.464 ' CE1' HG12 ' A' ' 8' ' ' VAL . 22.5 t80 -132.12 131.47 22.5 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.029 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.92 124.34 15.49 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.77 2.313 . . . . 0.0 112.514 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -106.67 141.37 22.69 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.02 -17.67 51.31 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.681 2.254 . . . . 0.0 112.92 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.3 p -69.16 -32.87 72.5 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.544 0.211 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.78 -41.55 1.12 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.315 -0.469 . . . . 0.0 112.356 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.8 -166.42 1.58 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 110.845 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -137.21 137.93 39.63 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.609 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 19.3 m-85 -60.02 165.54 3.26 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.984 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.7 p -147.57 139.0 23.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.795 0.331 . . . . 0.0 111.694 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.8 tt -152.07 124.93 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.63 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.6 p -71.88 149.02 45.56 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.868 0.366 . . . . 0.0 111.246 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.57 83.9 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.045 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.96 -37.99 84.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.809 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 43' ' ' GLU . 4.5 m-20 -56.42 -42.27 77.75 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.401 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.2 -46.84 88.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.776 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.92 -26.04 63.99 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -90.68 -37.34 13.8 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.42 -1.94 4.13 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.063 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 18.1 mm-40 -75.5 76.68 2.54 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-O 121.103 0.478 . . . . 0.0 110.705 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.66 35.83 0.84 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.443 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.03 133.18 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.087 0.47 . . . . 0.0 111.927 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.83 140.48 47.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.529 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.6 m -122.06 132.32 54.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.778 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.99 138.02 32.98 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.575 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.84 -4.82 15.98 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.636 2.224 . . . . 0.0 113.134 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.3 p -110.47 -69.05 0.89 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.41 0.148 . . . . 0.0 111.189 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.6 p -72.4 -27.88 62.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.8 t 63.91 42.7 5.77 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.09 0.471 . . . . 0.0 110.811 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.0 mt -96.11 -178.03 4.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.586 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 26.2 pt -129.0 143.47 41.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.208 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 pt -142.47 144.35 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.0 135.21 34.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.238 0.542 . . . . 0.0 111.375 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.08 113.31 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.201 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 mm -94.09 135.36 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CE1' ' HG2' ' A' ' 61' ' ' LYS . 32.9 p90 -159.35 -177.32 6.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.575 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -87.91 94.41 9.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.747 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.432 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 4.3 mtpm? -58.46 -29.42 66.17 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.068 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.81 -36.82 85.57 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.61 0.243 . . . . 0.0 110.671 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -79.02 -35.11 43.28 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.315 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -74.91 -44.0 51.11 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.67 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.7 t -80.53 81.0 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.097 0.475 . . . . 0.0 111.007 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 t -130.16 30.59 4.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.144 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.94 -41.33 61.87 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.48 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -99.81 31.81 3.11 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 111.207 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -139.73 104.63 4.95 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.763 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.3 t 67.55 141.88 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.746 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.78 154.99 34.49 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.924 2.416 . . . . 0.0 112.739 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.01 151.15 13.13 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.64 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.72 159.11 54.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.728 2.285 . . . . 0.0 112.335 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 51.1 m -98.61 73.53 2.07 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.973 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 67.58 160.27 0.16 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.709 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -114.91 146.91 40.64 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.224 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 89.83 3.0 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.023 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -150.7 117.0 5.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.935 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.79 34.7 0.61 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.3 p -109.42 128.34 65.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.193 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp 59.73 85.44 0.1 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.051 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.77 127.51 41.86 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -104.75 170.5 7.84 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 . . . . . 0 C--O 1.232 0.156 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.003 179.866 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 mtp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.781 0.324 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.81 37.0 27.76 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.457 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.53 154.83 40.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.755 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -62.09 138.78 58.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.962 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -58.4 -64.46 0.91 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.974 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -162.14 160.4 27.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -104.63 134.08 48.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.408 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.401 HG11 ' CE1' ' A' ' 24' ' ' TYR . 19.2 t -138.75 141.5 36.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.83 0.348 . . . . 0.0 111.313 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.72 139.92 57.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.939 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -55.26 -30.04 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.794 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -58.8 -33.34 70.25 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.588 0.232 . . . . 0.0 110.78 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -71.61 -30.52 65.89 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.999 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 16.1 m-85 -65.16 171.66 3.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 111.21 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.22 104.45 14.36 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.841 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -66.48 150.17 49.35 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.722 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 3.4 t0 -125.46 144.75 50.39 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.344 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.97 -29.01 14.39 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.276 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -49.26 -53.14 23.11 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.3 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -148.83 28.23 0.86 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.639 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 3.0 mt-10 53.74 82.28 0.08 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.891 0.377 . . . . 0.0 111.337 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 m -137.6 143.33 41.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -109.92 134.87 51.62 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.895 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -123.99 159.83 28.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.257 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.442 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 4.5 t80 -143.04 139.34 16.67 Favored Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.156 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 24' ' ' TYR . 50.7 Cg_endo -69.27 124.01 10.84 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.594 2.196 . . . . 0.0 112.494 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.419 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.37 144.46 28.14 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.406 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 39.9 Cg_endo -67.06 -18.23 51.44 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.658 2.239 . . . . 0.0 112.928 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p -76.55 -38.75 54.55 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.605 0.24 . . . . 0.0 111.188 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.82 -42.57 0.78 Allowed Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.668 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -176.69 4.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.506 0.193 . . . . 0.0 110.672 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -130.24 135.1 47.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.246 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.419 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 21.0 m-85 -63.39 164.36 9.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.738 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 p -150.6 139.2 20.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.872 0.368 . . . . 0.0 111.581 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 tt -151.6 125.43 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.7 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 p -73.07 148.45 44.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.431 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -60.58 -38.06 83.36 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.775 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.09 -37.15 81.7 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.134 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.79 -47.49 80.07 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.629 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.16 -45.89 91.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.885 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.03 -32.44 70.91 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.144 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -83.19 -37.81 23.16 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.694 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.81 -13.0 2.9 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.566 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.31 80.26 0.54 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.069 0.461 . . . . 0.0 111.054 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -97.33 41.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.497 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -132.37 135.05 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.163 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.87 137.04 51.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.481 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.4 m -117.09 132.03 56.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.841 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.9 t -96.54 115.72 65.78 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.389 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.13 -19.77 21.81 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.713 2.276 . . . . 0.0 113.74 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.02 -75.39 0.32 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.505 0.193 . . . . 0.0 111.341 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 53' ' ' LEU . 29.0 p -74.45 -22.93 58.87 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m 63.89 45.74 4.2 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.073 0.464 . . . . 0.0 110.817 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.422 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 3.9 mp -101.49 179.57 4.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.823 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.0 pt -126.9 143.58 39.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.352 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 pt -138.62 158.21 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.95 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -102.76 132.22 49.08 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.359 0.6 . . . . 0.0 111.502 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.08 113.36 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.972 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 mm -94.58 135.22 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -154.69 178.58 9.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.501 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -91.35 99.61 12.55 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.809 0.338 . . . . 0.0 110.95 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -58.97 -30.04 67.62 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.244 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.63 -38.94 90.8 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.946 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -74.18 -42.32 60.05 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.831 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -67.84 -44.61 76.8 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.037 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.7 t -100.93 82.25 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.699 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -113.27 91.46 3.66 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.151 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.03 -46.99 1.8 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.697 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.36 32.61 4.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.721 0.296 . . . . 0.0 111.598 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -151.39 127.54 10.5 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.867 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.99 138.35 19.63 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -85.82 51.67 2.88 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.883 2.388 . . . . 0.0 112.48 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.17 120.96 28.89 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.256 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.94 172.38 1.67 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.176 2.584 . . . . 0.0 112.959 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -70.09 -36.08 74.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.428 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.47 128.87 45.22 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.634 0.254 . . . . 0.0 111.159 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -66.97 148.42 51.98 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.174 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -106.78 152.5 23.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.437 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -147.02 98.48 3.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.213 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -172.85 128.57 0.49 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.151 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.12 90.3 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.688 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -108.17 103.63 12.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.011 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.9 mt -129.89 36.36 4.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.171 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.29 175.34 9.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.996 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 . . . . . 0 C--O 1.232 0.149 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.975 179.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.706 0.289 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.47 -70.43 0.59 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.771 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.51 26.36 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -73.99 145.38 44.64 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 111.354 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -64.19 -64.12 0.97 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.446 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -163.26 145.53 10.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.781 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -91.74 134.39 34.76 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.411 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.488 HG11 ' CE1' ' A' ' 24' ' ' TYR . 20.3 t -133.06 141.58 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.151 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.77 140.16 57.83 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.17 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -56.25 -28.19 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.416 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.28 -32.71 68.67 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.575 0.226 . . . . 0.0 110.858 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.49 -27.78 58.95 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.153 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 13.0 m-85 -65.48 173.02 2.88 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.824 0.345 . . . . 0.0 111.19 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -111.37 113.8 26.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -65.67 125.67 26.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.56 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -104.72 90.39 3.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.602 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.7 -27.87 43.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.336 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.44 -49.1 9.94 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.353 0.408 . . . . 0.0 111.456 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.8 m -151.44 32.39 0.58 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.534 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 51.65 70.49 0.54 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 111.559 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.7 m -137.6 153.2 49.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.815 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -120.47 131.18 54.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.8 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 33' ' ' SER . 13.5 m-85 -118.89 152.76 35.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 111.392 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.488 ' CE1' HG11 ' A' ' 8' ' ' VAL . 18.7 t80 -128.6 136.64 29.43 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.974 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 123.75 14.32 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.599 2.199 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.66 147.24 37.16 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.48 -30.76 65.81 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.918 2.412 . . . . 0.0 112.854 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.8 p -73.28 -42.39 62.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.282 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.6 -22.44 6.94 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.272 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -63.79 -35.73 81.55 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.921 0.36 . . . . 0.0 111.295 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 30' ' ' ASP . 66.7 m-20 73.37 131.5 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.116 0.484 . . . . 0.0 111.761 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 61.7 m-85 -61.06 163.57 5.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.916 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 81.6 p -148.15 139.23 23.29 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 111.374 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.2 tt -150.5 124.31 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.591 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.89 148.19 46.35 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -38.52 85.08 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.026 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -60.95 -38.47 85.98 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.107 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.53 -47.59 79.05 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.775 0.322 . . . . 0.0 110.688 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.26 -42.45 98.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.976 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -60.13 -31.65 70.28 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.336 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -86.81 -36.9 18.26 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.9 -14.14 2.63 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.551 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.02 80.22 0.22 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.037 0.446 . . . . 0.0 111.145 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -95.05 38.72 1.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.767 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.99 131.67 70.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.236 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . . . -113.01 127.15 56.15 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.97 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.8 m -111.67 122.74 48.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.796 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -70.79 141.13 86.92 Favored Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.744 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.6 36.62 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.956 2.437 . . . . 0.0 113.444 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 t -155.51 -64.11 0.12 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.709 0.29 . . . . 0.0 110.531 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.3 p -77.16 -24.73 51.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.358 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.7 m 65.87 41.39 3.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.962 0.41 . . . . 0.0 110.79 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.97 -179.59 5.97 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.9 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.9 pt -136.02 143.47 36.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.402 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.57 144.68 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.834 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.32 136.36 33.66 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.284 0.564 . . . . 0.0 111.165 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.3 114.53 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.981 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.4 mm -93.24 134.66 30.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.741 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CE2' ' HE3' ' A' ' 61' ' ' LYS . 19.0 p90 -156.95 178.35 10.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.049 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 31.5 t0 -88.56 91.28 8.75 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.25 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.454 ' HE3' ' CE2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -58.45 -34.5 70.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.913 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.05 -34.36 78.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.79 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 3.6 mm-40 -85.99 -35.46 20.38 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.001 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 59' ' ' TYR . 4.2 m-85 -59.9 -55.01 39.45 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.48 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.83 90.43 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 121.33 0.586 . . . . 0.0 111.076 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.7 p -141.36 28.36 1.85 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.449 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.82 -78.55 1.27 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.38 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.36 80.08 8.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.817 0.341 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 t -131.73 102.59 5.94 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.674 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.2 t -132.92 140.32 37.27 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.115 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -57.85 172.3 1.22 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.944 2.43 . . . . 0.0 112.918 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.29 150.07 74.49 Favored Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.987 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.69 -177.31 2.11 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.084 2.523 . . . . 0.0 112.691 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m -79.5 123.22 27.35 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.503 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 66.59 100.72 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.544 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -95.0 38.71 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.202 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.31 105.15 4.35 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.889 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.86 114.35 25.97 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.704 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.84 63.67 0.65 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 111.418 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.4 t -141.15 122.69 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.342 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.0 mttm 60.71 92.54 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.358 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.0 mt -87.48 104.05 16.1 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.6 -35.39 9.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.31 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 57.1 m80 . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.824 -179.482 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtm . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.605 0.241 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.34 -43.66 6.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.332 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 m -64.83 159.61 3.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.917 0.389 . . . . 0.0 111.452 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -71.91 163.4 27.91 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.233 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -89.88 -67.54 0.84 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -145.87 162.78 36.96 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.769 0.318 . . . . 0.0 111.288 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -114.03 134.03 55.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -132.76 140.79 46.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.178 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -66.73 139.65 57.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.021 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 tp -56.95 -30.4 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.657 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.32 -32.27 71.07 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.669 0.271 . . . . 0.0 110.806 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -72.88 -28.97 62.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.336 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.417 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 12.8 m-85 -62.75 160.48 14.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.991 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -96.39 82.53 3.41 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.586 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.466 ' HB2' ' CE2' ' A' ' 22' ' ' TYR . 87.2 t80 -68.26 153.35 43.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -144.55 122.93 12.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.549 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -65.93 -28.7 69.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.101 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.7 -60.81 3.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.658 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 m -94.19 -20.63 19.68 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.855 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 64.87 47.51 2.63 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.013 0.435 . . . . 0.0 110.776 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.3 m -139.63 145.86 39.01 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.496 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 15' ' ' TYR . 77.5 m-85 -98.25 141.03 31.67 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.751 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -127.3 157.0 41.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.766 0.317 . . . . 0.0 111.592 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.417 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 27.7 t80 -140.15 136.8 17.32 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HA ' ' ND2' ' A' ' 31' ' ' ASN . 40.3 Cg_endo -66.99 124.58 12.42 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.682 2.254 . . . . 0.0 112.627 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -97.43 144.04 27.23 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.906 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.05 -15.29 35.97 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.716 2.277 . . . . 0.0 112.942 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.4 p -77.86 -38.87 45.08 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.506 0.193 . . . . 0.0 111.081 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.87 -49.16 0.45 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.791 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -167.25 1.13 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.542 0.211 . . . . 0.0 111.046 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 5.2 m120 -135.6 140.13 44.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.633 0.254 . . . . 0.0 111.079 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.4 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 50.1 m-85 -63.54 165.27 8.21 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.826 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 p -150.39 139.13 20.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.447 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 tt -151.95 124.77 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 p -71.49 148.72 46.51 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.909 0.385 . . . . 0.0 111.423 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -38.2 87.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.21 -37.93 84.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.966 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -56.34 -46.98 79.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.531 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.2 mt -60.0 -45.45 92.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.964 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -59.45 -33.53 71.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.036 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -82.14 -38.19 25.1 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.48 -12.42 2.98 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.574 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -70.06 80.34 0.49 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.146 0.498 . . . . 0.0 111.026 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -97.66 41.78 1.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.478 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.4 p -129.01 132.36 67.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.329 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.85 134.69 54.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.773 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.5 m -116.7 132.59 56.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.9 t -91.4 134.12 30.16 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.524 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.02 1.77 8.87 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.583 2.188 . . . . 0.0 113.246 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.18 -51.39 2.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.615 0.245 . . . . 0.0 111.008 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.5 p -101.81 -24.22 14.08 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 69.17 41.05 1.44 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.059 0.457 . . . . 0.0 110.961 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -95.18 163.34 13.32 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.809 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.2 pt -113.55 143.26 23.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.168 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 pt -142.51 144.43 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.052 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -91.28 134.57 34.47 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.221 0.534 . . . . 0.0 111.67 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.417 HG11 ' CZ ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -108.04 113.22 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.006 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 mm -92.99 134.07 32.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.045 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -156.44 177.12 11.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.823 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -90.26 104.53 17.1 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.858 0.361 . . . . 0.0 110.905 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -30.6 69.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.078 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -64.94 -39.15 93.06 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.686 0.279 . . . . 0.0 110.661 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.97 -47.86 19.64 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.23 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -59.96 -43.63 94.91 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.191 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.95 83.88 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.787 0.327 . . . . 0.0 110.526 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.79 89.49 2.83 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.17 -37.96 6.96 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.603 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -101.96 37.74 1.79 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.742 0.306 . . . . 0.0 111.269 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.0 t -91.07 171.3 9.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.065 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.17 135.95 28.02 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.474 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.88 -175.19 2.36 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.781 2.321 . . . . 0.0 112.461 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.09 152.12 57.43 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.649 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.68 142.34 61.63 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.149 2.566 . . . . 0.0 112.714 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.9 135.25 8.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.012 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.44 113.82 27.56 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -83.51 105.29 14.33 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.9 0.381 . . . . 0.0 110.825 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -66.7 141.71 57.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.214 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -155.8 101.99 2.16 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.281 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.35 40.59 0.1 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.991 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -77.24 117.32 22.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.135 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -145.7 25.79 1.3 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.569 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 69.0 152.36 0.09 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.837 0.351 . . . . 0.0 111.337 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -67.61 147.18 53.07 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.067 -179.903 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 ttp . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.625 0.25 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.96 -66.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.892 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.1 m -134.98 24.82 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.397 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CD1' HD13 ' A' ' 54' ' ' ILE . 1.2 m-85 60.35 -179.95 0.1 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 111.22 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -97.28 -61.63 1.37 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.728 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -165.65 160.17 17.17 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.748 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -107.29 120.38 41.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.459 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.64 141.54 45.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -66.5 139.81 57.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.064 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -56.87 -28.99 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.441 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.96 -35.84 71.72 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.731 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.25 -28.87 63.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.293 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 15.6 m-85 -63.93 161.43 15.69 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 111.307 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.13 99.03 11.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.544 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.42 136.58 53.5 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.925 0.393 . . . . 0.0 110.745 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -119.42 89.99 3.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.518 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -55.85 -29.29 59.62 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.24 -44.21 22.6 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.9 m -138.68 24.37 2.64 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 47.09 59.73 3.85 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.06 0.457 . . . . 0.0 111.783 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.7 m -138.15 144.07 40.6 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.987 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -106.15 141.13 38.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.94 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 76.7 m-85 -124.18 161.11 26.38 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.331 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.444 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 7.7 t80 -148.53 137.45 11.96 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.01 126.34 13.04 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.456 2.104 . . . . 0.0 112.706 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 1.6 t -101.87 143.57 26.86 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 46.5 Cg_exo -56.25 -26.16 59.79 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.907 2.405 . . . . 0.0 113.043 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -69.19 -38.31 78.58 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.466 0.174 . . . . 0.0 111.463 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.63 -39.95 1.18 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.464 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.98 -176.23 2.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.682 0.277 . . . . 0.0 110.885 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -130.44 133.06 46.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.693 0.283 . . . . 0.0 111.416 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 47.3 m-85 -63.06 162.86 10.84 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.709 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 p -146.93 139.34 24.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 111.558 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 tt -151.82 122.06 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.759 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.6 p -72.17 149.44 44.68 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.103 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -60.05 -37.17 79.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.708 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.56 -38.34 84.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.933 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.3 -47.16 79.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.617 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.4 mt -61.7 -46.11 91.07 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.18 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.39 -31.04 69.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.851 -0.159 . . . . 0.0 111.284 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -83.88 -36.59 23.28 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.55 -12.8 3.21 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.722 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -71.65 81.28 0.84 Allowed 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.186 0.517 . . . . 0.0 110.849 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -97.44 41.79 1.11 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.469 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.02 137.3 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.54 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.71 131.51 55.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.788 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.3 m -112.56 132.39 55.14 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.145 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.26 138.43 39.24 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.26 2.46 8.45 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.546 2.164 . . . . 0.0 113.421 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.4 -64.22 1.33 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.452 0.168 . . . . 0.0 111.152 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.0 p -85.05 -20.68 30.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.6 m 65.56 38.69 5.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.872 0.368 . . . . 0.0 111.131 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.14 158.76 21.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.734 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.452 HD13 ' CD1' ' A' ' 4' ' ' PHE . 20.0 pt -112.83 142.91 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.794 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 pt -144.82 144.76 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.027 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -91.17 134.46 34.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.391 0.615 . . . . 0.0 111.614 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.24 113.24 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.744 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.47 135.03 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.805 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -155.92 168.23 27.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.804 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -85.68 97.77 10.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.814 0.34 . . . . 0.0 110.675 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -58.46 -30.03 66.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.109 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.78 -36.77 85.38 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.529 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -38.1 37.3 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.022 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -61.68 -60.11 4.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.11 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 p -111.47 95.16 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.246 0.546 . . . . 0.0 111.096 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -96.05 86.92 4.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.081 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.02 -45.9 90.73 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.649 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.49 83.59 2.06 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.947 0.403 . . . . 0.0 110.834 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -128.19 161.3 29.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.268 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.9 t -107.44 138.65 20.0 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.96 124.75 17.03 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.973 2.449 . . . . 0.0 112.827 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 72.25 158.1 0.16 Allowed Pre-proline 0 N--CA 1.468 0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.707 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.92 165.93 31.41 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.683 2.256 . . . . 0.0 112.772 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.5 m -147.63 -59.28 0.26 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.148 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.25 171.68 8.05 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.42 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -145.49 37.29 1.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -135.92 36.01 2.84 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.247 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.01 94.07 0.62 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.894 0.378 . . . . 0.0 110.382 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.67 -146.86 0.37 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.456 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.9 t -94.59 102.28 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.696 0.284 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.7 tttm 61.06 79.02 0.26 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.43 156.87 48.0 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 73.21 -64.69 0.39 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.296 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.8 t60 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.85 0.357 . . . . 0.0 110.719 179.871 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 ttm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.38 152.58 50.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.66 0.267 . . . . 0.0 111.663 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.48 30.9 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.305 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -75.71 173.5 11.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 111.279 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -94.52 -65.75 0.96 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.633 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.64 138.41 7.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.14 133.71 34.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.537 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 24' ' ' TYR . 19.1 t -136.78 141.69 40.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.836 0.351 . . . . 0.0 111.485 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -66.68 140.16 57.89 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.06 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -55.73 -27.68 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.692 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -58.98 -32.93 70.12 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.659 0.266 . . . . 0.0 110.689 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.88 -28.57 61.63 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 11.0 m-85 -66.77 170.86 5.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 111.364 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -105.23 109.37 21.34 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.874 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -66.74 110.95 3.45 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.747 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -88.69 95.4 10.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.833 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -25.58 64.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.552 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -49.18 -51.53 32.08 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.736 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.9 m -143.1 28.45 1.53 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 51.98 68.03 0.88 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.874 0.368 . . . . 0.0 111.544 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.4 m -137.88 149.89 46.65 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.67 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -114.09 138.7 50.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.655 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -126.89 157.14 40.16 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.777 0.322 . . . . 0.0 111.788 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.431 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 10.3 t80 -135.87 136.61 23.6 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.327 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 37.8 Cg_endo -65.92 124.64 12.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.805 2.337 . . . . 0.0 112.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.407 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -100.84 144.9 29.43 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.34 -17.48 44.42 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.647 2.232 . . . . 0.0 112.898 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.2 p -75.99 -36.24 59.3 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.152 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.99 -49.55 0.55 Allowed Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.763 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.3 -168.21 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.51 0.195 . . . . 0.0 110.928 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 6.1 m-80 -137.87 138.65 39.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.687 0.28 . . . . 0.0 111.261 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 28.6 m-85 -61.07 163.22 6.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.787 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.7 p -147.18 139.28 24.46 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.86 0.362 . . . . 0.0 111.568 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 tt -151.96 124.8 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.618 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.9 p -71.96 149.2 45.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 111.315 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -38.46 86.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -61.56 -38.11 86.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.93 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.46 -47.76 78.5 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.616 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 mt -62.5 -41.21 98.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -62.67 -31.04 71.85 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.449 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -86.62 -36.45 18.81 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.78 -15.04 2.65 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.443 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.8 80.76 0.29 Allowed 'General case' 0 C--N 1.34 0.165 0 CA-C-O 121.203 0.525 . . . . 0.0 110.561 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -98.49 41.9 1.12 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.282 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.36 131.9 65.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.095 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.5 137.0 52.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.421 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 m -118.57 131.71 56.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.652 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 49.4 t -92.03 117.19 67.58 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.43 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.87 -19.1 24.06 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.758 2.305 . . . . 0.0 113.402 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.1 m -83.21 -73.85 0.39 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.3 p -76.86 -24.94 52.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.21 38.77 2.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.048 0.452 . . . . 0.0 110.722 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.3 mt -92.06 178.06 5.99 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.732 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.9 pt -125.68 143.5 39.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.4 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 pt -140.6 159.19 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.979 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.37 133.98 49.24 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.273 0.558 . . . . 0.0 111.409 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.7 113.28 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.082 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mm -92.61 135.42 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.986 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -151.67 178.21 9.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 15.3 t0 -87.08 99.8 12.18 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.622 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -61.17 -31.92 71.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.01 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.22 -35.12 80.07 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.66 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 6.1 mt-30 -80.82 -42.16 22.09 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.94 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -72.4 -72.2 0.25 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.28 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.81 92.04 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 121.276 0.56 . . . . 0.0 111.662 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 p -78.03 88.54 4.17 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.344 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -99.39 0.04 OUTLIER Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.368 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.55 32.33 4.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 t -81.82 125.72 31.01 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.9 t -97.12 139.62 21.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.493 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.11 86.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.795 2.33 . . . . 0.0 112.53 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -174.71 148.2 1.17 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.86 135.28 21.17 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.869 2.379 . . . . 0.0 112.84 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -163.99 -54.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.143 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.47 -42.64 92.51 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.774 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -158.67 163.11 37.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.664 0.268 . . . . 0.0 111.09 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -146.71 80.57 1.55 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.155 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -134.92 95.7 3.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.282 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -150.17 31.14 0.69 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.348 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.42 113.13 43.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.658 0.266 . . . . 0.0 111.455 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -170.85 101.75 0.23 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.949 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.17 152.38 34.86 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.099 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -152.92 167.14 30.13 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.427 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 15.6 m80 . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.746 179.654 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.456 0.17 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.86 -72.21 0.65 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.259 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.4 m -151.54 76.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 111.265 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -71.09 162.89 28.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.375 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -92.81 -64.43 1.1 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.681 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -160.79 136.31 7.99 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.963 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.21 134.57 34.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.595 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' A' ' 24' ' ' TYR . 20.2 t -137.09 141.5 40.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.244 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -66.82 140.04 57.8 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.041 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 tp -55.34 -28.58 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.732 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.49 -31.34 67.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.6 0.238 . . . . 0.0 110.982 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.51 -31.11 60.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.964 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -63.68 168.68 4.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.146 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -101.95 110.52 22.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -65.73 127.23 31.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.751 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -102.36 97.72 7.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.559 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -59.54 -26.11 65.08 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.554 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -49.15 -50.87 35.62 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.73 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 t -152.93 34.77 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.569 0.223 . . . . 0.0 111.583 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 52.11 77.03 0.16 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.897 0.379 . . . . 0.0 111.863 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.8 m -137.92 151.48 48.04 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.685 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -122.02 139.87 53.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.769 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -130.6 157.35 42.96 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.626 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.426 ' CE1' HG11 ' A' ' 8' ' ' VAL . 7.7 t80 -135.74 137.28 25.23 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.23 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.407 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 43.6 Cg_endo -68.16 124.61 11.94 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.611 2.208 . . . . 0.0 112.557 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.23 142.99 25.76 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.55 -17.7 48.54 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.644 2.229 . . . . 0.0 112.864 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.1 p -71.34 -31.75 67.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.578 0.227 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.48 -40.18 1.35 Allowed Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.38 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.3 -171.99 3.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.679 0.276 . . . . 0.0 110.897 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.407 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 6.7 m-80 -136.17 133.39 37.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.933 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -59.62 163.14 4.46 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.4 p -147.56 139.22 23.97 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.85 0.357 . . . . 0.0 111.627 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 tt -152.32 124.57 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.777 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.7 p -71.82 149.56 45.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 111.263 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -37.18 82.95 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -60.96 -39.34 89.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.789 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.24 -47.91 77.55 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.691 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mt -62.14 -43.97 97.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -60.69 -28.94 69.0 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.353 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -88.1 -36.87 16.66 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.35 -14.51 2.52 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.649 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -69.74 80.47 0.44 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.191 0.519 . . . . 0.0 111.125 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.71 40.14 1.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.502 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.78 134.23 65.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.371 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.1 139.42 48.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.178 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.5 m -118.8 132.12 56.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.746 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -91.69 135.86 27.17 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.794 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.84 -2.06 12.2 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.566 2.177 . . . . 0.0 113.239 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.58 -65.51 1.14 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.455 0.169 . . . . 0.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.3 p -79.61 -24.65 41.82 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.94 39.67 5.71 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 111.093 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.6 mt -95.86 -179.59 4.76 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.5 pt -128.83 143.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.224 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 pt -139.99 143.68 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -91.62 132.76 36.11 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.347 0.594 . . . . 0.0 111.493 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.77 116.03 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.854 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.7 mm -94.06 135.56 28.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.785 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -154.82 178.04 10.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.916 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.87 99.79 12.39 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.565 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -60.39 -30.39 69.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.068 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -65.23 -33.57 76.31 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.709 0.29 . . . . 0.0 110.851 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -88.96 -45.52 9.6 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.013 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -66.97 -55.65 13.57 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.248 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 t -81.01 82.74 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.93 0.395 . . . . 0.0 110.693 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -95.81 88.82 5.07 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.074 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.67 -60.17 0.94 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.785 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.24 22.63 10.25 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.9 m -153.13 117.86 5.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.655 0.264 . . . . 0.0 110.949 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 p -134.36 135.65 24.35 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.92 168.23 24.59 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.002 2.468 . . . . 0.0 112.818 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.16 150.83 19.16 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.725 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.7 135.75 70.95 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.474 2.783 . . . . 0.0 113.346 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.6 m -147.42 87.43 1.65 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.18 155.87 37.73 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.364 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 25.05 15.06 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.63 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.96 74.5 0.15 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.826 0.346 . . . . 0.0 111.147 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -145.09 87.38 1.82 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.801 0.334 . . . . 0.0 111.101 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.5 34.1 3.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.1 p -99.43 24.49 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.06 0.457 . . . . 0.0 111.36 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.75 31.3 5.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 tp -122.48 32.02 5.91 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 110.978 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -88.83 -56.33 3.34 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.876 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.462 0.133 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.049 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.7 mtt . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 120.609 0.242 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.87 150.2 26.63 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.315 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.27 108.29 5.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.825 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -63.65 142.59 58.34 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.043 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -68.28 -65.4 0.7 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.367 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -156.82 149.46 23.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.887 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.41 134.57 44.29 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.449 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.475 HG12 ' CE1' ' A' ' 24' ' ' TYR . 19.2 t -132.9 141.52 44.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -67.17 139.99 57.46 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.02 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.9 tp -56.38 -29.92 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.513 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -58.76 -33.94 70.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.577 0.227 . . . . 0.0 110.858 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.45 -30.37 63.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.135 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.02 164.49 8.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.124 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.26 110.89 23.37 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.653 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -66.86 121.3 15.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.732 0.301 . . . . 0.0 110.512 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -102.17 85.17 2.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.653 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -55.81 -29.4 59.69 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.815 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.12 -41.56 17.66 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.16 0.288 . . . . 0.0 111.324 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.93 28.95 0.83 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 48.46 66.45 1.07 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.042 0.449 . . . . 0.0 111.909 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -138.09 154.26 49.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.589 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -118.88 139.33 51.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.466 0.174 . . . . 0.0 110.573 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -128.8 156.81 42.99 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.829 0.347 . . . . 0.0 111.529 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.475 ' CE1' HG12 ' A' ' 8' ' ' VAL . 31.8 t80 -137.14 136.21 20.62 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.238 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.481 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 40.0 Cg_endo -66.72 124.04 11.83 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.447 2.098 . . . . 0.0 112.622 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.41 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.6 143.36 26.19 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.16 -17.62 50.58 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.692 2.261 . . . . 0.0 112.829 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.0 p -74.76 -39.37 61.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.47 0.176 . . . . 0.0 111.153 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.43 -47.94 0.52 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.539 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.58 -173.99 4.43 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.487 0.184 . . . . 0.0 110.665 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 65.6 m-20 -131.99 140.42 48.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.683 0.278 . . . . 0.0 111.084 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 27.2 m-85 -64.48 166.25 8.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.789 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -149.8 139.49 21.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 111.57 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 tt -151.87 125.29 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.605 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.9 p -72.72 150.54 42.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.382 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -59.39 -38.81 81.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.722 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -60.7 -38.09 83.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.115 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -57.82 -47.99 81.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.375 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.06 -38.34 90.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -65.03 -29.02 69.9 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.497 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.26 -36.98 14.41 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.17 -15.23 2.33 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.647 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -68.22 80.6 0.24 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-O 121.146 0.498 . . . . 0.0 110.619 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -96.7 38.88 1.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.421 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.12 134.93 64.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.253 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.67 138.52 49.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.153 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.3 m -117.05 131.16 57.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.636 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.2 t -99.48 114.23 65.44 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.264 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.0 -18.53 28.68 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.706 2.271 . . . . 0.0 113.34 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 m -81.11 -73.76 0.36 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.4 p -79.8 -24.29 41.51 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.4 m 69.28 42.46 1.2 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.978 0.418 . . . . 0.0 111.03 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.0 mp -98.69 -179.75 4.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 pt -129.55 143.41 41.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.176 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.2 pt -140.18 143.09 30.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.76 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -91.75 134.26 34.89 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.335 0.588 . . . . 0.0 111.426 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.37 114.78 47.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.834 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 mm -93.61 134.49 31.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.679 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -154.42 177.97 10.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.44 102.49 14.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.448 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -60.39 -30.68 69.74 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.296 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -64.83 -33.67 76.56 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.619 0.247 . . . . 0.0 111.04 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -87.16 -41.55 13.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.995 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -71.55 -34.72 70.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.42 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.23 93.61 2.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.905 0.383 . . . . 0.0 110.691 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.8 t 61.06 74.9 0.43 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.823 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.89 -55.11 0.02 OUTLIER Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.186 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -117.59 41.7 2.78 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.796 0.332 . . . . 0.0 111.139 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.7 t -66.77 154.44 40.77 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.472 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 p -78.79 137.33 58.15 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.406 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.84 127.52 25.9 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 123.009 2.473 . . . . 0.0 112.548 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 72.85 153.17 0.15 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.187 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.58 81.1 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.371 2.047 . . . . 0.0 112.071 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.84 113.82 26.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.253 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.0 37.28 0.35 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -103.29 126.79 50.63 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.9 pttt -137.58 76.88 1.6 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.289 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -106.9 38.43 2.09 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.762 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.71 70.85 9.78 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.092 0.472 . . . . 0.0 111.04 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.1 t -129.04 108.38 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.991 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -73.67 109.32 7.08 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.801 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 70.28 150.31 0.09 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -158.61 -62.26 0.08 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.321 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 82.1 t60 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.948 0.404 . . . . 0.0 110.853 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.0 177.07 9.04 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.621 0.248 . . . . 0.0 111.631 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.0 m -75.4 80.4 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.154 0.502 . . . . 0.0 111.214 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -77.28 160.32 28.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.418 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -76.44 -62.16 1.71 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.614 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -157.96 141.24 15.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.988 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -94.68 132.66 39.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.471 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.96 141.57 45.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.214 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -69.52 140.14 53.9 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.203 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -55.64 -29.01 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.537 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.97 -32.41 69.61 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.638 0.256 . . . . 0.0 110.809 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.28 -30.6 62.17 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.88 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 11.9 m-85 -64.08 171.32 3.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.3 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -109.35 112.65 24.9 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -65.85 124.1 21.58 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.386 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -100.38 93.82 5.85 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.81 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.49 -26.45 54.28 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.67 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -47.77 -52.97 16.76 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.521 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.9 m -145.27 29.91 1.15 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.73 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.96 70.3 0.57 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.958 0.409 . . . . 0.0 111.458 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.3 m -138.35 154.87 48.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.595 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.93 140.37 51.01 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.6 0.238 . . . . 0.0 110.583 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -131.37 153.72 49.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.602 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.408 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 7.4 t80 -129.55 137.13 30.28 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.25 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 54.6 Cg_endo -69.93 124.17 10.76 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.605 2.203 . . . . 0.0 112.665 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.43 143.47 26.59 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.929 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.08 -17.08 45.75 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.759 2.306 . . . . 0.0 112.851 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.9 p -74.35 -41.16 61.5 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.422 0.153 . . . . 0.0 111.168 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.63 -52.57 0.4 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.917 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.56 -169.59 1.76 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.67 0.235 . . . . 0.0 111.231 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 5.3 m-80 -136.37 142.36 43.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 112.068 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -64.1 162.03 15.05 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.153 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.82 138.89 25.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.774 0.321 . . . . 0.0 111.83 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 tt -152.01 124.39 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.992 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.0 p -72.81 148.84 44.14 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.572 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -58.71 -39.62 81.34 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.768 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -61.11 -39.16 88.96 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.134 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -57.06 -47.98 79.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.692 0.282 . . . . 0.0 110.49 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mt -64.49 -39.15 93.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.876 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.51 -26.4 68.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.579 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -92.97 -36.57 12.68 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.67 -17.2 2.02 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.634 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -67.61 81.13 0.17 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-O 121.219 0.533 . . . . 0.0 110.875 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.64 39.43 1.13 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.519 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.1 p -126.17 130.85 72.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.074 0.464 . . . . 0.0 111.501 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.8 135.08 54.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.714 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 m -111.0 125.87 54.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.562 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 49.4 t -78.63 133.92 62.17 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.812 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.34 45.95 2.11 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.955 2.437 . . . . 0.0 113.328 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.77 -67.93 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.348 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 30.0 p -80.5 -24.96 39.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.484 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.86 37.86 2.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.853 0.359 . . . . 0.0 110.981 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.66 -179.82 6.1 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.713 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.1 pt -128.57 143.36 41.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.863 0.363 . . . . 0.0 111.291 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 pt -142.56 141.27 27.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.975 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.18 135.64 33.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.207 0.527 . . . . 0.0 111.324 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG11 ' CE1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -109.36 113.35 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.033 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 mm -90.51 134.85 28.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' CZ ' ' HE2' ' A' ' 61' ' ' LYS . 22.5 p90 -154.86 174.3 15.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.795 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.37 102.48 12.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.622 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.406 ' HE2' ' CZ ' ' A' ' 59' ' ' TYR . 8.8 mmtp -59.82 -30.49 68.97 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.5 -40.31 89.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.831 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -78.14 -44.2 26.67 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.934 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -68.02 -38.97 83.22 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.442 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -114.73 91.33 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.651 0.263 . . . . 0.0 111.558 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.58 79.13 0.36 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.114 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -104.86 -50.18 0.97 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.379 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.65 33.77 2.86 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.641 0.258 . . . . 0.0 111.226 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.0 t -133.04 154.77 50.23 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.686 0.279 . . . . 0.0 111.133 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.9 t -139.76 141.33 27.39 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.411 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.14 175.81 0.61 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.015 2.477 . . . . 0.0 112.675 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.06 114.85 8.48 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.801 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.89 98.21 0.6 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.625 2.216 . . . . 0.0 111.802 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.7 m 58.41 37.05 25.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.042 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.51 172.3 13.76 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -134.74 161.33 35.47 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.009 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -87.67 103.83 15.96 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.455 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -140.85 37.94 1.8 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.9 35.43 4.11 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.984 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.54 138.52 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.08 115.35 23.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.832 0.348 . . . . 0.0 111.18 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.5 tp -130.61 34.73 4.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.072 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.31 -52.02 0.95 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.904 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 . . . . . 0 C--O 1.231 0.12 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.54 0.21 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.8 157.47 27.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.341 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 t -120.99 31.59 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.36 175.46 5.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.108 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.74 -62.07 1.67 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.832 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -165.42 139.57 4.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.969 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.33 133.07 35.21 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.662 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG12 ' CE1' ' A' ' 24' ' ' TYR . 21.2 t -134.12 141.51 43.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.179 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -67.19 139.9 57.44 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.965 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.7 tp -54.15 -31.16 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.606 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -59.28 -34.14 71.92 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.709 0.29 . . . . 0.0 110.822 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.2 -28.52 62.24 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.136 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 27.4 m-85 -66.12 169.21 7.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.875 0.369 . . . . 0.0 110.974 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -103.32 109.02 20.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -65.75 128.01 34.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.644 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -103.96 94.99 5.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.0 -26.28 59.98 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.357 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.52 -51.66 19.99 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.679 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -152.0 33.61 0.53 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.667 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 52.53 74.32 0.29 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.812 0.339 . . . . 0.0 111.838 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 m -138.48 151.17 47.15 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.791 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -122.02 137.69 54.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.724 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -130.19 156.94 43.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.482 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.449 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 24.8 t80 -141.09 134.33 14.56 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.043 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 24' ' ' TYR . 32.1 Cg_exo -58.19 127.47 25.01 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.903 2.402 . . . . 0.0 113.03 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 2.0 t -102.74 138.04 19.49 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 60.4 Cg_endo -73.11 60.78 3.9 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.665 2.243 . . . . 0.0 112.64 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.1 p -157.16 -47.57 0.07 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.971 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.59 -52.15 0.19 Allowed Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.645 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.46 -179.38 6.07 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.642 0.258 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -127.43 142.41 51.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.722 0.296 . . . . 0.0 111.455 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -58.91 166.86 1.79 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.295 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.1 p -150.97 139.02 20.06 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.611 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 tt -152.22 124.6 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.828 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.0 p -72.1 149.48 44.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 111.347 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -39.3 87.31 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.952 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -61.25 -37.88 84.71 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.236 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -56.41 -43.95 79.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.413 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.0 mt -61.7 -41.77 98.04 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.874 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.57 -28.12 67.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.597 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -85.85 -39.63 16.83 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.22 -13.38 2.55 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.534 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -71.13 81.31 0.7 Allowed 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.088 0.471 . . . . 0.0 110.866 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -96.6 39.95 1.15 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -130.33 128.9 64.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.324 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.92 140.93 47.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.32 132.89 55.94 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.0 t -74.25 133.5 77.93 Favored Pre-proline 0 C--O 1.234 0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.857 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.28 52.93 4.49 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.874 2.382 . . . . 0.0 112.93 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.0 t -164.64 -56.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.445 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.2 p -98.01 -22.83 16.06 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.61 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 t 71.95 41.87 0.64 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 110.444 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mp -77.31 -175.44 3.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.665 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 pt -139.1 143.66 31.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.893 0.377 . . . . 0.0 111.557 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 pt -147.09 147.8 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.908 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -93.2 133.56 36.27 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.252 0.548 . . . . 0.0 111.229 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.25 113.95 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.948 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.7 mm -95.41 135.04 30.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.84 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -156.22 178.42 10.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.984 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 10.9 t0 -80.55 98.04 7.43 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.394 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -61.89 -29.9 70.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.695 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 66' ' ' SER . 1.0 OUTLIER -69.18 -32.6 72.03 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.761 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 17.7 mm-40 -82.92 -45.41 14.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.742 0.306 . . . . 0.0 110.848 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -72.46 -42.57 64.82 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.468 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.6 t -105.5 84.18 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.923 0.392 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 7.4 t -168.47 43.83 0.04 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.766 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -141.31 -50.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.275 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -103.76 33.23 3.49 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.687 0.28 . . . . 0.0 111.308 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.6 m -112.24 80.08 1.29 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.819 0.343 . . . . 0.0 110.487 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -168.99 135.87 1.51 Allowed Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.76 151.02 35.75 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.641 2.227 . . . . 0.0 112.601 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.58 150.46 88.98 Favored Pre-proline 0 C--O 1.231 0.104 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.886 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.16 88.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.94 2.427 . . . . 0.0 112.764 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.6 m 63.38 100.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.815 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.13 154.95 31.27 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.582 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m120 64.93 -179.33 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.618 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -132.62 121.07 22.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.903 0.383 . . . . 0.0 111.291 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -137.12 92.83 2.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.734 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.92 68.29 1.2 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.071 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.8 t -118.13 86.82 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 95.5 10.07 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 132.44 45.89 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.132 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.72 152.13 36.47 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.297 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.9 t60 . . . . . 0 C--O 1.232 0.145 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.735 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.611 0.243 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.09 -66.67 0.61 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.138 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.3 m -63.28 122.77 14.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.967 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.404 ' CD1' HD12 ' A' ' 54' ' ' ILE . 5.2 m-85 -67.33 146.42 54.11 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -64.96 -61.39 2.19 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.692 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -166.95 156.51 10.9 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.73 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.92 136.06 39.45 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.528 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' CZ ' ' A' ' 24' ' ' TYR . 19.7 t -136.66 141.3 41.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.195 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.63 139.91 57.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.084 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -28.84 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.378 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -57.18 -32.05 66.06 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.898 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -76.16 -29.38 57.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.114 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 7.6 m-85 -63.92 174.99 1.29 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.026 0.441 . . . . 0.0 111.251 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -113.95 111.78 22.23 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -64.9 124.91 23.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.655 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -107.36 88.73 2.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.897 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -55.34 -28.21 52.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.267 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.2 -44.56 11.07 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.611 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.1 p -146.51 25.47 1.2 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 50.8 62.89 2.47 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.098 0.475 . . . . 0.0 111.563 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.1 m -138.52 153.29 48.74 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.673 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -113.51 138.76 49.66 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.61 0.243 . . . . 0.0 110.679 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 7.9 m-85 -122.36 149.58 43.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.375 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.44 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 40.8 t80 -127.45 131.56 23.9 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.794 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.15 123.94 14.79 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.717 2.278 . . . . 0.0 112.626 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.36 146.07 32.85 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.601 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.29 -28.27 70.95 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.005 2.47 . . . . 0.0 112.847 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -72.88 -39.25 66.59 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.045 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.31 21.01 6.37 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.193 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 -32.47 9.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.932 0.366 . . . . 0.0 111.399 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 73.89 122.01 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.128 0.49 . . . . 0.0 111.944 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 68.7 m-85 -62.65 165.2 6.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.423 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -143.17 139.39 30.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.819 0.343 . . . . 0.0 111.561 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.0 tt -151.73 122.92 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.705 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 p -71.63 148.56 46.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.379 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -58.94 -39.54 81.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.985 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -60.88 -38.07 84.33 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.6 -47.49 81.99 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.638 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mt -65.0 -36.13 83.42 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.863 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -67.85 -24.77 65.3 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.499 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -94.83 -35.82 11.91 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.91 -16.32 2.38 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.46 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.63 81.8 0.18 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-O 121.036 0.445 . . . . 0.0 110.606 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -96.64 38.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.749 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.48 132.61 70.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.946 0.403 . . . . 0.0 111.278 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -112.74 130.3 56.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.962 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.2 132.91 56.46 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.046 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.96 143.65 53.75 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.629 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -79.42 1.83 8.86 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.621 2.214 . . . . 0.0 113.277 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.1 t -120.36 -68.75 0.89 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.395 0.14 . . . . 0.0 111.038 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -75.0 -24.98 58.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.381 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 m 64.67 40.69 5.7 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 110.851 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 mt -81.05 -178.68 7.0 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.768 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.404 HD12 ' CD1' ' A' ' 4' ' ' PHE . 14.4 pt -135.82 143.19 37.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.351 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 pt -147.62 144.91 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.902 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -92.74 133.97 35.5 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.293 0.568 . . . . 0.0 111.477 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.62 113.94 45.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.158 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.0 mm -92.55 134.9 29.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.668 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -153.44 178.63 9.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.477 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -86.5 105.89 17.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.893 0.377 . . . . 0.0 110.7 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -60.28 -29.33 68.74 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.093 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -68.15 -41.76 81.09 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.91 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -76.28 -47.93 21.97 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.238 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -69.99 -35.36 74.34 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.321 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 t -125.12 93.33 2.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.94 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 t -95.47 42.66 1.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.944 0.402 . . . . 0.0 110.951 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -136.28 -58.75 0.06 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.961 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -121.31 42.51 3.06 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.734 0.302 . . . . 0.0 111.044 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 t -63.79 152.08 40.42 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.834 0.349 . . . . 0.0 110.967 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.8 p -161.07 136.29 5.66 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.41 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.1 -174.37 2.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.841 2.36 . . . . 0.0 112.322 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.73 150.03 18.82 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.534 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.17 -179.84 3.87 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.821 2.348 . . . . 0.0 112.427 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -152.32 126.67 9.3 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.13 -60.4 2.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -162.65 154.18 17.97 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.99 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -134.35 117.08 15.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.041 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.82 103.82 3.66 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.74 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -175.91 130.11 0.24 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -112.98 137.31 46.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -78.36 114.66 17.46 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.804 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.66 119.18 20.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -138.48 35.14 2.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.067 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.905 0.383 . . . . 0.0 110.781 179.84 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mtt . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.21 93.75 1.11 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 111.135 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.23 148.35 24.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.856 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' CD1' HD12 ' A' ' 54' ' ' ILE . 7.8 m-85 -61.22 125.69 24.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -59.57 -64.41 0.95 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -156.99 161.05 39.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.912 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 56' ' ' LYS . 23.4 mt-10 -99.87 135.57 41.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.488 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.454 HG11 ' CE1' ' A' ' 24' ' ' TYR . 21.4 t -130.72 140.95 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.189 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -73.86 139.8 45.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.994 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -57.21 -28.72 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.576 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.92 -33.44 71.88 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.573 0.225 . . . . 0.0 110.681 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -74.92 -29.98 61.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.779 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 24' ' ' TYR . 6.1 m-85 -62.38 172.61 1.45 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.301 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -115.03 108.52 16.79 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -66.13 135.88 55.18 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.525 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -113.11 97.14 6.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.609 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -57.74 -26.09 61.33 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -48.16 -52.91 18.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.428 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -146.65 30.84 0.98 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.648 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 52.32 71.75 0.45 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 111.482 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 m -137.94 143.54 40.8 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.512 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -113.68 138.84 49.65 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -128.71 157.05 42.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.625 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.454 ' CE1' HG11 ' A' ' 8' ' ' VAL . 22.0 t80 -138.09 135.54 18.69 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.091 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 32.2 Cg_exo -58.3 124.44 15.88 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.79 2.326 . . . . 0.0 112.559 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.432 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.8 144.17 27.69 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.45 -17.14 43.88 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.612 2.208 . . . . 0.0 112.84 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.8 p -77.86 -33.15 52.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.248 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.06 -47.72 0.65 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.623 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 -163.25 0.37 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.538 0.209 . . . . 0.0 110.954 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 5.6 m-80 -140.39 139.41 35.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.728 0.299 . . . . 0.0 110.848 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.432 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 22.7 m-85 -62.61 162.6 10.29 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.978 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m -144.13 139.22 28.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.793 0.33 . . . . 0.0 111.638 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.8 tt -151.95 124.38 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.752 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 p -72.08 148.56 45.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.368 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -38.91 85.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.854 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -36.89 81.23 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.169 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.14 -48.0 83.21 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.532 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.2 -36.61 84.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.99 -32.46 73.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.303 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -89.49 -34.38 16.43 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.15 -12.54 3.06 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.57 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.05 79.17 0.23 Allowed 'General case' 0 C--N 1.343 0.283 0 CA-C-O 121.135 0.493 . . . . 0.0 110.728 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -95.02 39.37 1.11 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.408 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.2 p -124.24 133.81 68.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.256 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.75 137.0 51.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.391 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 130.58 56.18 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.1 t -93.08 133.36 28.9 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.423 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.07 -4.59 15.62 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.629 2.219 . . . . 0.0 113.241 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.81 -65.92 0.96 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.528 0.204 . . . . 0.0 111.262 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -80.45 -26.28 38.44 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m 66.81 42.92 2.45 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.935 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -100.51 179.69 4.36 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.851 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.413 HD12 ' CD1' ' A' ' 4' ' ' PHE . 13.5 pt -128.98 143.43 41.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.185 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 pt -141.79 147.98 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.014 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HB3' ' HG2' ' A' ' 7' ' ' GLU . 1.9 tppp? -93.17 134.58 35.2 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.334 0.588 . . . . 0.0 111.381 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.79 113.2 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.826 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.56 134.29 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -155.12 178.62 9.99 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.894 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 5.6 t70 -92.42 93.82 8.79 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.73 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -57.68 -31.15 66.08 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.288 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -34.92 79.51 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.762 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 2.3 mt-30 -84.3 -36.37 22.66 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.769 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -61.75 -61.13 2.73 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.434 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -112.17 94.61 3.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.349 0.595 . . . . 0.0 111.229 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.22 32.85 2.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.83 -92.83 1.01 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.15 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.73 78.56 1.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 0.0 111.034 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 t -97.32 97.28 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.713 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.11 138.35 19.27 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.192 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.76 140.68 77.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.806 2.338 . . . . 0.0 112.654 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 71.38 159.33 0.16 Allowed Pre-proline 0 N--CA 1.467 0.392 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.329 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.54 156.23 58.24 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.429 2.086 . . . . 0.0 112.575 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.2 m -107.12 -45.76 4.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.128 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.93 138.85 32.97 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.298 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -103.14 -34.94 8.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -160.37 113.25 2.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.988 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -136.62 102.37 4.9 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.118 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -173.44 129.17 0.44 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.53 117.54 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.129 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -113.12 104.51 12.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.008 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.67 143.77 32.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.044 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.21 117.94 17.06 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.956 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 . . . . . 0 N--CA 1.465 0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.959 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.676 0.274 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.38 33.16 3.01 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.254 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.9 m -120.32 25.49 4.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.176 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 59.45 178.67 0.08 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.961 0.41 . . . . 0.0 111.295 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -96.77 -62.54 1.25 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -167.82 144.67 4.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.752 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -93.28 124.21 37.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.461 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.432 HG13 ' CE1' ' A' ' 24' ' ' TYR . 30.2 t -121.67 141.51 41.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.229 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -69.48 140.07 53.97 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.141 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 tp -56.81 -29.83 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.754 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -59.44 -34.02 71.99 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.691 0.281 . . . . 0.0 110.816 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -72.54 -34.03 67.26 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -59.04 159.49 7.16 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.433 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.71 87.62 4.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.323 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.534 ' HB2' ' CE2' ' A' ' 22' ' ' TYR . 83.9 t80 -72.64 150.04 43.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.908 0.385 . . . . 0.0 111.017 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.48 135.15 47.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.636 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.26 -31.72 26.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.554 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.22 -34.39 42.89 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.805 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.6 t -96.02 -29.5 14.1 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.875 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 61.37 39.57 15.15 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.081 0.467 . . . . 0.0 110.73 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.8 m -142.04 146.11 35.12 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.418 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.534 ' CE2' ' HB2' ' A' ' 15' ' ' TYR . 65.0 m-85 -98.83 140.73 32.58 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.709 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -127.96 156.46 42.63 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.454 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.432 ' CE1' HG13 ' A' ' 8' ' ' VAL . 23.1 t80 -148.91 136.86 11.37 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.146 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.444 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 37.2 Cg_endo -65.47 130.73 25.89 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.656 2.237 . . . . 0.0 112.731 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.75 144.95 28.73 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.818 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.91 -25.78 63.98 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.927 2.418 . . . . 0.0 112.912 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -74.91 -40.54 60.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.31 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.27 -46.17 0.55 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.609 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.69 -178.76 2.35 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.524 0.202 . . . . 0.0 110.66 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 35.8 m-20 -127.73 138.14 52.68 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.713 0.292 . . . . 0.0 111.095 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -65.34 169.19 6.08 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.511 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 p -152.18 139.14 19.05 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.4 tt -150.99 124.5 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.28 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 p -71.72 149.36 45.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.197 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -56.29 -36.61 68.83 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.641 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.09 -39.29 89.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.287 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.46 -47.82 78.37 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.76 0.314 . . . . 0.0 110.988 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.73 -42.44 98.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -68.16 -30.28 69.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.275 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -82.27 -39.76 22.51 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.94 -13.99 2.62 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.64 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -69.46 80.19 0.39 Allowed 'General case' 0 C--N 1.341 0.224 0 CA-C-O 120.902 0.382 . . . . 0.0 110.941 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.37 40.32 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.76 137.94 54.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.319 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.12 132.27 55.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.764 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -113.56 132.6 55.66 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.147 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.1 t -89.81 134.43 32.1 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.572 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.98 0.04 10.09 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.668 2.245 . . . . 0.0 113.439 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.69 -65.28 1.1 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.512 0.196 . . . . 0.0 111.272 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.1 p -88.18 -22.86 23.8 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t 69.36 42.77 1.13 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.078 0.465 . . . . 0.0 110.784 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mp -88.74 179.54 6.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.744 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.0 pt -132.24 143.31 40.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.271 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.0 pt -143.85 146.74 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.935 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.16 136.01 33.38 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.297 0.57 . . . . 0.0 111.248 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.19 114.05 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.867 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.3 mm -93.62 135.39 28.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.787 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -157.98 176.47 12.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.058 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 6.6 t0 -88.94 94.38 9.92 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -59.09 -33.1 70.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.822 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.09 -30.24 71.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.035 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 1.9 mm-40 -89.49 -33.41 16.79 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.636 0.255 . . . . 0.0 110.769 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.82 -64.02 0.96 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.244 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.74 96.02 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.24 0.543 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.3 t -157.34 84.44 0.92 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.634 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -149.82 -65.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.142 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -103.07 37.4 1.98 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.69 0.281 . . . . 0.0 110.673 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -130.68 120.7 24.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.666 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.87 140.42 93.52 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.344 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.86 171.61 1.0 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.988 2.459 . . . . 0.0 112.844 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.98 150.2 73.75 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.993 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.79 168.38 21.75 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.023 2.482 . . . . 0.0 112.643 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 p -96.41 142.64 28.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.328 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 71.83 -70.4 0.16 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.95 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -153.47 165.76 34.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.557 0.218 . . . . 0.0 110.876 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -70.24 127.9 34.37 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.652 0.263 . . . . 0.0 110.701 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.86 118.43 30.77 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.878 0.371 . . . . 0.0 111.371 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.54 33.03 0.56 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.243 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 p -116.36 129.55 72.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.012 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -108.51 73.36 0.87 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.818 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mt -148.27 167.35 25.38 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.054 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.44 -52.78 8.53 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 . . . . . 0 N--CA 1.461 0.119 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.817 179.767 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.662 0.268 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.19 153.56 24.7 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.309 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p -105.37 148.93 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.413 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -80.47 167.96 19.53 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -78.38 -60.32 2.42 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.877 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -160.63 161.12 32.37 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.002 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -110.69 132.99 53.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.466 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.7 141.54 36.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.12 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.13 139.71 57.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.006 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -56.62 -29.57 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.926 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.46 -30.54 69.74 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.592 0.234 . . . . 0.0 110.991 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.43 -31.13 65.23 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.06 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 7.6 m-85 -61.93 156.73 20.21 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.977 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -92.96 83.65 4.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.414 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.455 ' HB2' ' CE2' ' A' ' 22' ' ' TYR . 76.5 t80 -67.38 153.46 43.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.966 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.82 99.18 2.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.299 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.15 -31.8 20.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.01 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -53.23 -43.1 67.03 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.066 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 t -107.22 -18.86 13.77 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 63.85 42.59 5.93 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 110.524 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.2 m -142.9 146.35 33.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.819 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 15' ' ' TYR . 81.6 m-85 -101.46 141.15 34.76 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.739 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -127.41 149.07 50.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.388 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.442 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 12.6 t80 -131.52 137.13 29.77 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.175 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.78 124.24 10.04 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.639 2.226 . . . . 0.0 112.58 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.47 145.2 29.26 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.724 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.29 -18.6 50.35 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.617 2.211 . . . . 0.0 112.83 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.0 p -76.77 -33.95 58.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.183 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.25 -45.53 0.79 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.546 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 0.4 OUTLIER -74.02 -173.33 1.57 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.704 0.288 . . . . 0.0 110.876 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -139.51 133.16 30.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.675 0.274 . . . . 0.0 111.405 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -61.16 159.06 12.63 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.847 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 p -146.33 139.21 25.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 111.603 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -152.02 125.58 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.556 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.0 p -71.53 151.95 43.42 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.274 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -57.46 -37.15 72.42 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.734 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -60.86 -38.15 84.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.034 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.17 -47.96 81.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.804 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.69 -42.04 98.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.862 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.59 -29.73 69.16 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.4 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -84.23 -40.98 17.41 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.74 -13.79 2.2 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.715 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -68.68 79.2 0.29 Allowed 'General case' 0 C--N 1.343 0.297 0 CA-C-O 121.044 0.449 . . . . 0.0 110.877 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 p30 -94.07 39.47 1.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.639 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.5 p -129.58 132.07 66.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.16 138.63 49.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.632 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.0 m -117.57 132.1 56.58 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.3 t -89.97 133.91 32.84 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.569 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.53 -4.76 15.98 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.595 2.196 . . . . 0.0 113.385 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -104.01 -67.03 0.92 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.517 0.199 . . . . 0.0 111.149 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.3 p -80.68 -26.83 37.32 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.716 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.46 40.36 2.66 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.999 0.428 . . . . 0.0 110.902 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 mt -93.87 -179.84 5.11 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.707 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.9 pt -126.13 143.51 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.185 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 pt -141.66 144.2 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.15 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -91.68 133.82 35.24 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.282 0.563 . . . . 0.0 111.412 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.32 113.18 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.908 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mm -91.22 134.46 29.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.058 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -155.19 176.55 12.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.619 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.37 99.43 12.45 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.835 0.35 . . . . 0.0 110.801 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -60.32 -29.99 69.22 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.102 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.95 -36.2 83.63 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.739 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -82.26 -44.51 16.21 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.865 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -64.16 -38.09 89.79 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.132 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.3 t -112.37 84.9 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.95 0.405 . . . . 0.0 110.983 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.1 p -108.77 40.9 1.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.994 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.32 -67.25 1.72 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.073 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -116.02 79.62 1.33 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.809 0.337 . . . . 0.0 111.487 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.0 m -153.92 126.52 8.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.48 140.39 21.27 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.022 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.03 -178.0 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.965 2.443 . . . . 0.0 112.723 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.64 144.42 13.22 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.602 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.25 51.94 4.11 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.772 2.315 . . . . 0.0 112.275 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.69 -73.15 0.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.257 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -176.03 178.88 1.38 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.027 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -99.12 -42.95 6.84 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.135 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -174.43 121.27 0.26 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.171 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -157.48 95.51 1.46 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.022 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.39 33.18 5.69 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.04 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.47 23.86 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.069 0.461 . . . . 0.0 111.273 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -156.97 90.89 1.16 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.113 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tp 65.25 106.48 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.466 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -121.39 132.9 55.02 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.999 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 m80 . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 121.11 0.481 . . . . 0.0 111.018 179.429 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.758 0.313 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.8 94.68 2.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.04 78.44 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.054 0.455 . . . . 0.0 111.448 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -101.23 175.26 5.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.303 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -88.29 -62.35 1.51 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.947 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -159.53 155.57 26.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.074 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -103.09 134.76 45.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.669 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -134.68 139.93 46.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.042 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -67.13 140.07 57.52 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.989 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -56.76 -29.73 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.495 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -58.99 -33.24 70.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.703 0.287 . . . . 0.0 110.686 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.86 -29.6 65.76 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.156 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 11.2 m-85 -66.54 172.33 4.22 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.134 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.87 110.31 22.44 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.736 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -66.84 112.02 4.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.877 0.37 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -94.02 87.38 5.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.442 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -56.01 -28.55 57.74 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.354 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -47.23 -43.91 22.22 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.278 0.361 . . . . 0.0 111.498 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.0 m -143.93 28.06 1.43 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.647 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 46.98 62.52 2.34 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.898 0.38 . . . . 0.0 111.645 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.2 m -137.8 151.7 48.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -112.97 139.54 48.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.528 0.204 . . . . 0.0 110.758 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -128.9 153.84 47.1 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.466 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 4.4 t80 -134.63 137.14 26.89 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 52.1 Cg_endo -69.38 126.58 13.74 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.573 2.182 . . . . 0.0 112.947 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -98.84 142.28 24.33 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 35.3 Cg_endo -64.97 -18.5 62.38 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.733 2.289 . . . . 0.0 113.045 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.7 p -76.36 -41.48 48.04 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.338 0.113 . . . . 0.0 111.168 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.42 -55.46 0.33 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.968 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.93 -175.82 3.18 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.596 0.236 . . . . 0.0 111.039 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 48.7 m-20 -129.89 144.24 51.22 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.854 0.359 . . . . 0.0 111.506 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -66.27 168.94 7.89 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.646 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.4 p -153.1 139.2 18.27 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 111.736 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.6 tt -151.97 123.49 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.778 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.5 p -72.1 151.77 42.83 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 111.386 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -60.18 -38.83 84.41 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.826 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.86 -38.13 84.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.231 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -57.14 -48.05 79.63 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.684 0.278 . . . . 0.0 110.582 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.5 mt -61.4 -46.9 88.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.807 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -59.76 -27.18 66.3 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.665 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -89.98 -38.42 13.65 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.68 -4.6 3.04 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.844 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -76.55 79.92 3.23 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.125 0.488 . . . . 0.0 109.788 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.95 35.88 0.97 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.464 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -124.02 132.08 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.46 128.99 56.41 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.4 m -107.34 131.78 53.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.094 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 t -86.44 134.7 37.57 Favored Pre-proline 0 C--O 1.234 0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -82.48 40.77 1.01 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.771 2.314 . . . . 0.0 113.231 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.61 -59.09 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.328 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.7 p -93.38 -20.44 20.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.843 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m 67.23 37.89 3.51 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.975 0.417 . . . . 0.0 110.987 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.5 tp -89.11 160.79 16.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.959 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 pt -114.66 143.3 24.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.826 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.8 pt -143.43 147.26 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.029 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -93.19 134.75 35.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.301 0.572 . . . . 0.0 111.328 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.15 113.11 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.076 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.5 mm -91.63 134.95 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -151.17 -178.63 6.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -89.88 99.94 12.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.599 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -61.23 -31.13 70.91 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.941 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.04 -34.83 79.37 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.753 0.311 . . . . 0.0 110.614 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -85.27 -46.22 11.23 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.304 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -65.62 -51.35 60.33 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.694 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.17 77.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.059 0.457 . . . . 0.0 111.068 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.25 93.36 0.13 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.763 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.46 -60.95 0.56 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.424 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -97.16 31.89 2.32 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.657 0.265 . . . . 0.0 111.321 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.1 m -139.65 118.61 12.55 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.661 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 t -105.71 139.45 20.22 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.212 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -56.89 156.43 23.68 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.865 2.377 . . . . 0.0 112.542 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 74.52 157.99 0.16 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.223 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.17 138.49 36.63 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.462 2.108 . . . . 0.0 112.585 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.0 t -101.59 114.98 29.5 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.32 166.55 12.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.368 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -96.75 -37.62 10.22 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.522 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.55 104.76 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.58 0.352 . . . . 0.0 111.596 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -136.89 103.75 5.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.191 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.48 44.19 0.53 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.944 0.402 . . . . 0.0 111.027 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.78 152.42 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.209 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 mttt 64.77 78.28 0.29 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.046 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 tt -146.41 65.52 1.19 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 62.65 168.08 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.028 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 . . . . . 0 N--CA 1.463 0.206 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.91 179.574 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmm . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.685 0.279 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.76 93.95 0.33 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 m -92.02 143.89 10.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.173 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.404 ' CD1' HD12 ' A' ' 54' ' ' ILE . 4.2 m-85 -66.6 140.9 57.97 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.967 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -68.63 -63.77 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -157.09 162.64 39.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.038 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.409 ' CG ' ' HB3' ' A' ' 56' ' ' LYS . 1.5 mp0 -112.46 134.89 53.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.743 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.8 141.28 42.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 111.078 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -68.58 139.89 55.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.032 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 tp -54.6 -29.42 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.406 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -58.71 -32.87 69.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.637 0.256 . . . . 0.0 110.837 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.11 -30.82 63.92 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.914 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 15.0 m-85 -63.94 170.04 3.8 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.859 0.361 . . . . 0.0 111.349 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 23' ' ' PHE . 5.9 tt0 -107.02 112.98 26.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.63 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -66.02 116.44 7.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.581 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -95.02 88.49 5.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.539 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.84 -28.31 48.82 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.318 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.62 -47.08 10.41 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.33 0.394 . . . . 0.0 111.382 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 m -147.62 29.93 0.92 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.583 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 48.64 68.96 0.61 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.098 0.475 . . . . 0.0 111.485 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.4 m -138.8 157.73 45.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.86 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -121.9 139.72 53.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.603 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 14' ' ' GLN . 4.4 p90 -137.08 152.06 49.59 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.43 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.444 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 1.3 t80 -127.86 139.33 35.02 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.303 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HA ' ' ND2' ' A' ' 31' ' ' ASN . 37.3 Cg_endo -65.56 124.51 12.94 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.719 2.279 . . . . 0.0 112.763 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.96 144.6 28.32 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.835 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.62 -17.38 48.07 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.632 2.221 . . . . 0.0 112.945 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.0 p -75.94 -41.11 52.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.181 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.02 -59.38 0.3 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.751 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.93 -174.0 1.73 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.782 0.325 . . . . 0.0 110.999 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 3.0 m120 -128.42 142.36 51.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.662 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -61.76 171.9 1.46 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.576 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.0 p -154.31 139.17 17.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 111.737 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 tt -152.07 125.06 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.684 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -72.15 148.65 45.44 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.437 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -59.58 -40.21 86.65 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -60.62 -38.35 84.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.943 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -57.33 -47.74 80.78 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.694 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.5 mt -63.42 -43.17 98.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.073 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.38 -28.29 69.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.572 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -88.14 -37.84 15.85 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.79 -0.186 . . . . 0.0 111.363 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.68 -15.39 2.44 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.563 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -68.09 80.63 0.22 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-O 121.215 0.531 . . . . 0.0 110.616 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -96.54 40.09 1.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.566 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -125.77 130.97 72.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.254 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.75 134.91 54.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.353 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 m -116.23 131.92 56.81 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.2 t -88.59 133.79 35.46 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.66 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.89 1.76 8.85 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.689 2.26 . . . . 0.0 112.912 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 t -106.66 -54.51 2.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.553 0.216 . . . . 0.0 111.039 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.6 p -98.15 -20.7 17.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.94 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m 65.04 43.82 3.61 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.005 0.431 . . . . 0.0 110.815 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.4 mt -96.47 -179.79 4.74 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.723 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.404 HD12 ' CD1' ' A' ' 4' ' ' PHE . 14.1 pt -129.04 143.37 41.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.129 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 pt -144.38 145.22 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.018 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HB3' ' CG ' ' A' ' 7' ' ' GLU . 13.7 tptp -92.91 134.7 34.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.348 0.594 . . . . 0.0 111.421 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.71 113.27 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.74 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mm -91.12 134.87 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.015 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -152.39 179.28 8.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.221 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -81.28 99.4 8.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.456 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -60.86 -31.16 70.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.112 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -65.16 -31.28 72.39 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.993 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -95.76 -32.04 12.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.398 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -81.3 -61.96 1.8 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.643 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 p -113.85 87.6 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.206 0.526 . . . . 0.0 111.776 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -154.0 39.68 0.48 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.273 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -127.08 -84.99 0.52 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.017 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -99.2 37.63 1.52 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.793 0.33 . . . . 0.0 110.983 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.9 t -85.08 107.66 17.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.995 0.426 . . . . 0.0 110.768 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.21 135.38 11.85 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.212 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.81 123.98 7.79 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.776 2.318 . . . . 0.0 112.803 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -171.2 150.22 2.81 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.414 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.6 110.7 2.79 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.631 2.221 . . . . 0.0 112.192 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.9 m 57.42 41.48 26.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.172 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.6 139.09 35.77 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.404 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -104.29 -36.61 7.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.005 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -171.56 147.22 2.31 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.03 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -119.2 90.88 3.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.139 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -173.18 128.93 0.46 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.178 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 t -107.6 38.2 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.662 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -93.87 107.85 19.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 tp -123.78 31.82 5.76 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.17 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -135.1 82.01 1.93 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.775 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.9 t60 . . . . . 0 N--CA 1.464 0.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.12 -179.76 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.7 0.286 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.92 143.57 29.62 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.025 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.5 82.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.46 161.25 20.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.398 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -83.17 -58.95 2.63 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.869 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -157.72 162.77 38.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.273 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -110.53 134.82 52.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.575 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.403 HG12 ' CE1' ' A' ' 24' ' ' TYR . 21.5 t -134.61 140.52 45.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.212 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -67.71 139.82 56.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.102 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 tp -56.91 -30.17 32.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.91 -32.45 70.76 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.632 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.95 -29.92 66.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 9.5 m-85 -65.04 170.78 4.09 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.866 0.365 . . . . 0.0 111.194 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.75 109.6 21.54 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.715 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -66.28 118.73 10.39 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.769 0.319 . . . . 0.0 110.464 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.95 91.39 4.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.839 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.27 -29.06 60.63 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.176 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -48.23 -37.99 17.38 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.3 t -151.09 28.24 0.67 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 46.44 68.15 0.66 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.94 0.4 . . . . 0.0 111.748 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.4 m -137.53 155.04 49.7 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -117.56 139.42 50.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.75 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -130.96 153.07 49.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.261 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.406 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 17.0 t80 -133.0 133.74 23.58 Favored Pre-proline 0 N--CA 1.463 0.196 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 32.4 Cg_exo -58.17 124.09 15.13 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.681 2.254 . . . . 0.0 112.479 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -99.05 143.74 26.94 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.699 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.29 -16.66 44.17 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.756 2.304 . . . . 0.0 113.029 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.9 p -77.16 -33.0 56.64 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.494 0.187 . . . . 0.0 111.214 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.17 -47.65 0.63 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.361 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -80.24 -168.89 1.84 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.282 0.233 . . . . 0.0 110.682 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 48.0 m-20 -135.35 141.95 45.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.666 0.269 . . . . 0.0 110.654 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.425 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 31.6 m-85 -62.68 168.58 3.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.807 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.9 p -150.27 139.34 21.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.754 0.311 . . . . 0.0 111.66 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.8 tt -152.58 124.44 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.615 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 p -72.28 148.72 45.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.767 0.318 . . . . 0.0 111.469 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -59.73 -37.7 79.66 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.036 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -60.95 -38.6 86.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.983 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -57.05 -47.53 80.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.575 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.5 mt -59.87 -46.74 88.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.865 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -60.01 -27.95 67.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.645 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -88.25 -37.53 15.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.59 -4.72 3.7 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.925 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -75.08 78.45 2.25 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.113 0.482 . . . . 0.0 110.156 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -92.18 36.82 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.302 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -124.83 131.02 73.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.935 0.397 . . . . 0.0 111.702 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.0 131.85 55.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.431 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.8 m -115.7 130.36 56.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.9 t -92.75 118.55 67.98 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.154 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.01 -18.85 24.02 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.935 2.424 . . . . 0.0 113.293 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 m -82.45 -74.34 0.35 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.405 0.15 . . . . 0.0 111.405 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.1 p -76.61 -25.07 53.48 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.36 40.73 2.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.114 0.483 . . . . 0.0 110.644 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mp -95.01 -178.45 4.49 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.756 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.4 pt -129.38 143.5 40.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.361 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 pt -143.38 146.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.945 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -92.59 136.44 33.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.236 0.541 . . . . 0.0 111.401 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.56 112.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.957 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.8 mm -91.37 134.2 30.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.849 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.08 -177.9 6.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.664 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.13 101.29 14.01 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 110.814 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -60.29 -31.07 69.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.93 -33.74 76.75 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.956 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -82.84 -42.09 18.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.941 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -72.39 -72.93 0.21 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.15 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.72 93.51 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.206 0.527 . . . . 0.0 111.507 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.77 36.84 1.84 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.448 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.74 -81.14 0.23 Allowed Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.002 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -102.81 36.22 2.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.2 t -66.59 106.43 1.79 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.024 0.44 . . . . 0.0 111.027 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 t -148.08 140.73 14.86 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.068 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.16 176.71 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.975 2.45 . . . . 0.0 112.814 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.73 157.59 65.89 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.691 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.24 130.74 20.53 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.803 2.335 . . . . 0.0 112.84 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.0 39.64 0.1 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.227 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.12 -72.71 0.53 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.133 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 62.23 104.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.411 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -127.96 141.93 51.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.343 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -130.13 119.21 22.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.142 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.34 127.33 0.96 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.05 109.81 29.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.121 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -95.75 114.06 25.76 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.897 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.7 mt -113.02 123.01 49.33 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.983 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -138.18 101.07 4.3 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.941 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 . . . . . 0 N--CA 1.462 0.168 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.052 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.934 0.397 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.8 179.59 4.16 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.492 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 m -87.81 144.47 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.473 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 62.4 174.31 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.365 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -89.48 -61.37 1.71 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.739 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.37 161.9 14.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.037 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -109.8 123.77 50.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.3 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.99 141.56 46.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.099 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -67.49 140.06 57.04 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.204 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -55.51 -29.73 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.611 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.82 -31.85 68.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.647 0.26 . . . . 0.0 110.784 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -75.0 -29.08 60.77 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.023 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 7.4 m-85 -64.62 173.02 2.35 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.098 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -104.7 106.59 17.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.786 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -65.48 131.3 46.06 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.49 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -113.29 89.78 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.623 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -57.57 -26.83 62.02 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.609 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.92 -50.67 34.14 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.632 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.33 28.44 1.67 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.596 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 50.48 70.37 0.52 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.51 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -139.21 153.36 47.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.652 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -121.95 139.64 53.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.615 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -128.69 151.99 48.9 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.478 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.424 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 12.0 t80 -129.02 136.81 29.76 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.117 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.446 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 39.6 Cg_endo -67.39 124.26 11.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.534 2.156 . . . . 0.0 112.52 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -100.66 145.15 29.84 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.844 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.9 -16.09 36.82 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.646 2.231 . . . . 0.0 112.969 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.4 p -76.64 -40.21 49.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.53 0.205 . . . . 0.0 111.111 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.12 -55.37 0.37 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.613 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.71 -174.41 2.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.579 0.228 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 65.3 m-20 -130.91 141.61 50.31 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.765 0.317 . . . . 0.0 111.232 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.401 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 34.0 m-85 -61.45 164.96 5.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.706 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 p -147.37 138.94 23.98 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 111.527 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 tt -152.3 124.79 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.76 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.0 p -72.03 149.61 44.75 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 111.263 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -39.16 83.77 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.898 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -60.98 -39.99 91.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.039 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.52 -47.55 79.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.633 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -63.82 -40.66 97.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -64.08 -27.48 69.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.476 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -90.54 -37.32 13.93 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.99 -18.4 1.96 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 121.138 -0.554 . . . . 0.0 112.369 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -66.43 80.24 0.1 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.153 0.501 . . . . 0.0 110.93 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -96.66 39.94 1.15 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.515 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.79 129.97 72.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.365 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.97 132.35 55.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.476 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.4 m -112.59 131.52 55.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.3 t -92.4 115.88 65.51 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.535 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.14 -19.23 20.06 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.737 2.291 . . . . 0.0 113.311 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -83.41 -75.11 0.34 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.14 -26.9 56.77 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.35 41.24 1.04 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.074 0.464 . . . . 0.0 110.816 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -94.99 -179.95 5.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.647 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.6 pt -126.39 143.56 39.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.057 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 pt -143.66 143.13 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.775 0.321 . . . . 0.0 111.167 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -91.52 133.64 35.34 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.421 0.629 . . . . 0.0 111.41 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.05 113.53 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.985 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.0 mm -91.34 134.71 29.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.076 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -154.98 179.54 9.03 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.899 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -84.78 99.79 11.11 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.501 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -60.86 -29.6 69.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.34 -33.15 75.28 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.632 0.253 . . . . 0.0 110.911 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -93.56 -40.72 10.15 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.143 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -74.26 -58.59 3.2 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.724 0.297 . . . . 0.0 111.047 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 t -78.79 82.69 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.168 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 99.5 p -93.28 92.25 7.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.911 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.17 -95.85 0.13 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.327 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.8 33.25 2.6 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 111.227 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -139.37 128.46 23.79 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.73 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 19.3 t -99.11 140.66 21.86 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.038 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 70' ' ' VAL . 32.4 Cg_exo -57.87 175.5 0.44 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.835 2.356 . . . . 0.0 112.686 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.62 151.12 53.0 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.854 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.21 150.73 65.88 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.984 2.456 . . . . 0.0 112.58 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.0 m -151.31 157.91 43.12 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.363 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.27 145.6 31.41 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.297 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -127.21 36.8 4.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.015 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.54 37.6 4.38 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.053 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -88.1 95.56 10.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.038 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.44 36.43 4.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.75 107.61 19.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.076 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.5 tttp 62.53 88.51 0.09 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.337 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.57 144.67 30.2 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.054 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -146.6 170.1 17.61 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.955 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.921 -179.986 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.778 0.323 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.8 -171.58 0.22 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.4 t 69.37 57.58 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.09 0.471 . . . . 0.0 110.382 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.426 ' CD1' HD12 ' A' ' 54' ' ' ILE . 1.5 m-85 57.42 -176.05 0.07 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.074 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -103.47 -59.54 1.7 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.799 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -167.35 158.43 11.71 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.814 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -100.23 135.0 42.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.543 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.429 HG12 ' CE1' ' A' ' 24' ' ' TYR . 23.9 t -136.22 139.96 44.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.749 0.309 . . . . 0.0 111.198 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -72.87 139.87 47.19 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.98 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -57.19 -29.82 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.765 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -58.68 -32.49 69.18 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.714 0.292 . . . . 0.0 110.875 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.87 -30.5 64.02 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.198 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 14.2 m-85 -64.3 157.28 26.46 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.201 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -96.34 87.9 4.6 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.49 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.435 ' HB2' ' CE2' ' A' ' 22' ' ' TYR . 76.5 t80 -66.47 152.36 45.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.63 101.71 3.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.535 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -52.04 -30.24 24.67 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.098 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -51.61 -47.79 63.49 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.223 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.3 m -108.33 -17.63 13.95 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.068 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 64.25 44.53 4.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.053 0.454 . . . . 0.0 110.651 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.5 m -140.3 149.8 43.23 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.746 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 15' ' ' TYR . 67.4 m-85 -105.42 141.19 37.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.888 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -129.08 157.67 41.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.481 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.429 ' CE1' HG12 ' A' ' 8' ' ' VAL . 3.2 t80 -139.28 138.0 19.99 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.445 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 37.0 Cg_endo -65.6 124.03 12.24 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.59 2.193 . . . . 0.0 112.551 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -97.84 144.42 27.98 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.807 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.88 -17.22 46.75 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.705 2.27 . . . . 0.0 112.884 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.1 p -76.54 -38.18 55.47 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.559 0.219 . . . . 0.0 111.105 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.45 -49.41 0.49 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.681 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.98 -171.18 2.51 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.595 0.236 . . . . 0.0 110.763 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 61.1 m-20 -132.42 141.76 48.99 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.643 0.259 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.4 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 24.9 m-85 -63.97 168.36 5.29 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 p -151.39 139.43 20.09 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.786 0.327 . . . . 0.0 111.565 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 tt -151.89 124.07 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.522 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 p -71.88 148.62 45.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.857 0.36 . . . . 0.0 111.416 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -59.51 -38.99 82.38 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.078 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.03 -37.82 83.95 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.102 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.28 -47.86 82.3 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.716 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.0 mt -61.75 -44.23 97.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.863 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -62.14 -32.14 72.7 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -83.41 -38.48 21.89 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.678 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.18 -16.13 2.32 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.483 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -68.59 81.41 0.27 Allowed 'General case' 0 C--N 1.341 0.211 0 CA-C-O 121.25 0.548 . . . . 0.0 110.938 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -97.24 41.29 1.12 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.484 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.5 p -127.87 132.01 69.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.287 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.82 134.36 54.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.278 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.5 m -117.76 132.05 56.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.781 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 t -88.64 133.59 35.78 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.681 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.03 -8.48 23.68 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.588 2.192 . . . . 0.0 113.255 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.1 m -99.43 -71.84 0.68 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.272 0.101 . . . . 0.0 111.272 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.5 p -74.94 -27.96 60.4 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.05 42.93 1.72 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.019 0.437 . . . . 0.0 110.804 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mp -95.19 -175.14 3.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.749 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.426 HD12 ' CD1' ' A' ' 4' ' ' PHE . 14.8 pt -131.4 143.58 40.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.384 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 pt -144.68 144.31 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.969 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -91.05 134.7 34.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.225 0.536 . . . . 0.0 111.607 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.81 113.34 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.852 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.0 mm -91.14 135.61 26.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.789 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -152.72 179.35 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 9.9 t0 -85.64 96.36 9.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.588 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -60.24 -33.8 72.79 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.077 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.94 -33.07 75.16 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 121.168 -0.213 . . . . 0.0 110.707 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 0.9 OUTLIER -85.98 -36.74 19.62 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.859 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -74.29 -66.11 0.77 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.399 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.8 94.69 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.244 0.545 . . . . 0.0 111.318 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.4 t -107.49 33.97 3.76 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.163 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.88 -49.51 5.04 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.257 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.07 33.02 4.01 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.796 0.331 . . . . 0.0 111.121 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.5 m -133.95 143.37 48.14 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.687 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.42 114.44 54.93 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.4 126.88 23.78 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.758 2.306 . . . . 0.0 112.484 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.87 149.74 71.5 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.663 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.04 169.12 21.29 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.869 2.379 . . . . 0.0 112.638 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.77 108.13 0.88 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.17 109.16 8.71 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.05 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -71.17 116.6 11.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.075 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.9 138.22 30.05 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.338 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 63.84 66.26 0.67 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.354 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 pp -164.25 33.96 0.08 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.377 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 p -75.28 124.16 32.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.043 0.449 . . . . 0.0 111.443 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -121.39 108.58 13.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.857 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.8 mp -68.15 163.43 22.63 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -151.67 174.6 13.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.289 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.9 m80 . . . . . 0 C--O 1.232 0.157 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.004 179.958 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.531 0.205 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.3 -50.26 0.93 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.368 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 m -127.99 111.52 24.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.036 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.621 ' CD1' HD12 ' A' ' 54' ' ' ILE . 0.7 OUTLIER 60.23 175.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.372 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -91.01 -63.51 1.26 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.486 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -170.51 137.28 1.37 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.681 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -85.47 132.66 34.17 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.506 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.743 HG11 ' CE1' ' A' ' 24' ' ' TYR . 18.6 t -131.33 141.43 45.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.832 0.348 . . . . 0.0 111.25 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -67.0 139.99 57.7 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.253 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.503 HD11 ' CD2' ' A' ' 22' ' ' TYR . 1.1 tp -56.69 -29.06 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.612 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -59.01 -32.64 69.89 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.675 0.274 . . . . 0.0 110.682 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -73.07 -33.04 65.41 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CE1' HG13 ' A' ' 57' ' ' VAL . 8.3 m-85 -61.61 172.35 1.25 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.431 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.45 107.65 16.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.91 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -65.26 134.6 53.99 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.703 0.287 . . . . 0.0 110.636 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -110.56 98.54 7.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.493 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.04 -26.58 64.7 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.755 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -48.68 -50.95 30.96 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.3 t -149.11 32.75 0.74 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.41 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 50.25 73.49 0.26 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.936 0.398 . . . . 0.0 111.726 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.9 m -138.21 145.26 41.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.747 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.503 ' CD2' HD11 ' A' ' 10' ' ' ILE . 53.3 m-85 -113.15 140.25 48.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.554 0.216 . . . . 0.0 110.645 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -129.31 151.69 49.68 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.62 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.743 ' CE1' HG11 ' A' ' 8' ' ' VAL . 15.5 t80 -127.71 136.93 29.72 Favored Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.252 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 42.8 Cg_endo -67.89 124.07 11.43 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.56 2.173 . . . . 0.0 112.576 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.26 142.06 24.08 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.31 -17.08 44.6 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.649 2.233 . . . . 0.0 112.833 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.7 p -69.38 -32.01 70.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.518 0.199 . . . . 0.0 111.208 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.37 -39.77 1.28 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.738 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.08 -170.17 2.58 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.687 0.279 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -134.68 137.0 43.19 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.012 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.619 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 31.6 m-85 -60.14 164.33 4.18 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.734 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -147.0 139.12 24.56 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.773 0.32 . . . . 0.0 111.691 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.81 HD11 ' O ' ' A' ' 43' ' ' GLU . 13.3 tt -152.08 124.8 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.895 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -72.12 150.39 43.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.464 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -59.93 -38.23 81.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.837 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.94 -37.8 83.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.6 -47.83 81.09 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.622 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.463 HD22 ' CD1' ' A' ' 59' ' ' TYR . 5.8 mt -64.79 -36.22 83.61 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -65.49 -28.82 69.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.43 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -91.7 -35.21 14.3 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.31 -13.52 2.77 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.683 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.81 ' O ' HD11 ' A' ' 34' ' ' ILE . 60.8 mm-40 -67.85 79.22 0.21 Allowed 'General case' 0 C--N 1.34 0.184 0 CA-C-O 120.995 0.426 . . . . 0.0 110.616 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.7 p30 -96.34 39.39 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.565 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.6 p -126.82 133.62 68.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.143 0.497 . . . . 0.0 111.447 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.731 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.87 135.71 53.32 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.407 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.37 132.21 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -87.71 137.32 32.0 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.644 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.29 -5.0 16.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.573 2.182 . . . . 0.0 113.145 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.6 m -109.84 -68.03 0.95 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.914 -0.13 . . . . 0.0 111.111 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.53 ' SG ' HD12 ' A' ' 53' ' ' LEU . 30.3 p -73.85 -27.29 61.01 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.0 m 65.04 40.72 4.98 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.873 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.53 HD12 ' SG ' ' A' ' 51' ' ' CYS . 10.2 mt -93.55 -179.53 5.06 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.737 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 4' ' ' PHE . 11.6 pt -129.5 143.26 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.02 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.731 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 6.7 pt -143.69 143.62 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -91.42 135.99 33.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.361 0.601 . . . . 0.0 111.547 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.576 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -109.58 114.53 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.869 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.1 mm -92.79 135.36 27.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.706 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CD1' HD22 ' A' ' 39' ' ' LEU . 19.9 p90 -157.3 177.93 10.9 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.124 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 5.3 t0 -90.79 104.33 16.93 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -60.29 -32.09 70.87 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.788 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.04 -35.16 80.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.661 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 1.7 mm100 -79.63 -47.0 16.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -63.52 -42.76 98.44 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.345 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.5 t -84.53 83.05 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.918 0.389 . . . . 0.0 110.218 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -113.51 93.73 4.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.89 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.01 -61.91 3.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.822 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -124.63 35.54 4.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 111.347 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.7 m -140.2 103.35 4.58 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.753 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 70' ' ' VAL . 11.1 p -86.2 116.08 64.45 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.123 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.9 174.83 1.13 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.01 2.473 . . . . 0.0 112.812 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.73 155.84 62.62 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.043 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.08 154.26 62.48 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.238 2.625 . . . . 0.0 112.848 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 m -148.25 90.76 1.84 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 62.35 -179.72 0.13 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.629 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -133.59 154.89 50.52 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.114 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.48 127.44 37.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.127 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -132.67 85.02 2.19 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.67 33.79 3.73 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.99 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.86 82.59 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.973 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -141.86 35.11 1.58 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.989 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tt -92.64 99.41 12.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.97 141.4 36.24 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.6 p80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.907 179.784 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.52 -58.6 1.25 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.525 0.203 . . . . 0.0 111.513 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.515 ' O ' HD11 ' A' ' 54' ' ' ILE . 15.8 m -64.1 140.06 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 111.408 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.426 ' CD1' HD12 ' A' ' 54' ' ' ILE . 5.6 m-85 -76.36 139.82 41.15 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -62.86 -67.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.711 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -161.4 141.38 10.61 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.702 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -87.51 135.12 33.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.572 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.533 HG11 ' CE1' ' A' ' 24' ' ' TYR . 21.2 t -129.97 141.54 46.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.288 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.81 139.92 57.8 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.821 HD11 ' CD2' ' A' ' 22' ' ' TYR . 8.9 tp -56.92 -28.26 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.468 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.02 -33.74 69.29 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.617 0.246 . . . . 0.0 110.797 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.62 -29.55 62.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.042 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.457 ' HZ ' HD12 ' A' ' 55' ' ' ILE . 13.9 m-85 -64.31 173.99 1.82 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.186 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -116.0 111.85 20.96 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.771 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -65.71 122.08 16.45 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.846 0.355 . . . . 0.0 110.647 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -100.19 92.08 5.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.94 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.23 -27.29 54.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.675 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -47.15 -52.2 16.13 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.488 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.8 m -142.87 27.73 1.62 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.692 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 52.29 67.8 0.92 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.882 0.373 . . . . 0.0 111.473 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.8 m -138.27 150.05 46.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.563 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.821 ' CD2' HD11 ' A' ' 10' ' ' ILE . 20.3 m-85 -114.46 139.3 49.64 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.619 0.247 . . . . 0.0 110.655 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -126.6 153.93 44.62 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.549 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' CE1' HG11 ' A' ' 8' ' ' VAL . 22.5 t80 -132.12 131.47 22.5 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.029 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 32.0 Cg_exo -58.92 124.34 15.49 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.77 2.313 . . . . 0.0 112.514 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -106.67 141.37 22.69 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.02 -17.67 51.31 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.681 2.254 . . . . 0.0 112.92 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.3 p -69.16 -32.87 72.5 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.544 0.211 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.78 -41.55 1.12 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.315 -0.469 . . . . 0.0 112.356 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.8 -166.42 1.58 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 110.845 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -137.21 137.93 39.63 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.609 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 19.3 m-85 -60.02 165.54 3.26 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.984 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.7 p -147.57 139.0 23.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.795 0.331 . . . . 0.0 111.694 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.824 HD11 ' O ' ' A' ' 43' ' ' GLU . 7.8 tt -152.07 124.93 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.63 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.6 p -71.88 149.02 45.56 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.868 0.366 . . . . 0.0 111.246 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.57 83.9 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.045 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.96 -37.99 84.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.809 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 43' ' ' GLU . 4.5 m-20 -56.42 -42.27 77.75 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.401 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.665 HD22 ' CE2' ' A' ' 59' ' ' TYR . 24.6 mt -61.2 -46.84 88.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.776 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.92 -26.04 63.99 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -90.68 -37.34 13.8 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.42 -1.94 4.13 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.063 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.824 ' O ' HD11 ' A' ' 34' ' ' ILE . 18.1 mm-40 -75.5 76.68 2.54 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-O 121.103 0.478 . . . . 0.0 110.705 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.5 m-20 -89.66 35.83 0.84 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.443 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.03 133.18 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.087 0.47 . . . . 0.0 111.927 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.715 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.83 140.48 47.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.529 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.6 m -122.06 132.32 54.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.778 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.99 138.02 32.98 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.575 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.84 -4.82 15.98 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.636 2.224 . . . . 0.0 113.134 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.3 p -110.47 -69.05 0.89 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.41 0.148 . . . . 0.0 111.189 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 53' ' ' LEU . 31.6 p -72.4 -27.88 62.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.8 t 63.91 42.7 5.77 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.09 0.471 . . . . 0.0 110.811 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.547 HD12 ' SG ' ' A' ' 51' ' ' CYS . 5.0 mt -96.11 -178.03 4.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.586 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.515 HD11 ' O ' ' A' ' 3' ' ' VAL . 26.2 pt -129.0 143.47 41.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.208 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.715 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.7 pt -142.47 144.35 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.0 135.21 34.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.238 0.542 . . . . 0.0 111.375 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.805 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -108.08 113.31 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.201 -179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 mm -94.09 135.36 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.665 ' CE2' HD22 ' A' ' 39' ' ' LEU . 32.9 p90 -159.35 -177.32 6.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.575 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -87.91 94.41 9.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.747 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 4.3 mtpm? -58.46 -29.42 66.17 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.068 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.81 -36.82 85.57 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.61 0.243 . . . . 0.0 110.671 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -79.02 -35.11 43.28 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.315 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -74.91 -44.0 51.11 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.67 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 61' ' ' LYS . 32.7 t -80.53 81.0 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.097 0.475 . . . . 0.0 111.007 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 t -130.16 30.59 4.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.144 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.94 -41.33 61.87 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.48 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -99.81 31.81 3.11 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 111.207 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -139.73 104.63 4.95 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.763 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' HD2' ' A' ' 71' ' ' PRO . 87.3 t 67.55 141.88 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.746 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.508 ' HD2' HG13 ' A' ' 70' ' ' VAL . 35.4 Cg_exo -57.78 154.99 34.49 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.924 2.416 . . . . 0.0 112.739 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.01 151.15 13.13 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.64 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.72 159.11 54.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.728 2.285 . . . . 0.0 112.335 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 51.1 m -98.61 73.53 2.07 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.973 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 67.58 160.27 0.16 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.709 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -114.91 146.91 40.64 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.224 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 89.83 3.0 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.023 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -150.7 117.0 5.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.935 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.79 34.7 0.61 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.3 p -109.42 128.34 65.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.193 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp 59.73 85.44 0.1 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.051 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.77 127.51 41.86 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -104.75 170.5 7.84 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 . . . . . 0 C--O 1.232 0.156 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.003 179.866 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 mtp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.781 0.324 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.81 37.0 27.76 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.457 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.53 154.83 40.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.755 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.696 ' CD1' HD12 ' A' ' 54' ' ' ILE . 4.3 m-85 -62.09 138.78 58.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.962 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.434 ' HB3' HG22 ' A' ' 55' ' ' ILE . 45.4 t60 -58.4 -64.46 0.91 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.974 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -162.14 160.4 27.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -104.63 134.08 48.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.408 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.509 HG11 ' CZ ' ' A' ' 24' ' ' TYR . 19.2 t -138.75 141.5 36.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.83 0.348 . . . . 0.0 111.313 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.72 139.92 57.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.939 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.661 HD11 ' CG ' ' A' ' 22' ' ' TYR . 1.1 tp -55.26 -30.04 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.794 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -58.8 -33.34 70.25 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.588 0.232 . . . . 0.0 110.78 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -71.61 -30.52 65.89 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.999 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 16.1 m-85 -65.16 171.66 3.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 111.21 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.22 104.45 14.36 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.841 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -66.48 150.17 49.35 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.722 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 3.4 t0 -125.46 144.75 50.39 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.344 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.97 -29.01 14.39 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.276 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -49.26 -53.14 23.11 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.3 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -148.83 28.23 0.86 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.639 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 3.0 mt-10 53.74 82.28 0.08 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.891 0.377 . . . . 0.0 111.337 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 m -137.6 143.33 41.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.661 ' CG ' HD11 ' A' ' 10' ' ' ILE . 82.2 m-85 -109.92 134.87 51.62 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.895 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -123.99 159.83 28.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.257 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.509 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 4.5 t80 -143.04 139.34 16.67 Favored Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.156 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 24' ' ' TYR . 50.7 Cg_endo -69.27 124.01 10.84 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.594 2.196 . . . . 0.0 112.494 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.419 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.37 144.46 28.14 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 39.9 Cg_endo -67.06 -18.23 51.44 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.658 2.239 . . . . 0.0 112.928 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p -76.55 -38.75 54.55 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.605 0.24 . . . . 0.0 111.188 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.82 -42.57 0.78 Allowed Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.668 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -176.69 4.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.506 0.193 . . . . 0.0 110.672 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -130.24 135.1 47.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.246 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.419 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 21.0 m-85 -63.39 164.36 9.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.738 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 p -150.6 139.2 20.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.872 0.368 . . . . 0.0 111.581 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.821 HD11 ' O ' ' A' ' 43' ' ' GLU . 2.5 tt -151.6 125.43 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.7 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 p -73.07 148.45 44.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.431 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -60.58 -38.06 83.36 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.775 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.09 -37.15 81.7 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.134 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.79 -47.49 80.07 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.629 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.539 HD22 ' CD1' ' A' ' 59' ' ' TYR . 14.9 mt -60.16 -45.89 91.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.885 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.03 -32.44 70.91 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.144 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -83.19 -37.81 23.16 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.694 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.81 -13.0 2.9 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.566 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.821 ' O ' HD11 ' A' ' 34' ' ' ILE . 8.7 mt-10 -70.31 80.26 0.54 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.069 0.461 . . . . 0.0 111.054 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -97.33 41.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.497 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -132.37 135.05 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.163 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.719 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.87 137.04 51.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.481 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.4 m -117.09 132.03 56.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.841 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.9 t -96.54 115.72 65.78 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.389 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.13 -19.77 21.81 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.713 2.276 . . . . 0.0 113.74 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.02 -75.39 0.32 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.505 0.193 . . . . 0.0 111.341 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.528 ' HB2' HD13 ' A' ' 53' ' ' LEU . 29.0 p -74.45 -22.93 58.87 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m 63.89 45.74 4.2 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.073 0.464 . . . . 0.0 110.817 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 51' ' ' CYS . 3.9 mp -101.49 179.57 4.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.823 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.696 HD12 ' CD1' ' A' ' 4' ' ' PHE . 18.0 pt -126.9 143.58 39.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.352 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.719 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 7.2 pt -138.62 158.21 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.95 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -102.76 132.22 49.08 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.359 0.6 . . . . 0.0 111.502 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.714 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -109.08 113.36 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.972 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 mm -94.58 135.22 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.539 ' CD1' HD22 ' A' ' 39' ' ' LEU . 17.3 p90 -154.69 178.58 9.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.501 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -91.35 99.61 12.55 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.809 0.338 . . . . 0.0 110.95 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -58.97 -30.04 67.62 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.244 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.63 -38.94 90.8 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.946 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -74.18 -42.32 60.05 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.831 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -67.84 -44.61 76.8 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.037 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.7 t -100.93 82.25 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.699 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -113.27 91.46 3.66 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.151 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.03 -46.99 1.8 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.697 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.36 32.61 4.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.721 0.296 . . . . 0.0 111.598 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -151.39 127.54 10.5 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.867 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.99 138.35 19.63 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -85.82 51.67 2.88 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.883 2.388 . . . . 0.0 112.48 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.17 120.96 28.89 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.256 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.94 172.38 1.67 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.176 2.584 . . . . 0.0 112.959 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -70.09 -36.08 74.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.428 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.47 128.87 45.22 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.634 0.254 . . . . 0.0 111.159 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -66.97 148.42 51.98 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.174 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -106.78 152.5 23.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.437 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.416 ' C ' HD23 ' A' ' 79' ' ' LEU . 20.7 mt-10 -147.02 98.48 3.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.213 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 78' ' ' GLU . 0.9 OUTLIER -172.85 128.57 0.49 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.151 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.12 90.3 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.688 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -108.17 103.63 12.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.011 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.9 mt -129.89 36.36 4.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.171 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.29 175.34 9.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.996 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 . . . . . 0 C--O 1.232 0.149 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.975 179.875 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.706 0.289 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.47 -70.43 0.59 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.771 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.497 ' O ' HD11 ' A' ' 54' ' ' ILE . 18.0 m -146.51 26.36 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.496 ' CD1' HD12 ' A' ' 54' ' ' ILE . 3.8 m-85 -73.99 145.38 44.64 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 111.354 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -64.19 -64.12 0.97 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.446 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -163.26 145.53 10.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.781 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -91.74 134.39 34.76 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.411 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.565 HG21 ' CZ ' ' A' ' 24' ' ' TYR . 20.3 t -133.06 141.58 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.151 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.77 140.16 57.83 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.17 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.573 HD11 ' CD2' ' A' ' 22' ' ' TYR . 1.1 tp -56.25 -28.19 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.416 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.28 -32.71 68.67 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.575 0.226 . . . . 0.0 110.858 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.49 -27.78 58.95 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.153 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.479 ' HZ ' HD12 ' A' ' 55' ' ' ILE . 13.0 m-85 -65.48 173.02 2.88 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.824 0.345 . . . . 0.0 111.19 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -111.37 113.8 26.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -65.67 125.67 26.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.56 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -104.72 90.39 3.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.602 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.7 -27.87 43.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.336 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.44 -49.1 9.94 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.353 0.408 . . . . 0.0 111.456 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.8 m -151.44 32.39 0.58 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.534 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 51.65 70.49 0.54 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 111.559 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.7 m -137.6 153.2 49.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.815 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.573 ' CD2' HD11 ' A' ' 10' ' ' ILE . 35.3 m-85 -120.47 131.18 54.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.8 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 33' ' ' SER . 13.5 m-85 -118.89 152.76 35.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 111.392 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CZ ' HG21 ' A' ' 8' ' ' VAL . 18.7 t80 -128.6 136.64 29.43 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.974 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 24' ' ' TYR . 32.0 Cg_exo -58.37 123.75 14.32 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.599 2.199 . . . . 0.0 112.493 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -113.66 147.24 37.16 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.405 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 51.6 Cg_exo -54.48 -30.76 65.81 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.918 2.412 . . . . 0.0 112.854 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.8 p -73.28 -42.39 62.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.282 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.6 -22.44 6.94 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.272 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -63.79 -35.73 81.55 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.921 0.36 . . . . 0.0 111.295 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 30' ' ' ASP . 66.7 m-20 73.37 131.5 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.116 0.484 . . . . 0.0 111.761 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 61.7 m-85 -61.06 163.57 5.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.916 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.445 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 81.6 p -148.15 139.23 23.29 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 111.374 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.908 HD13 HG21 ' A' ' 57' ' ' VAL . 6.2 tt -150.5 124.31 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.591 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.89 148.19 46.35 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -60.64 -38.52 85.08 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.026 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -60.95 -38.47 85.98 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.107 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.53 -47.59 79.05 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.775 0.322 . . . . 0.0 110.688 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 36' ' ' LYS . 4.8 mt -61.26 -42.45 98.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.976 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -60.13 -31.65 70.28 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.336 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -86.81 -36.9 18.26 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.9 -14.14 2.63 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.551 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.789 ' O ' HD11 ' A' ' 34' ' ' ILE . 58.7 mm-40 -68.02 80.22 0.22 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.037 0.446 . . . . 0.0 111.145 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.9 p30 -95.05 38.72 1.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.767 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.99 131.67 70.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.236 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -113.01 127.15 56.15 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.97 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.8 m -111.67 122.74 48.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.796 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -70.79 141.13 86.92 Favored Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.744 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.6 36.62 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.956 2.437 . . . . 0.0 113.444 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 t -155.51 -64.11 0.12 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.709 0.29 . . . . 0.0 110.531 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.616 ' SG ' HD12 ' A' ' 53' ' ' LEU . 29.3 p -77.16 -24.73 51.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.358 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.7 m 65.87 41.39 3.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.962 0.41 . . . . 0.0 110.79 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.616 HD12 ' SG ' ' A' ' 51' ' ' CYS . 2.7 mt -88.97 -179.59 5.97 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.9 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.497 HD11 ' O ' ' A' ' 3' ' ' VAL . 10.9 pt -136.02 143.47 36.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.402 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 ' HB3' ' A' ' 46' ' ' ALA . 3.1 pt -146.57 144.68 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.834 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.32 136.36 33.66 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.284 0.564 . . . . 0.0 111.165 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.908 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -109.3 114.53 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.981 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.4 mm -93.24 134.66 30.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.741 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.468 ' CE2' ' HE3' ' A' ' 61' ' ' LYS . 19.0 p90 -156.95 178.35 10.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.049 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 31.5 t0 -88.56 91.28 8.75 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.25 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.487 ' O ' HG12 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -58.45 -34.5 70.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.913 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.05 -34.36 78.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.79 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 3.6 mm-40 -85.99 -35.46 20.38 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.001 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 59' ' ' TYR . 4.2 m-85 -59.9 -55.01 39.45 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.48 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 65' ' ' VAL . 7.3 p -101.83 90.43 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 121.33 0.586 . . . . 0.0 111.076 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.7 p -141.36 28.36 1.85 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.449 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.82 -78.55 1.27 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.38 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.36 80.08 8.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.817 0.341 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 69' ' ' THR . 6.2 t -131.73 102.59 5.94 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.674 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.2 t -132.92 140.32 37.27 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.115 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -57.85 172.3 1.22 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.944 2.43 . . . . 0.0 112.918 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.29 150.07 74.49 Favored Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.987 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.69 -177.31 2.11 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.084 2.523 . . . . 0.0 112.691 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m -79.5 123.22 27.35 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.503 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 66.59 100.72 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.544 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -95.0 38.71 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.202 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.31 105.15 4.35 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.889 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.86 114.35 25.97 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.704 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.84 63.67 0.65 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 111.418 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.4 t -141.15 122.69 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.342 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.0 mttm 60.71 92.54 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.358 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.0 mt -87.48 104.05 16.1 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.6 -35.39 9.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.31 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 57.1 m80 . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.824 -179.482 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtm . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.605 0.241 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.34 -43.66 6.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.332 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.405 ' O ' HD11 ' A' ' 54' ' ' ILE . 23.9 m -64.83 159.61 3.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.917 0.389 . . . . 0.0 111.452 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -71.91 163.4 27.91 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.233 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.608 ' CD2' HD21 ' A' ' 53' ' ' LEU . 9.9 t-80 -89.88 -67.54 0.84 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -145.87 162.78 36.96 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.769 0.318 . . . . 0.0 111.288 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -114.03 134.03 55.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.671 HG11 ' CE1' ' A' ' 24' ' ' TYR . 17.0 t -132.76 140.79 46.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.178 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -66.73 139.65 57.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.021 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.767 HD11 ' CG ' ' A' ' 22' ' ' TYR . 5.9 tp -56.95 -30.4 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.657 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.32 -32.27 71.07 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.669 0.271 . . . . 0.0 110.806 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -72.88 -28.97 62.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.336 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.461 ' CZ ' HG13 ' A' ' 57' ' ' VAL . 12.8 m-85 -62.75 160.48 14.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.991 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -96.39 82.53 3.41 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.586 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.461 ' HB2' ' CE2' ' A' ' 22' ' ' TYR . 87.2 t80 -68.26 153.35 43.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -144.55 122.93 12.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.549 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -65.93 -28.7 69.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.101 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.7 -60.81 3.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.658 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 m -94.19 -20.63 19.68 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.855 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 64.87 47.51 2.63 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.013 0.435 . . . . 0.0 110.776 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.501 HG23 ' C ' ' A' ' 34' ' ' ILE . 87.3 m -139.63 145.86 39.01 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.496 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.767 ' CG ' HD11 ' A' ' 10' ' ' ILE . 77.5 m-85 -98.25 141.03 31.67 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.751 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -127.3 157.0 41.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.766 0.317 . . . . 0.0 111.592 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.671 ' CE1' HG11 ' A' ' 8' ' ' VAL . 27.7 t80 -140.15 136.8 17.32 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.99 124.58 12.42 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.682 2.254 . . . . 0.0 112.627 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -97.43 144.04 27.23 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.906 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.05 -15.29 35.97 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.716 2.277 . . . . 0.0 112.942 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.4 p -77.86 -38.87 45.08 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.506 0.193 . . . . 0.0 111.081 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.87 -49.16 0.45 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.791 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -167.25 1.13 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.542 0.211 . . . . 0.0 111.046 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -135.6 140.13 44.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.633 0.254 . . . . 0.0 111.079 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.438 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 50.1 m-85 -63.54 165.27 8.21 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.826 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 p -150.39 139.13 20.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.447 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.842 HD11 ' O ' ' A' ' 43' ' ' GLU . 2.4 tt -151.95 124.77 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 p -71.49 148.72 46.51 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.909 0.385 . . . . 0.0 111.423 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -38.2 87.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.21 -37.93 84.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.966 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -56.34 -46.98 79.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.531 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.517 HD12 ' CE2' ' A' ' 64' ' ' PHE . 35.2 mt -60.0 -45.45 92.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.964 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -59.45 -33.53 71.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.036 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -82.14 -38.19 25.1 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.48 -12.42 2.98 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.574 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.842 ' O ' HD11 ' A' ' 34' ' ' ILE . 5.2 mt-10 -70.06 80.34 0.49 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.146 0.498 . . . . 0.0 111.026 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -97.66 41.78 1.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.478 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.442 ' O ' HD12 ' A' ' 34' ' ' ILE . 10.4 p -129.01 132.36 67.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.329 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.85 134.69 54.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.773 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.5 m -116.7 132.59 56.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.9 t -91.4 134.12 30.16 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.524 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.02 1.77 8.87 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.583 2.188 . . . . 0.0 113.246 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.18 -51.39 2.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.615 0.245 . . . . 0.0 111.008 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.5 p -101.81 -24.22 14.08 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 69.17 41.05 1.44 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.059 0.457 . . . . 0.0 110.961 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.608 HD21 ' CD2' ' A' ' 5' ' ' HIS . 15.2 tp -95.18 163.34 13.32 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.809 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.405 HD11 ' O ' ' A' ' 3' ' ' VAL . 29.2 pt -113.55 143.26 23.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.168 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.748 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -142.51 144.43 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.052 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -91.28 134.57 34.47 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.221 0.534 . . . . 0.0 111.67 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.792 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -108.04 113.22 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.006 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 mm -92.99 134.07 32.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.045 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.415 ' CE1' HD22 ' A' ' 39' ' ' LEU . 26.5 p90 -156.44 177.12 11.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.823 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -90.26 104.53 17.1 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.858 0.361 . . . . 0.0 110.905 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -30.6 69.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.078 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -64.94 -39.15 93.06 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.686 0.279 . . . . 0.0 110.661 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.97 -47.86 19.64 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.23 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.517 ' CE2' HD12 ' A' ' 39' ' ' LEU . 16.1 m-85 -59.96 -43.63 94.91 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.191 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.95 83.88 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.787 0.327 . . . . 0.0 110.526 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.79 89.49 2.83 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.17 -37.96 6.96 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.603 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -101.96 37.74 1.79 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.742 0.306 . . . . 0.0 111.269 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.0 t -91.07 171.3 9.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.065 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.422 HG23 ' HD2' ' A' ' 71' ' ' PRO . 9.7 p -131.17 135.95 28.02 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.474 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.422 ' HD2' HG23 ' A' ' 70' ' ' VAL . 73.3 Cg_endo -75.88 -175.19 2.36 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.781 2.321 . . . . 0.0 112.461 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.09 152.12 57.43 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.649 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.68 142.34 61.63 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.149 2.566 . . . . 0.0 112.714 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.9 135.25 8.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.012 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.44 113.82 27.56 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -83.51 105.29 14.33 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.9 0.381 . . . . 0.0 110.825 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -66.7 141.71 57.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.214 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' C ' HD23 ' A' ' 79' ' ' LEU . 3.2 tt0 -155.8 101.99 2.16 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.281 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 78' ' ' GLU . 0.5 OUTLIER -163.35 40.59 0.1 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.991 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -77.24 117.32 22.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.135 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -145.7 25.79 1.3 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.569 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 83' ' ' GLU . 0.7 OUTLIER 69.0 152.36 0.09 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.837 0.351 . . . . 0.0 111.337 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.481 ' N ' HD23 ' A' ' 82' ' ' LEU . 2.6 mt-10 -67.61 147.18 53.07 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.067 -179.903 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 ttp . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.625 0.25 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.96 -66.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.892 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.1 m -134.98 24.82 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.397 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' CD1' HD12 ' A' ' 54' ' ' ILE . 1.2 m-85 60.35 -179.95 0.1 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 111.22 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.557 ' CG ' HD21 ' A' ' 53' ' ' LEU . 53.8 t60 -97.28 -61.63 1.37 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.728 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -165.65 160.17 17.17 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.748 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -107.29 120.38 41.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.459 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.64 141.54 45.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -66.5 139.81 57.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.064 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.661 HD11 ' CG ' ' A' ' 22' ' ' TYR . 8.2 tp -56.87 -28.99 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.441 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.96 -35.84 71.72 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.731 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.25 -28.87 63.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.293 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 15.6 m-85 -63.93 161.43 15.69 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 111.307 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.13 99.03 11.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.544 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.42 136.58 53.5 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.925 0.393 . . . . 0.0 110.745 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -119.42 89.99 3.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.518 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -55.85 -29.29 59.62 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.24 -44.21 22.6 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.9 m -138.68 24.37 2.64 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 47.09 59.73 3.85 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.06 0.457 . . . . 0.0 111.783 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.7 m -138.15 144.07 40.6 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.987 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.661 ' CG ' HD11 ' A' ' 10' ' ' ILE . 44.1 m-85 -106.15 141.13 38.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.94 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 76.7 m-85 -124.18 161.11 26.38 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.331 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.454 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 7.7 t80 -148.53 137.45 11.96 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.01 126.34 13.04 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.456 2.104 . . . . 0.0 112.706 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.437 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 1.6 t -101.87 143.57 26.86 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 46.5 Cg_exo -56.25 -26.16 59.79 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.907 2.405 . . . . 0.0 113.043 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -69.19 -38.31 78.58 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.466 0.174 . . . . 0.0 111.463 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.63 -39.95 1.18 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.464 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.98 -176.23 2.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.682 0.277 . . . . 0.0 110.885 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -130.44 133.06 46.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.693 0.283 . . . . 0.0 111.416 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.599 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 47.3 m-85 -63.06 162.86 10.84 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.709 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 p -146.93 139.34 24.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 111.558 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.781 HD11 ' O ' ' A' ' 43' ' ' GLU . 2.3 tt -151.82 122.06 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.759 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.6 p -72.17 149.44 44.68 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.103 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -60.05 -37.17 79.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.708 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.56 -38.34 84.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.933 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.3 -47.16 79.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.617 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.508 HD22 ' CE1' ' A' ' 59' ' ' TYR . 13.4 mt -61.7 -46.11 91.07 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.18 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.39 -31.04 69.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.851 -0.159 . . . . 0.0 111.284 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -83.88 -36.59 23.28 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.55 -12.8 3.21 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.722 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.781 ' O ' HD11 ' A' ' 34' ' ' ILE . 8.1 mt-10 -71.65 81.28 0.84 Allowed 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.186 0.517 . . . . 0.0 110.849 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -97.44 41.79 1.11 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.469 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.02 137.3 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.54 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.724 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.71 131.51 55.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.788 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.3 m -112.56 132.39 55.14 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.145 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.26 138.43 39.24 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.26 2.46 8.45 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.546 2.164 . . . . 0.0 113.421 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.4 -64.22 1.33 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.452 0.168 . . . . 0.0 111.152 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.0 p -85.05 -20.68 30.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.6 m 65.56 38.69 5.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.872 0.368 . . . . 0.0 111.131 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.557 HD21 ' CG ' ' A' ' 5' ' ' HIS . 57.9 tp -84.14 158.76 21.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.734 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 4' ' ' PHE . 20.0 pt -112.83 142.91 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.794 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.724 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.3 pt -144.82 144.76 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.027 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -91.17 134.46 34.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.391 0.615 . . . . 0.0 111.614 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -108.24 113.24 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.744 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.47 135.03 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.805 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.508 ' CE1' HD22 ' A' ' 39' ' ' LEU . 20.1 p90 -155.92 168.23 27.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.804 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -85.68 97.77 10.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.814 0.34 . . . . 0.0 110.675 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -58.46 -30.03 66.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.109 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.78 -36.77 85.38 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.529 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -38.1 37.3 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.022 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -61.68 -60.11 4.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.11 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 65' ' ' VAL . 7.8 p -111.47 95.16 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.246 0.546 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -96.05 86.92 4.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.081 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.02 -45.9 90.73 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.649 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.49 83.59 2.06 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.947 0.403 . . . . 0.0 110.834 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -128.19 161.3 29.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.268 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 16.9 t -107.44 138.65 20.0 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.428 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 48.4 Cg_exo -55.96 124.75 17.03 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.973 2.449 . . . . 0.0 112.827 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . 72.25 158.1 0.16 Allowed Pre-proline 0 N--CA 1.468 0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.707 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 65.8 Cg_endo -72.92 165.93 31.41 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.683 2.256 . . . . 0.0 112.772 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.5 m -147.63 -59.28 0.26 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.148 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.25 171.68 8.05 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.42 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -145.49 37.29 1.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -135.92 36.01 2.84 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.247 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.01 94.07 0.62 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.894 0.378 . . . . 0.0 110.382 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.67 -146.86 0.37 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.456 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.9 t -94.59 102.28 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.696 0.284 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.7 tttm 61.06 79.02 0.26 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.43 156.87 48.0 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 73.21 -64.69 0.39 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.296 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.8 t60 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.85 0.357 . . . . 0.0 110.719 179.871 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 ttm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.38 152.58 50.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.66 0.267 . . . . 0.0 111.663 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.424 HG23 HD11 ' A' ' 54' ' ' ILE . 16.0 m -103.48 30.9 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.305 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CD1' HD12 ' A' ' 54' ' ' ILE . 3.9 m-85 -75.71 173.5 11.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 111.279 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -94.52 -65.75 0.96 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.633 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.64 138.41 7.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.14 133.71 34.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.537 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.433 HG11 ' CE1' ' A' ' 24' ' ' TYR . 19.1 t -136.78 141.69 40.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.836 0.351 . . . . 0.0 111.485 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . 8.7 mt-10 -66.68 140.16 57.89 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.06 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.669 HD11 ' CG ' ' A' ' 22' ' ' TYR . 1.0 OUTLIER -55.73 -27.68 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.692 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -58.98 -32.93 70.12 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.659 0.266 . . . . 0.0 110.689 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.88 -28.57 61.63 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 11.0 m-85 -66.77 170.86 5.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 111.364 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -105.23 109.37 21.34 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.874 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -66.74 110.95 3.45 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.747 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -88.69 95.4 10.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.833 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -25.58 64.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.552 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -49.18 -51.53 32.08 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.736 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.9 m -143.1 28.45 1.53 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 51.98 68.03 0.88 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.874 0.368 . . . . 0.0 111.544 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.4 m -137.88 149.89 46.65 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.67 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.669 ' CG ' HD11 ' A' ' 10' ' ' ILE . 39.1 m-85 -114.09 138.7 50.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.655 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -126.89 157.14 40.16 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.777 0.322 . . . . 0.0 111.788 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 10.3 t80 -135.87 136.61 23.6 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.327 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.409 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 37.8 Cg_endo -65.92 124.64 12.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.805 2.337 . . . . 0.0 112.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.407 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -100.84 144.9 29.43 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.34 -17.48 44.42 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.647 2.232 . . . . 0.0 112.898 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.2 p -75.99 -36.24 59.3 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.152 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.99 -49.55 0.55 Allowed Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.763 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.3 -168.21 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.51 0.195 . . . . 0.0 110.928 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -137.87 138.65 39.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.687 0.28 . . . . 0.0 111.261 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 28.6 m-85 -61.07 163.22 6.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.787 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.7 p -147.18 139.28 24.46 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.86 0.362 . . . . 0.0 111.568 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.794 HD11 ' O ' ' A' ' 43' ' ' GLU . 2.1 tt -151.96 124.8 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.618 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.9 p -71.96 149.2 45.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 111.315 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -38.46 86.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -61.56 -38.11 86.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.93 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.46 -47.76 78.5 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.616 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.563 HD13 HD13 ' A' ' 10' ' ' ILE . 7.5 mt -62.5 -41.21 98.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -62.67 -31.04 71.85 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.449 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -86.62 -36.45 18.81 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.78 -15.04 2.65 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.443 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.794 ' O ' HD11 ' A' ' 34' ' ' ILE . 7.9 mt-10 -68.8 80.76 0.29 Allowed 'General case' 0 C--N 1.34 0.165 0 CA-C-O 121.203 0.525 . . . . 0.0 110.561 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -98.49 41.9 1.12 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.282 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.36 131.9 65.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.095 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.693 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -113.5 137.0 52.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.421 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 m -118.57 131.71 56.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.652 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 49.4 t -92.03 117.19 67.58 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.43 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.87 -19.1 24.06 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.758 2.305 . . . . 0.0 113.402 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.1 m -83.21 -73.85 0.39 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.539 ' SG ' HD12 ' A' ' 53' ' ' LEU . 26.3 p -76.86 -24.94 52.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.21 38.77 2.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.048 0.452 . . . . 0.0 110.722 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.539 HD12 ' SG ' ' A' ' 51' ' ' CYS . 5.3 mt -92.06 178.06 5.99 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.732 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.489 HD12 ' CD1' ' A' ' 4' ' ' PHE . 16.9 pt -125.68 143.5 39.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.4 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.693 HD11 ' HB3' ' A' ' 46' ' ' ALA . 4.5 pt -140.6 159.19 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.979 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.37 133.98 49.24 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.273 0.558 . . . . 0.0 111.409 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.752 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -109.7 113.28 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.082 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 27.3 mm -92.61 135.42 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.986 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' CD2' HD22 ' A' ' 39' ' ' LEU . 30.5 p90 -151.67 178.21 9.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -87.08 99.8 12.18 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.622 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -61.17 -31.92 71.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.01 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.22 -35.12 80.07 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.66 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -80.82 -42.16 22.09 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.94 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -72.4 -72.2 0.25 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.28 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 65' ' ' VAL . 7.5 p -114.81 92.04 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 121.276 0.56 . . . . 0.0 111.662 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 p -78.03 88.54 4.17 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.344 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -99.39 0.04 OUTLIER Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.368 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.55 32.33 4.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 t -81.82 125.72 31.01 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.9 t -97.12 139.62 21.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.493 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.11 86.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.795 2.33 . . . . 0.0 112.53 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -174.71 148.2 1.17 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.86 135.28 21.17 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.869 2.379 . . . . 0.0 112.84 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -163.99 -54.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.143 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.47 -42.64 92.51 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.774 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -158.67 163.11 37.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.664 0.268 . . . . 0.0 111.09 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -146.71 80.57 1.55 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.155 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -134.92 95.7 3.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.282 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -150.17 31.14 0.69 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.348 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.42 113.13 43.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.658 0.266 . . . . 0.0 111.455 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -170.85 101.75 0.23 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.949 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.17 152.38 34.86 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.099 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -152.92 167.14 30.13 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.427 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 15.6 m80 . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.746 179.654 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.456 0.17 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.86 -72.21 0.65 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.259 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.4 m -151.54 76.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 111.265 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -71.09 162.89 28.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.375 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -92.81 -64.43 1.1 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.681 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -160.79 136.31 7.99 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.963 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.21 134.57 34.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.595 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 24' ' ' TYR . 20.2 t -137.09 141.5 40.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.244 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . 55.1 mt-10 -66.82 140.04 57.8 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.041 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.743 HD11 ' CG ' ' A' ' 22' ' ' TYR . 1.2 tp -55.34 -28.58 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.732 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.49 -31.34 67.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.6 0.238 . . . . 0.0 110.982 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.51 -31.11 60.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.964 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.41 ' HZ ' HD12 ' A' ' 55' ' ' ILE . 8.2 m-85 -63.68 168.68 4.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.146 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -101.95 110.52 22.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -65.73 127.23 31.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.751 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -102.36 97.72 7.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.559 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -59.54 -26.11 65.08 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.554 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -49.15 -50.87 35.62 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.73 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 t -152.93 34.77 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.569 0.223 . . . . 0.0 111.583 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 52.11 77.03 0.16 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.897 0.379 . . . . 0.0 111.863 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.8 m -137.92 151.48 48.04 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.685 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.743 ' CG ' HD11 ' A' ' 10' ' ' ILE . 78.4 m-85 -122.02 139.87 53.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.769 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -130.6 157.35 42.96 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.626 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.436 ' CE1' HG11 ' A' ' 8' ' ' VAL . 7.7 t80 -135.74 137.28 25.23 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.23 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 43.6 Cg_endo -68.16 124.61 11.94 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.611 2.208 . . . . 0.0 112.557 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.23 142.99 25.76 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.55 -17.7 48.54 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.644 2.229 . . . . 0.0 112.864 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.1 p -71.34 -31.75 67.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.578 0.227 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.48 -40.18 1.35 Allowed Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.38 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.3 -171.99 3.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.679 0.276 . . . . 0.0 110.897 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -136.17 133.39 37.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -59.62 163.14 4.46 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.4 p -147.56 139.22 23.97 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.85 0.357 . . . . 0.0 111.627 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.841 HD11 ' O ' ' A' ' 43' ' ' GLU . 2.6 tt -152.32 124.57 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.777 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.7 p -71.82 149.56 45.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 111.263 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -37.18 82.95 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -60.96 -39.34 89.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.789 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.24 -47.91 77.55 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.691 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 10' ' ' ILE . 9.8 mt -62.14 -43.97 97.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.067 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.413 ' O ' HG22 ' A' ' 65' ' ' VAL . 54.5 mt-10 -60.69 -28.94 69.0 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.353 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -88.1 -36.87 16.66 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.35 -14.51 2.52 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.649 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.841 ' O ' HD11 ' A' ' 34' ' ' ILE . 10.0 mt-10 -69.74 80.47 0.44 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.191 0.519 . . . . 0.0 111.125 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.412 ' HB3' ' HE1' ' A' ' 59' ' ' TYR . 1.6 p30 -96.71 40.14 1.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.502 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -127.78 134.23 65.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.371 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.745 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -113.1 139.42 48.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.178 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.5 m -118.8 132.12 56.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.746 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -91.69 135.86 27.17 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.794 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.84 -2.06 12.2 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.566 2.177 . . . . 0.0 113.239 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.58 -65.51 1.14 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.455 0.169 . . . . 0.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.581 ' SG ' HD12 ' A' ' 53' ' ' LEU . 31.3 p -79.61 -24.65 41.82 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.94 39.67 5.71 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 111.093 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.581 HD12 ' SG ' ' A' ' 51' ' ' CYS . 11.6 mt -95.86 -179.59 4.76 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.5 pt -128.83 143.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.224 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.745 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 6.1 pt -139.99 143.68 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -91.62 132.76 36.11 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.347 0.594 . . . . 0.0 111.493 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.738 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -106.77 116.03 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.854 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 24.7 mm -94.06 135.56 28.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.785 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CD1' HD22 ' A' ' 39' ' ' LEU . 16.0 p90 -154.82 178.04 10.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.916 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.87 99.79 12.39 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.565 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -60.39 -30.39 69.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.068 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -65.23 -33.57 76.31 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.709 0.29 . . . . 0.0 110.851 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -88.96 -45.52 9.6 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.013 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -66.97 -55.65 13.57 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.248 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 40' ' ' GLU . 18.5 t -81.01 82.74 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.93 0.395 . . . . 0.0 110.693 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -95.81 88.82 5.07 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.074 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.67 -60.17 0.94 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.785 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.24 22.63 10.25 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.9 m -153.13 117.86 5.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.655 0.264 . . . . 0.0 110.949 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 71' ' ' PRO . 11.2 p -134.36 135.65 24.35 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.416 ' HD2' HG23 ' A' ' 70' ' ' VAL . 74.5 Cg_endo -75.92 168.23 24.59 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.002 2.468 . . . . 0.0 112.818 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.16 150.83 19.16 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.725 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.7 135.75 70.95 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.474 2.783 . . . . 0.0 113.346 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.6 m -147.42 87.43 1.65 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.18 155.87 37.73 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.364 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 25.05 15.06 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.63 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.96 74.5 0.15 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.826 0.346 . . . . 0.0 111.147 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -145.09 87.38 1.82 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.801 0.334 . . . . 0.0 111.101 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.422 ' N ' HD23 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -133.5 34.1 3.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 80' ' ' VAL . 10.1 p -99.43 24.49 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.06 0.457 . . . . 0.0 111.36 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.469 ' CE ' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -127.75 31.3 5.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 tp -122.48 32.02 5.91 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 110.978 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -88.83 -56.33 3.34 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.876 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.462 0.133 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.049 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.7 mtt . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 120.609 0.242 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.87 150.2 26.63 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.315 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.27 108.29 5.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.825 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -63.65 142.59 58.34 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.043 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -68.28 -65.4 0.7 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.367 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -156.82 149.46 23.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.887 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.41 134.57 44.29 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.449 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 24' ' ' TYR . 19.2 t -132.9 141.52 44.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -67.17 139.99 57.46 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.02 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.664 HD11 ' CD2' ' A' ' 22' ' ' TYR . 7.9 tp -56.38 -29.92 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.513 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -58.76 -33.94 70.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.577 0.227 . . . . 0.0 110.858 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.45 -30.37 63.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.135 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.405 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 6.8 m-85 -63.02 164.49 8.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.124 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.26 110.89 23.37 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.653 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -66.86 121.3 15.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.732 0.301 . . . . 0.0 110.512 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -102.17 85.17 2.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.653 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -55.81 -29.4 59.69 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.815 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.12 -41.56 17.66 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.16 0.288 . . . . 0.0 111.324 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.93 28.95 0.83 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 48.46 66.45 1.07 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.042 0.449 . . . . 0.0 111.909 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -138.09 154.26 49.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.589 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.664 ' CD2' HD11 ' A' ' 10' ' ' ILE . 67.4 m-85 -118.88 139.33 51.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.466 0.174 . . . . 0.0 110.573 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -128.8 156.81 42.99 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.829 0.347 . . . . 0.0 111.529 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CE1' HG11 ' A' ' 8' ' ' VAL . 31.8 t80 -137.14 136.21 20.62 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.238 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 40.0 Cg_endo -66.72 124.04 11.83 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.447 2.098 . . . . 0.0 112.622 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.41 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.6 143.36 26.19 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.16 -17.62 50.58 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.692 2.261 . . . . 0.0 112.829 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.0 p -74.76 -39.37 61.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.47 0.176 . . . . 0.0 111.153 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.43 -47.94 0.52 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.539 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.58 -173.99 4.43 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.487 0.184 . . . . 0.0 110.665 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.495 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 65.6 m-20 -131.99 140.42 48.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.683 0.278 . . . . 0.0 111.084 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.517 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 27.2 m-85 -64.48 166.25 8.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.789 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -149.8 139.49 21.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 111.57 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.791 HD11 ' O ' ' A' ' 43' ' ' GLU . 12.7 tt -151.87 125.29 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.605 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.9 p -72.72 150.54 42.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.382 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 39' ' ' LEU . 8.7 tptt -59.39 -38.81 81.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.722 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -60.7 -38.09 83.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.115 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -57.82 -47.99 81.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.375 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' A' ' 59' ' ' TYR . 4.3 mt -64.06 -38.34 90.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -65.03 -29.02 69.9 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.497 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.26 -36.98 14.41 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.17 -15.23 2.33 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.647 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.791 ' O ' HD11 ' A' ' 34' ' ' ILE . 20.9 mm-40 -68.22 80.6 0.24 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-O 121.146 0.498 . . . . 0.0 110.619 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.2 p30 -96.7 38.88 1.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.421 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.12 134.93 64.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.253 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.726 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.67 138.52 49.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.153 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.3 m -117.05 131.16 57.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.636 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.2 t -99.48 114.23 65.44 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.264 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.0 -18.53 28.68 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.706 2.271 . . . . 0.0 113.34 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 m -81.11 -73.76 0.36 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 53' ' ' LEU . 27.4 p -79.8 -24.29 41.51 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.4 m 69.28 42.46 1.2 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.978 0.418 . . . . 0.0 111.03 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.584 HD13 ' SG ' ' A' ' 51' ' ' CYS . 5.0 mp -98.69 -179.75 4.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 pt -129.55 143.41 41.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.176 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.726 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 17.2 pt -140.18 143.09 30.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.76 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -91.75 134.26 34.89 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.335 0.588 . . . . 0.0 111.426 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -108.37 114.78 47.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.834 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 mm -93.61 134.49 31.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.679 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.465 ' CD2' HD22 ' A' ' 39' ' ' LEU . 19.9 p90 -154.42 177.97 10.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.44 102.49 14.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.448 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -60.39 -30.68 69.74 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.296 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -64.83 -33.67 76.56 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.619 0.247 . . . . 0.0 111.04 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -87.16 -41.55 13.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.995 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -71.55 -34.72 70.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.42 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.23 93.61 2.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.905 0.383 . . . . 0.0 110.691 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.8 t 61.06 74.9 0.43 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.823 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.89 -55.11 0.02 OUTLIER Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.186 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -117.59 41.7 2.78 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.796 0.332 . . . . 0.0 111.139 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.7 t -66.77 154.44 40.77 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.472 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 14.3 p -78.79 137.33 58.15 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.406 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 50.6 Cg_exo -53.84 127.52 25.9 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 123.009 2.473 . . . . 0.0 112.548 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 71' ' ' PRO . . . 72.85 153.17 0.15 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.187 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.58 81.1 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.371 2.047 . . . . 0.0 112.071 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.84 113.82 26.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.253 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.0 37.28 0.35 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -103.29 126.79 50.63 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.9 pttt -137.58 76.88 1.6 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.289 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -106.9 38.43 2.09 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.762 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -82.71 70.85 9.78 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.092 0.472 . . . . 0.0 111.04 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.1 t -129.04 108.38 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.991 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -73.67 109.32 7.08 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.801 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 83' ' ' GLU . 0.6 OUTLIER 70.28 150.31 0.09 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' N ' HD23 ' A' ' 82' ' ' LEU . 1.5 tt0 -158.61 -62.26 0.08 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.321 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 82.1 t60 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.948 0.404 . . . . 0.0 110.853 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.0 177.07 9.04 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.621 0.248 . . . . 0.0 111.631 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.0 m -75.4 80.4 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.154 0.502 . . . . 0.0 111.214 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.437 ' CE2' HG23 ' A' ' 45' ' ' VAL . 8.4 m-85 -77.28 160.32 28.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.418 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -76.44 -62.16 1.71 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.614 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -157.96 141.24 15.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.988 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -94.68 132.66 39.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.471 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.734 HG11 ' CE1' ' A' ' 24' ' ' TYR . 20.7 t -130.96 141.57 45.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.214 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -69.52 140.14 53.9 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.203 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.551 HD13 HD13 ' A' ' 39' ' ' LEU . 1.1 tp -55.64 -29.01 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.537 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.97 -32.41 69.61 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.638 0.256 . . . . 0.0 110.809 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.28 -30.6 62.17 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.88 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.466 ' HZ ' HD12 ' A' ' 55' ' ' ILE . 11.9 m-85 -64.08 171.32 3.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.3 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -109.35 112.65 24.9 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -65.85 124.1 21.58 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.386 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -100.38 93.82 5.85 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.81 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.49 -26.45 54.28 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.67 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -47.77 -52.97 16.76 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.521 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.9 m -145.27 29.91 1.15 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.73 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.96 70.3 0.57 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.958 0.409 . . . . 0.0 111.458 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.3 m -138.35 154.87 48.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.595 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.53 ' CG ' HD11 ' A' ' 10' ' ' ILE . 51.7 m-85 -119.93 140.37 51.01 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.6 0.238 . . . . 0.0 110.583 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -131.37 153.72 49.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.602 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.734 ' CE1' HG11 ' A' ' 8' ' ' VAL . 7.4 t80 -129.55 137.13 30.28 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.25 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 54.6 Cg_endo -69.93 124.17 10.76 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.605 2.203 . . . . 0.0 112.665 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.43 143.47 26.59 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.929 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.08 -17.08 45.75 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.759 2.306 . . . . 0.0 112.851 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.9 p -74.35 -41.16 61.5 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.422 0.153 . . . . 0.0 111.168 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.63 -52.57 0.4 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.917 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.56 -169.59 1.76 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.67 0.235 . . . . 0.0 111.231 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 5.3 m-80 -136.37 142.36 43.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 112.068 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -64.1 162.03 15.05 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.153 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.82 138.89 25.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.774 0.321 . . . . 0.0 111.83 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.804 HD11 ' O ' ' A' ' 43' ' ' GLU . 3.5 tt -152.01 124.39 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.992 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.0 p -72.81 148.84 44.14 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.572 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HA ' HD12 ' A' ' 39' ' ' LEU . 8.5 tptt -58.71 -39.62 81.34 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.768 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -61.11 -39.16 88.96 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.134 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -57.06 -47.98 79.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.692 0.282 . . . . 0.0 110.49 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.551 HD13 HD13 ' A' ' 10' ' ' ILE . 3.9 mt -64.49 -39.15 93.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.876 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.474 ' O ' HG22 ' A' ' 65' ' ' VAL . 52.9 mt-10 -64.51 -26.4 68.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.579 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -92.97 -36.57 12.68 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.67 -17.2 2.02 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.634 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.804 ' O ' HD11 ' A' ' 34' ' ' ILE . 8.7 mt-10 -67.61 81.13 0.17 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-O 121.219 0.533 . . . . 0.0 110.875 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.3 p30 -95.64 39.43 1.13 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.519 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG23 ' CE2' ' A' ' 4' ' ' PHE . 8.1 p -126.17 130.85 72.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.074 0.464 . . . . 0.0 111.501 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -114.8 135.08 54.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.714 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 m -111.0 125.87 54.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.562 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 49.4 t -78.63 133.92 62.17 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.812 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.34 45.95 2.11 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.955 2.437 . . . . 0.0 113.328 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.77 -67.93 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.348 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 53' ' ' LEU . 30.0 p -80.5 -24.96 39.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.484 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.86 37.86 2.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.853 0.359 . . . . 0.0 110.981 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.547 HD12 ' SG ' ' A' ' 51' ' ' CYS . 10.9 mt -88.66 -179.82 6.1 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.713 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.1 pt -128.57 143.36 41.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.863 0.363 . . . . 0.0 111.291 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 46' ' ' ALA . 4.0 pt -142.56 141.27 27.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.975 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.18 135.64 33.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.207 0.527 . . . . 0.0 111.324 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.769 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -109.36 113.35 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.033 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 mm -90.51 134.85 28.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.428 ' CZ ' ' HE2' ' A' ' 61' ' ' LYS . 22.5 p90 -154.86 174.3 15.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.795 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.37 102.48 12.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.622 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HE2' ' CZ ' ' A' ' 59' ' ' TYR . 8.8 mmtp -59.82 -30.49 68.97 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.5 -40.31 89.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.831 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -78.14 -44.2 26.67 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.934 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -68.02 -38.97 83.22 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.442 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 40' ' ' GLU . 21.2 t -114.73 91.33 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.651 0.263 . . . . 0.0 111.558 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.58 79.13 0.36 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.114 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -104.86 -50.18 0.97 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.379 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.65 33.77 2.86 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.641 0.258 . . . . 0.0 111.226 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.0 t -133.04 154.77 50.23 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.686 0.279 . . . . 0.0 111.133 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.9 t -139.76 141.33 27.39 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.411 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.14 175.81 0.61 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.015 2.477 . . . . 0.0 112.675 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.06 114.85 8.48 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.801 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.89 98.21 0.6 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.625 2.216 . . . . 0.0 111.802 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.7 m 58.41 37.05 25.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.042 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.51 172.3 13.76 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -134.74 161.33 35.47 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.009 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -87.67 103.83 15.96 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.455 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -140.85 37.94 1.8 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.9 35.43 4.11 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.984 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.54 138.52 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.08 115.35 23.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.832 0.348 . . . . 0.0 111.18 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.5 tp -130.61 34.73 4.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.072 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.31 -52.02 0.95 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.904 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 . . . . . 0 C--O 1.231 0.12 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.54 0.21 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.8 157.47 27.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.341 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.514 ' O ' HD11 ' A' ' 54' ' ' ILE . 7.1 t -120.99 31.59 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.426 ' CE2' HG23 ' A' ' 45' ' ' VAL . 3.2 m-85 -110.36 175.46 5.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.74 -62.07 1.67 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.832 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -165.42 139.57 4.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.969 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.33 133.07 35.21 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.662 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.506 HG11 ' CE1' ' A' ' 24' ' ' TYR . 21.2 t -134.12 141.51 43.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.179 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -67.19 139.9 57.44 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.965 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.625 HD11 ' CG ' ' A' ' 22' ' ' TYR . 6.7 tp -54.15 -31.16 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.606 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -59.28 -34.14 71.92 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.709 0.29 . . . . 0.0 110.822 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.2 -28.52 62.24 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.136 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 27.4 m-85 -66.12 169.21 7.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.875 0.369 . . . . 0.0 110.974 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -103.32 109.02 20.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -65.75 128.01 34.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.644 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -103.96 94.99 5.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.0 -26.28 59.98 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.357 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.52 -51.66 19.99 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.679 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -152.0 33.61 0.53 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.667 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 52.53 74.32 0.29 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.812 0.339 . . . . 0.0 111.838 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 m -138.48 151.17 47.15 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.791 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.625 ' CG ' HD11 ' A' ' 10' ' ' ILE . 54.0 m-85 -122.02 137.69 54.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.724 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -130.19 156.94 43.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.482 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.506 ' CE1' HG11 ' A' ' 8' ' ' VAL . 24.8 t80 -141.09 134.33 14.56 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.043 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 24' ' ' TYR . 32.1 Cg_exo -58.19 127.47 25.01 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.903 2.402 . . . . 0.0 113.03 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.433 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 2.0 t -102.74 138.04 19.49 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.433 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 60.4 Cg_endo -73.11 60.78 3.9 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.665 2.243 . . . . 0.0 112.64 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.1 p -157.16 -47.57 0.07 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.971 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.59 -52.15 0.19 Allowed Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.645 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.46 -179.38 6.07 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.642 0.258 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -127.43 142.41 51.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.722 0.296 . . . . 0.0 111.455 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.416 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 89.0 m-85 -58.91 166.86 1.79 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.295 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.1 p -150.97 139.02 20.06 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.611 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.878 HD13 HG21 ' A' ' 57' ' ' VAL . 1.7 tt -152.22 124.6 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.828 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.0 p -72.1 149.48 44.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 111.347 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -39.3 87.31 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.952 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -61.25 -37.88 84.71 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.236 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 43' ' ' GLU . 4.8 m-20 -56.41 -43.95 79.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.413 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.605 HD22 ' CE2' ' A' ' 59' ' ' TYR . 29.0 mt -61.7 -41.77 98.04 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.874 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.57 -28.12 67.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.597 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -85.85 -39.63 16.83 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.22 -13.38 2.55 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.534 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.823 ' O ' HD11 ' A' ' 34' ' ' ILE . 32.0 mm-40 -71.13 81.31 0.7 Allowed 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.088 0.471 . . . . 0.0 110.866 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -96.6 39.95 1.15 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 4' ' ' PHE . 7.8 p -130.33 128.9 64.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.324 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.62 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.92 140.93 47.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 52' ' ' SER . 1.0 OUTLIER -119.32 132.89 55.94 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.0 t -74.25 133.5 77.93 Favored Pre-proline 0 C--O 1.234 0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.857 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.28 52.93 4.49 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.874 2.382 . . . . 0.0 112.93 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.0 t -164.64 -56.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.445 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.742 ' SG ' HD13 ' A' ' 53' ' ' LEU . 29.2 p -98.01 -22.83 16.06 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.61 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.579 ' HA ' HG22 ' A' ' 47' ' ' THR . 1.9 t 71.95 41.87 0.64 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 110.444 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.742 HD13 ' SG ' ' A' ' 51' ' ' CYS . 1.4 mp -77.31 -175.44 3.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.665 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.514 HD11 ' O ' ' A' ' 3' ' ' VAL . 8.4 pt -139.1 143.66 31.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.893 0.377 . . . . 0.0 111.557 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.62 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 12.0 pt -147.09 147.8 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.908 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -93.2 133.56 36.27 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.252 0.548 . . . . 0.0 111.229 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.878 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -107.25 113.95 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.948 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.7 mm -95.41 135.04 30.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.84 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.605 ' CE2' HD22 ' A' ' 39' ' ' LEU . 15.9 p90 -156.22 178.42 10.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.984 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 10.9 t0 -80.55 98.04 7.43 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.394 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -61.89 -29.9 70.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.695 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 66' ' ' SER . 1.0 OUTLIER -69.18 -32.6 72.03 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.761 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 17.7 mm-40 -82.92 -45.41 14.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.742 0.306 . . . . 0.0 110.848 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -72.46 -42.57 64.82 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.468 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.6 t -105.5 84.18 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.923 0.392 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 7.4 t -168.47 43.83 0.04 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.766 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -141.31 -50.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.275 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -103.76 33.23 3.49 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.687 0.28 . . . . 0.0 111.308 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.6 m -112.24 80.08 1.29 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.819 0.343 . . . . 0.0 110.487 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.406 HG23 ' HD2' ' A' ' 71' ' ' PRO . 9.1 p -168.99 135.87 1.51 Allowed Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 70' ' ' VAL . 74.3 Cg_endo -75.76 151.02 35.75 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.641 2.227 . . . . 0.0 112.601 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.58 150.46 88.98 Favored Pre-proline 0 C--O 1.231 0.104 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.886 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.16 88.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.94 2.427 . . . . 0.0 112.764 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.6 m 63.38 100.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.815 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.13 154.95 31.27 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.582 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m120 64.93 -179.33 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.618 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -132.62 121.07 22.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.903 0.383 . . . . 0.0 111.291 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -137.12 92.83 2.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.734 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.92 68.29 1.2 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.071 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.8 t -118.13 86.82 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 95.5 10.07 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -70.04 132.44 45.89 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.132 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.422 ' N ' HD13 ' A' ' 82' ' ' LEU . 1.6 tm-20 -62.72 152.13 36.47 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.297 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.9 t60 . . . . . 0 C--O 1.232 0.145 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.735 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.611 0.243 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.09 -66.67 0.61 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.138 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.3 m -63.28 122.77 14.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.967 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.414 ' CD1' HD12 ' A' ' 54' ' ' ILE . 5.2 m-85 -67.33 146.42 54.11 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -64.96 -61.39 2.19 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.692 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -166.95 156.51 10.9 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.73 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.92 136.06 39.45 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.528 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG21 ' CZ ' ' A' ' 24' ' ' TYR . 19.7 t -136.66 141.3 41.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.195 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.63 139.91 57.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.084 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.571 HD11 ' CD2' ' A' ' 22' ' ' TYR . 1.0 OUTLIER -55.45 -28.84 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.378 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -57.18 -32.05 66.06 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.898 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -76.16 -29.38 57.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.114 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' HZ ' HD12 ' A' ' 55' ' ' ILE . 7.6 m-85 -63.92 174.99 1.29 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.026 0.441 . . . . 0.0 111.251 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -113.95 111.78 22.23 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -64.9 124.91 23.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.655 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -107.36 88.73 2.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.897 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -55.34 -28.21 52.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.267 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.2 -44.56 11.07 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.611 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.1 p -146.51 25.47 1.2 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 50.8 62.89 2.47 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.098 0.475 . . . . 0.0 111.563 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.1 m -138.52 153.29 48.74 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.673 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.571 ' CD2' HD11 ' A' ' 10' ' ' ILE . 27.1 m-85 -113.51 138.76 49.66 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.61 0.243 . . . . 0.0 110.679 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 7.9 m-85 -122.36 149.58 43.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.375 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.454 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 40.8 t80 -127.45 131.56 23.9 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.794 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.15 123.94 14.79 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.717 2.278 . . . . 0.0 112.626 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -108.36 146.07 32.85 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.601 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 26' ' ' CYS . 44.3 Cg_exo -56.29 -28.27 70.95 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.005 2.47 . . . . 0.0 112.847 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -72.88 -39.25 66.59 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.045 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.31 21.01 6.37 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.193 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 -32.47 9.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.932 0.366 . . . . 0.0 111.399 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 73.89 122.01 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.128 0.49 . . . . 0.0 111.944 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.695 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 68.7 m-85 -62.65 165.2 6.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.423 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -143.17 139.39 30.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.819 0.343 . . . . 0.0 111.561 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.773 HD11 ' O ' ' A' ' 43' ' ' GLU . 6.0 tt -151.73 122.92 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.705 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 p -71.63 148.56 46.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.379 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HA ' HD12 ' A' ' 39' ' ' LEU . 19.3 tptm -58.94 -39.54 81.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.985 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -60.88 -38.07 84.33 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.6 -47.49 81.99 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.638 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.508 HD13 HD13 ' A' ' 10' ' ' ILE . 4.2 mt -65.0 -36.13 83.42 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.863 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.596 ' O ' HG22 ' A' ' 65' ' ' VAL . 57.4 mt-10 -67.85 -24.77 65.3 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.499 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -94.83 -35.82 11.91 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.91 -16.32 2.38 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.46 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.773 ' O ' HD11 ' A' ' 34' ' ' ILE . 20.6 mm-40 -67.63 81.8 0.18 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-O 121.036 0.445 . . . . 0.0 110.606 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.6 p30 -96.64 38.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.749 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.48 132.61 70.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.946 0.403 . . . . 0.0 111.278 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.695 ' HB1' ' HB3' ' A' ' 32' ' ' PHE . . . -112.74 130.3 56.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.962 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.2 132.91 56.46 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.046 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.96 143.65 53.75 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.629 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -79.42 1.83 8.86 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.621 2.214 . . . . 0.0 113.277 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.1 t -120.36 -68.75 0.89 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.395 0.14 . . . . 0.0 111.038 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.497 ' SG ' HD12 ' A' ' 53' ' ' LEU . 31.9 p -75.0 -24.98 58.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.381 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 m 64.67 40.69 5.7 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 110.851 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.497 HD12 ' SG ' ' A' ' 51' ' ' CYS . 3.4 mt -81.05 -178.68 7.0 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.768 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.414 HD12 ' CD1' ' A' ' 4' ' ' PHE . 14.4 pt -135.82 143.19 37.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.351 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.641 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.7 pt -147.62 144.91 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.902 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -92.74 133.97 35.5 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.293 0.568 . . . . 0.0 111.477 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.738 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -108.62 113.94 45.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.158 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.0 mm -92.55 134.9 29.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.668 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.433 ' CD2' HD22 ' A' ' 39' ' ' LEU . 17.9 p90 -153.44 178.63 9.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.477 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -86.5 105.89 17.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.893 0.377 . . . . 0.0 110.7 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -60.28 -29.33 68.74 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.093 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -68.15 -41.76 81.09 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.91 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -76.28 -47.93 21.97 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.238 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -69.99 -35.36 74.34 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.321 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 40' ' ' GLU . 17.8 t -125.12 93.33 2.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.94 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 t -95.47 42.66 1.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.944 0.402 . . . . 0.0 110.951 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -136.28 -58.75 0.06 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.961 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -121.31 42.51 3.06 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.734 0.302 . . . . 0.0 111.044 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 t -63.79 152.08 40.42 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.834 0.349 . . . . 0.0 110.967 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.433 HG23 ' HD2' ' A' ' 71' ' ' PRO . 9.8 p -161.07 136.29 5.66 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.41 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 70' ' ' VAL . 72.2 Cg_endo -76.1 -174.37 2.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.841 2.36 . . . . 0.0 112.322 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.73 150.03 18.82 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.534 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.17 -179.84 3.87 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.821 2.348 . . . . 0.0 112.427 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -152.32 126.67 9.3 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.13 -60.4 2.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -162.65 154.18 17.97 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.99 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -134.35 117.08 15.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.041 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.82 103.82 3.66 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.74 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 79' ' ' LEU . 2.3 pt? -175.91 130.11 0.24 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -112.98 137.31 46.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -78.36 114.66 17.46 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.804 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.66 119.18 20.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -138.48 35.14 2.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.067 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.905 0.383 . . . . 0.0 110.781 179.84 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mtt . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.21 93.75 1.11 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 111.135 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.23 148.35 24.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.856 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CD1' HD12 ' A' ' 54' ' ' ILE . 7.8 m-85 -61.22 125.69 24.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -59.57 -64.41 0.95 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -156.99 161.05 39.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.912 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 56' ' ' LYS . 23.4 mt-10 -99.87 135.57 41.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.488 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.592 HG11 ' CE1' ' A' ' 24' ' ' TYR . 21.4 t -130.72 140.95 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.189 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -73.86 139.8 45.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.994 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.804 HD11 ' CD2' ' A' ' 22' ' ' TYR . 9.0 tp -57.21 -28.72 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.576 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.92 -33.44 71.88 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.573 0.225 . . . . 0.0 110.681 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -74.92 -29.98 61.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.779 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 24' ' ' TYR . 6.1 m-85 -62.38 172.61 1.45 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.301 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -115.03 108.52 16.79 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -66.13 135.88 55.18 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.525 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -113.11 97.14 6.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.609 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -57.74 -26.09 61.33 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -48.16 -52.91 18.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.428 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -146.65 30.84 0.98 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.648 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 52.32 71.75 0.45 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 111.482 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 m -137.94 143.54 40.8 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.512 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.804 ' CD2' HD11 ' A' ' 10' ' ' ILE . 14.6 m-85 -113.68 138.84 49.65 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.788 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -128.71 157.05 42.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.625 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.592 ' CE1' HG11 ' A' ' 8' ' ' VAL . 22.0 t80 -138.09 135.54 18.69 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.091 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 24' ' ' TYR . 32.2 Cg_exo -58.3 124.44 15.88 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.79 2.326 . . . . 0.0 112.559 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.432 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.8 144.17 27.69 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.45 -17.14 43.88 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.612 2.208 . . . . 0.0 112.84 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.8 p -77.86 -33.15 52.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.248 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.06 -47.72 0.65 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.623 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 -163.25 0.37 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.538 0.209 . . . . 0.0 110.954 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -140.39 139.41 35.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.728 0.299 . . . . 0.0 110.848 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.493 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 22.7 m-85 -62.61 162.6 10.29 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.978 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m -144.13 139.22 28.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.793 0.33 . . . . 0.0 111.638 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.807 HD11 ' O ' ' A' ' 43' ' ' GLU . 5.8 tt -151.95 124.38 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.752 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 p -72.08 148.56 45.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.368 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -38.91 85.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.854 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -36.89 81.23 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.169 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.14 -48.0 83.21 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.532 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.427 HD22 ' CE1' ' A' ' 59' ' ' TYR . 6.7 mt -63.2 -36.61 84.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.99 -32.46 73.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.303 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -89.49 -34.38 16.43 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.15 -12.54 3.06 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.57 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.807 ' O ' HD11 ' A' ' 34' ' ' ILE . 20.1 mm-40 -68.05 79.17 0.23 Allowed 'General case' 0 C--N 1.343 0.283 0 CA-C-O 121.135 0.493 . . . . 0.0 110.728 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 57' ' ' VAL . 11.3 p30 -95.02 39.37 1.11 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.408 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.2 p -124.24 133.81 68.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.256 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.671 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.75 137.0 51.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.391 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 130.58 56.18 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.1 t -93.08 133.36 28.9 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.423 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.07 -4.59 15.62 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.629 2.219 . . . . 0.0 113.241 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.81 -65.92 0.96 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.528 0.204 . . . . 0.0 111.262 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 53' ' ' LEU . 31.9 p -80.45 -26.28 38.44 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m 66.81 42.92 2.45 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.935 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.543 HD12 ' SG ' ' A' ' 51' ' ' CYS . 7.9 mt -100.51 179.69 4.36 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.851 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 4' ' ' PHE . 13.5 pt -128.98 143.43 41.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.185 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.671 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 7.1 pt -141.79 147.98 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.014 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 7' ' ' GLU . 1.9 tppp? -93.17 134.58 35.2 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.334 0.588 . . . . 0.0 111.381 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.718 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -108.79 113.2 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.826 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.56 134.29 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CE1' HD22 ' A' ' 39' ' ' LEU . 12.6 p90 -155.12 178.62 9.99 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.894 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 5.6 t70 -92.42 93.82 8.79 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.73 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -57.68 -31.15 66.08 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.288 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -34.92 79.51 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.762 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 2.3 mt-30 -84.3 -36.37 22.66 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.769 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -61.75 -61.13 2.73 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.434 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 65' ' ' VAL . 9.9 p -112.17 94.61 3.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.349 0.595 . . . . 0.0 111.229 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.22 32.85 2.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.83 -92.83 1.01 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.15 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.73 78.56 1.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 0.0 111.034 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 t -97.32 97.28 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.713 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.11 138.35 19.27 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.192 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 52.0 Cg_exo -54.76 140.68 77.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.806 2.338 . . . . 0.0 112.654 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . 71.38 159.33 0.16 Allowed Pre-proline 0 N--CA 1.467 0.392 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.329 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 58.6 Cg_endo -71.54 156.23 58.24 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.429 2.086 . . . . 0.0 112.575 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.2 m -107.12 -45.76 4.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.128 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.93 138.85 32.97 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.298 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -103.14 -34.94 8.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HG2' HD21 ' A' ' 79' ' ' LEU . 9.4 ttpt -160.37 113.25 2.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.988 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -136.62 102.37 4.9 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.118 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 79' ' ' LEU . 1.4 pt? -173.44 129.17 0.44 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 80' ' ' VAL . 12.2 p -69.53 117.54 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.129 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -113.12 104.51 12.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.008 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 82' ' ' LEU . 4.2 mm? -80.67 143.77 32.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.044 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.21 117.94 17.06 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.956 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 . . . . . 0 N--CA 1.465 0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.959 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.521 ' HB3' HG22 ' A' ' 3' ' ' VAL . 1.8 mmt . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.676 0.274 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.38 33.16 3.01 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.254 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 1' ' ' MET . 11.9 m -120.32 25.49 4.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.176 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.552 ' CD1' HD12 ' A' ' 54' ' ' ILE . 1.0 OUTLIER 59.45 178.67 0.08 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.961 0.41 . . . . 0.0 111.295 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -96.77 -62.54 1.25 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -167.82 144.67 4.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.752 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -93.28 124.21 37.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.461 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.52 HG11 ' CE1' ' A' ' 24' ' ' TYR . 30.2 t -121.67 141.51 41.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.229 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -69.48 140.07 53.97 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.141 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.55 HD11 ' CD2' ' A' ' 22' ' ' TYR . 1.2 tp -56.81 -29.83 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.754 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -59.44 -34.02 71.99 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.691 0.281 . . . . 0.0 110.816 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -72.54 -34.03 67.26 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -59.04 159.49 7.16 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.433 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.71 87.62 4.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.323 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.53 ' HB2' ' CE2' ' A' ' 22' ' ' TYR . 83.9 t80 -72.64 150.04 43.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.908 0.385 . . . . 0.0 111.017 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.48 135.15 47.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.636 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.26 -31.72 26.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.554 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.22 -34.39 42.89 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.805 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.6 t -96.02 -29.5 14.1 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.875 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 61.37 39.57 15.15 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.081 0.467 . . . . 0.0 110.73 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.497 HG23 ' C ' ' A' ' 34' ' ' ILE . 48.8 m -142.04 146.11 35.12 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.418 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.55 ' CD2' HD11 ' A' ' 10' ' ' ILE . 65.0 m-85 -98.83 140.73 32.58 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.709 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -127.96 156.46 42.63 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.454 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.52 ' CE1' HG11 ' A' ' 8' ' ' VAL . 23.1 t80 -148.91 136.86 11.37 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.146 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 37.2 Cg_endo -65.47 130.73 25.89 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.656 2.237 . . . . 0.0 112.731 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.75 144.95 28.73 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.818 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.91 -25.78 63.98 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.927 2.418 . . . . 0.0 112.912 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -74.91 -40.54 60.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.31 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.27 -46.17 0.55 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.609 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.69 -178.76 2.35 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.524 0.202 . . . . 0.0 110.66 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 35.8 m-20 -127.73 138.14 52.68 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.713 0.292 . . . . 0.0 111.095 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.791 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 60.9 m-85 -65.34 169.19 6.08 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.511 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 p -152.18 139.14 19.05 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.653 HD11 ' O ' ' A' ' 43' ' ' GLU . 14.4 tt -150.99 124.5 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.28 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 p -71.72 149.36 45.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.197 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -56.29 -36.61 68.83 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.641 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.09 -39.29 89.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.287 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.409 ' CB ' ' HB2' ' A' ' 43' ' ' GLU . 5.0 m-20 -56.46 -47.82 78.37 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.76 0.314 . . . . 0.0 110.988 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.426 HD22 ' CD1' ' A' ' 59' ' ' TYR . 5.6 mt -61.73 -42.44 98.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -68.16 -30.28 69.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.275 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -82.27 -39.76 22.51 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.94 -13.99 2.62 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.64 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.653 ' O ' HD11 ' A' ' 34' ' ' ILE . 58.4 mm-40 -69.46 80.19 0.39 Allowed 'General case' 0 C--N 1.341 0.224 0 CA-C-O 120.902 0.382 . . . . 0.0 110.941 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.1 p30 -95.37 40.32 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.76 137.94 54.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.319 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.791 ' HB1' ' HB3' ' A' ' 32' ' ' PHE . . . -113.12 132.27 55.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.764 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -113.56 132.6 55.66 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.147 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.409 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . 26.1 t -89.81 134.43 32.1 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.572 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.98 0.04 10.09 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.668 2.245 . . . . 0.0 113.439 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.69 -65.28 1.1 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.512 0.196 . . . . 0.0 111.272 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.661 ' SG ' HD13 ' A' ' 53' ' ' LEU . 28.1 p -88.18 -22.86 23.8 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t 69.36 42.77 1.13 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.078 0.465 . . . . 0.0 110.784 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.661 HD13 ' SG ' ' A' ' 51' ' ' CYS . 4.7 mp -88.74 179.54 6.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.744 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.552 HD12 ' CD1' ' A' ' 4' ' ' PHE . 14.0 pt -132.24 143.31 40.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.271 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.756 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 11.0 pt -143.85 146.74 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.935 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.16 136.01 33.38 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.297 0.57 . . . . 0.0 111.248 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -110.19 114.05 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.867 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.3 mm -93.62 135.39 28.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.787 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.426 ' CD1' HD22 ' A' ' 39' ' ' LEU . 12.5 p90 -157.98 176.47 12.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.058 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 6.6 t0 -88.94 94.38 9.92 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -59.09 -33.1 70.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.822 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.09 -30.24 71.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.035 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 1.9 mm-40 -89.49 -33.41 16.79 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.636 0.255 . . . . 0.0 110.769 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.82 -64.02 0.96 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.244 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 65' ' ' VAL . 8.4 p -112.74 96.02 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.24 0.543 . . . . 0.0 111.382 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.3 t -157.34 84.44 0.92 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.634 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -149.82 -65.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.142 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -103.07 37.4 1.98 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.69 0.281 . . . . 0.0 110.673 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -130.68 120.7 24.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.666 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.87 140.42 93.52 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.344 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.86 171.61 1.0 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.988 2.459 . . . . 0.0 112.844 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.98 150.2 73.75 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.993 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.79 168.38 21.75 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.023 2.482 . . . . 0.0 112.643 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 12.5 p -96.41 142.64 28.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.328 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 74' ' ' SER . . . 71.83 -70.4 0.16 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.95 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -153.47 165.76 34.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.557 0.218 . . . . 0.0 110.876 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -70.24 127.9 34.37 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.652 0.263 . . . . 0.0 110.701 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.86 118.43 30.77 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.878 0.371 . . . . 0.0 111.371 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.54 33.03 0.56 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.243 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 p -116.36 129.55 72.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.012 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -108.51 73.36 0.87 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.818 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mt -148.27 167.35 25.38 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.054 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.44 -52.78 8.53 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 . . . . . 0 N--CA 1.461 0.119 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.817 179.767 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.662 0.268 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.19 153.56 24.7 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.309 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p -105.37 148.93 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.413 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -80.47 167.96 19.53 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -78.38 -60.32 2.42 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.877 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -160.63 161.12 32.37 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.002 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -110.69 132.99 53.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.466 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.621 HG11 ' CE1' ' A' ' 24' ' ' TYR . 22.1 t -138.7 141.54 36.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.12 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.13 139.71 57.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.006 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.751 HD11 ' CG ' ' A' ' 22' ' ' TYR . 8.2 tp -56.62 -29.57 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.926 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.46 -30.54 69.74 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.592 0.234 . . . . 0.0 110.991 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.43 -31.13 65.23 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.06 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 7.6 m-85 -61.93 156.73 20.21 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.977 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -92.96 83.65 4.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.414 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.45 ' HB2' ' CE2' ' A' ' 22' ' ' TYR . 76.5 t80 -67.38 153.46 43.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.966 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.82 99.18 2.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.299 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.15 -31.8 20.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.01 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -53.23 -43.1 67.03 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.066 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 t -107.22 -18.86 13.77 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 63.85 42.59 5.93 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 110.524 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.469 HG23 ' C ' ' A' ' 34' ' ' ILE . 24.2 m -142.9 146.35 33.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.819 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.751 ' CG ' HD11 ' A' ' 10' ' ' ILE . 81.6 m-85 -101.46 141.15 34.76 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.739 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -127.41 149.07 50.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.388 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.621 ' CE1' HG11 ' A' ' 8' ' ' VAL . 12.6 t80 -131.52 137.13 29.77 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.175 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.78 124.24 10.04 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.639 2.226 . . . . 0.0 112.58 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.47 145.2 29.26 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.724 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.29 -18.6 50.35 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.617 2.211 . . . . 0.0 112.83 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.0 p -76.77 -33.95 58.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.183 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.25 -45.53 0.79 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.546 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 0.4 OUTLIER -74.02 -173.33 1.57 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.704 0.288 . . . . 0.0 110.876 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -139.51 133.16 30.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.675 0.274 . . . . 0.0 111.405 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.564 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 40.0 m-85 -61.16 159.06 12.63 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.847 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 p -146.33 139.21 25.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 111.603 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.655 HD11 ' O ' ' A' ' 43' ' ' GLU . 11.5 tt -152.02 125.58 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.556 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.0 p -71.53 151.95 43.42 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.274 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -57.46 -37.15 72.42 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.734 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -60.86 -38.15 84.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.034 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.17 -47.96 81.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.804 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.69 -42.04 98.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.862 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.59 -29.73 69.16 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.4 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -84.23 -40.98 17.41 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.74 -13.79 2.2 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.715 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.655 ' O ' HD11 ' A' ' 34' ' ' ILE . 51.2 mm-40 -68.68 79.2 0.29 Allowed 'General case' 0 C--N 1.343 0.297 0 CA-C-O 121.044 0.449 . . . . 0.0 110.877 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 p30 -94.07 39.47 1.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.639 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.5 p -129.58 132.07 66.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.692 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -113.16 138.63 49.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.632 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.0 m -117.57 132.1 56.58 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.3 t -89.97 133.91 32.84 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.569 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.53 -4.76 15.98 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.595 2.196 . . . . 0.0 113.385 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -104.01 -67.03 0.92 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.517 0.199 . . . . 0.0 111.149 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.56 ' SG ' HD12 ' A' ' 53' ' ' LEU . 31.3 p -80.68 -26.83 37.32 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.716 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.46 40.36 2.66 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.999 0.428 . . . . 0.0 110.902 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.56 HD12 ' SG ' ' A' ' 51' ' ' CYS . 12.4 mt -93.87 -179.84 5.11 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.707 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.9 pt -126.13 143.51 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.185 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.692 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.2 pt -141.66 144.2 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.15 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -91.68 133.82 35.24 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.282 0.563 . . . . 0.0 111.412 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.442 HG13 ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -108.32 113.18 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.908 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mm -91.22 134.46 29.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.058 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -155.19 176.55 12.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.619 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.37 99.43 12.45 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.835 0.35 . . . . 0.0 110.801 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -60.32 -29.99 69.22 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.102 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.95 -36.2 83.63 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.739 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -82.26 -44.51 16.21 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.865 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -64.16 -38.09 89.79 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.132 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.3 t -112.37 84.9 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.95 0.405 . . . . 0.0 110.983 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.1 p -108.77 40.9 1.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.994 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.32 -67.25 1.72 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.073 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -116.02 79.62 1.33 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.809 0.337 . . . . 0.0 111.487 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.0 m -153.92 126.52 8.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.48 140.39 21.27 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.022 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.03 -178.0 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.965 2.443 . . . . 0.0 112.723 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.64 144.42 13.22 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.602 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.25 51.94 4.11 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.772 2.315 . . . . 0.0 112.275 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.69 -73.15 0.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.257 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -176.03 178.88 1.38 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.027 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -99.12 -42.95 6.84 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.135 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -174.43 121.27 0.26 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.171 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -157.48 95.51 1.46 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.022 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.39 33.18 5.69 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.04 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 80' ' ' VAL . 10.6 p -105.47 23.86 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.069 0.461 . . . . 0.0 111.273 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -156.97 90.89 1.16 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.113 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tp 65.25 106.48 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.466 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -121.39 132.9 55.02 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.999 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 m80 . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 121.11 0.481 . . . . 0.0 111.018 179.429 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.758 0.313 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.8 94.68 2.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.624 ' O ' HD11 ' A' ' 54' ' ' ILE . 15.9 m -139.04 78.44 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.054 0.455 . . . . 0.0 111.448 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -101.23 175.26 5.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.303 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.531 ' CG ' HD21 ' A' ' 53' ' ' LEU . 4.0 t60 -88.29 -62.35 1.51 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.947 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -159.53 155.57 26.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.074 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 56' ' ' LYS . 1.9 mp0 -103.09 134.76 45.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.669 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.656 HG11 ' CZ ' ' A' ' 24' ' ' TYR . 21.2 t -134.68 139.93 46.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.042 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -67.13 140.07 57.52 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.989 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.462 HD11 ' CD2' ' A' ' 22' ' ' TYR . 1.1 tp -56.76 -29.73 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.495 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -58.99 -33.24 70.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.703 0.287 . . . . 0.0 110.686 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.86 -29.6 65.76 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.156 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 11.2 m-85 -66.54 172.33 4.22 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.134 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.87 110.31 22.44 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.736 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -66.84 112.02 4.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.877 0.37 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -94.02 87.38 5.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.442 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -56.01 -28.55 57.74 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.354 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -47.23 -43.91 22.22 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.278 0.361 . . . . 0.0 111.498 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.0 m -143.93 28.06 1.43 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.647 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 46.98 62.52 2.34 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.898 0.38 . . . . 0.0 111.645 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.2 m -137.8 151.7 48.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.462 ' CD2' HD11 ' A' ' 10' ' ' ILE . 26.1 m-85 -112.97 139.54 48.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.528 0.204 . . . . 0.0 110.758 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -128.9 153.84 47.1 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.466 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.656 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 4.4 t80 -134.63 137.14 26.89 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 52.1 Cg_endo -69.38 126.58 13.74 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.573 2.182 . . . . 0.0 112.947 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.429 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -98.84 142.28 24.33 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 35.3 Cg_endo -64.97 -18.5 62.38 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.733 2.289 . . . . 0.0 113.045 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.7 p -76.36 -41.48 48.04 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.338 0.113 . . . . 0.0 111.168 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.42 -55.46 0.33 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.968 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 0.4 OUTLIER -75.93 -175.82 3.18 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.596 0.236 . . . . 0.0 111.039 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 48.7 m-20 -129.89 144.24 51.22 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.854 0.359 . . . . 0.0 111.506 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.619 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 68.4 m-85 -66.27 168.94 7.89 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.646 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.4 p -153.1 139.2 18.27 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 111.736 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.775 HD11 ' O ' ' A' ' 43' ' ' GLU . 9.6 tt -151.97 123.49 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.778 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.5 p -72.1 151.77 42.83 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 111.386 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -60.18 -38.83 84.41 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.826 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.86 -38.13 84.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.231 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -57.14 -48.05 79.63 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.684 0.278 . . . . 0.0 110.582 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.472 HD22 ' CD2' ' A' ' 59' ' ' TYR . 8.5 mt -61.4 -46.9 88.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.807 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -59.76 -27.18 66.3 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.665 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -89.98 -38.42 13.65 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.68 -4.6 3.04 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.844 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.775 ' O ' HD11 ' A' ' 34' ' ' ILE . 53.1 mm-40 -76.55 79.92 3.23 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.125 0.488 . . . . 0.0 109.788 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.0 m-20 -91.95 35.88 0.97 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.464 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -124.02 132.08 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.619 ' HB1' ' HB3' ' A' ' 32' ' ' PHE . . . -115.46 128.99 56.41 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.4 m -107.34 131.78 53.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.094 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 t -86.44 134.7 37.57 Favored Pre-proline 0 C--O 1.234 0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -82.48 40.77 1.01 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.771 2.314 . . . . 0.0 113.231 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -150.61 -59.09 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.328 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.7 p -93.38 -20.44 20.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.843 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m 67.23 37.89 3.51 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.975 0.417 . . . . 0.0 110.987 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.531 HD21 ' CG ' ' A' ' 5' ' ' HIS . 32.5 tp -89.11 160.79 16.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.959 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.624 HD11 ' O ' ' A' ' 3' ' ' VAL . 24.2 pt -114.66 143.3 24.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.826 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.526 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 21.8 pt -143.43 147.26 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.029 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.412 ' HB3' ' HG3' ' A' ' 7' ' ' GLU . 9.0 tppt? -93.19 134.75 35.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.301 0.572 . . . . 0.0 111.328 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.659 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -108.15 113.11 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.076 -179.46 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.5 mm -91.63 134.95 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.472 ' CD2' HD22 ' A' ' 39' ' ' LEU . 22.1 p90 -151.17 -178.63 6.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -89.88 99.94 12.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.599 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -61.23 -31.13 70.91 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.941 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.04 -34.83 79.37 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.753 0.311 . . . . 0.0 110.614 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -85.27 -46.22 11.23 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.304 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -65.62 -51.35 60.33 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.694 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.17 77.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.059 0.457 . . . . 0.0 111.068 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.25 93.36 0.13 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.763 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.46 -60.95 0.56 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.424 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -97.16 31.89 2.32 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.657 0.265 . . . . 0.0 111.321 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.1 m -139.65 118.61 12.55 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.661 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 t -105.71 139.45 20.22 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.212 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 40.2 Cg_exo -56.89 156.43 23.68 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.865 2.377 . . . . 0.0 112.542 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 71' ' ' PRO . . . 74.52 157.99 0.16 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.223 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.455 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 56.1 Cg_endo -70.17 138.49 36.63 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.462 2.108 . . . . 0.0 112.585 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.0 t -101.59 114.98 29.5 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.32 166.55 12.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.368 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -96.75 -37.62 10.22 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.522 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.55 104.76 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.58 0.352 . . . . 0.0 111.596 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -136.89 103.75 5.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.191 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -154.48 44.19 0.53 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.944 0.402 . . . . 0.0 111.027 179.375 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.78 152.42 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.209 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 mttt 64.77 78.28 0.29 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.046 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 tt -146.41 65.52 1.19 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 62.65 168.08 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.028 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 . . . . . 0 N--CA 1.463 0.206 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.91 179.574 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmm . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.685 0.279 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.76 93.95 0.33 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 m -92.02 143.89 10.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.173 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CD1' HD12 ' A' ' 54' ' ' ILE . 4.2 m-85 -66.6 140.9 57.97 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.967 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -68.63 -63.77 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -157.09 162.64 39.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.038 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.422 ' CG ' ' HB3' ' A' ' 56' ' ' LYS . 1.5 mp0 -112.46 134.89 53.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.743 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.795 HG11 ' CZ ' ' A' ' 24' ' ' TYR . 21.3 t -135.8 141.28 42.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 111.078 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -68.58 139.89 55.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.032 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.601 HD11 ' CG ' ' A' ' 22' ' ' TYR . 1.7 tp -54.6 -29.42 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.406 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -58.71 -32.87 69.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.637 0.256 . . . . 0.0 110.837 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.11 -30.82 63.92 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.914 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 15.0 m-85 -63.94 170.04 3.8 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.859 0.361 . . . . 0.0 111.349 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 23' ' ' PHE . 5.9 tt0 -107.02 112.98 26.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.63 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -66.02 116.44 7.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.581 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -95.02 88.49 5.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.539 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.84 -28.31 48.82 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.318 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.62 -47.08 10.41 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.33 0.394 . . . . 0.0 111.382 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 m -147.62 29.93 0.92 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.583 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 48.64 68.96 0.61 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.098 0.475 . . . . 0.0 111.485 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.4 m -138.8 157.73 45.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.86 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.601 ' CG ' HD11 ' A' ' 10' ' ' ILE . 53.2 m-85 -121.9 139.72 53.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.603 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 14' ' ' GLN . 4.4 p90 -137.08 152.06 49.59 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.43 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.795 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 1.3 t80 -127.86 139.33 35.02 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.303 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.56 124.51 12.94 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.719 2.279 . . . . 0.0 112.763 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.96 144.6 28.32 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.835 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.62 -17.38 48.07 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.632 2.221 . . . . 0.0 112.945 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.0 p -75.94 -41.11 52.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.181 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.02 -59.38 0.3 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.751 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.93 -174.0 1.73 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.782 0.325 . . . . 0.0 110.999 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -128.42 142.36 51.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.662 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.46 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 24.7 m-85 -61.76 171.9 1.46 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.576 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.0 p -154.31 139.17 17.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 111.737 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.823 HD11 ' O ' ' A' ' 43' ' ' GLU . 3.7 tt -152.07 125.06 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.684 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -72.15 148.65 45.44 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.437 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -59.58 -40.21 86.65 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -60.62 -38.35 84.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.943 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -57.33 -47.74 80.78 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.694 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD13 HD13 ' A' ' 10' ' ' ILE . 8.5 mt -63.42 -43.17 98.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.073 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.38 -28.29 69.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.572 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -88.14 -37.84 15.85 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.79 -0.186 . . . . 0.0 111.363 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.68 -15.39 2.44 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.563 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.823 ' O ' HD11 ' A' ' 34' ' ' ILE . 13.8 mt-10 -68.09 80.63 0.22 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-O 121.215 0.531 . . . . 0.0 110.616 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 57' ' ' VAL . 5.2 p30 -96.54 40.09 1.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.566 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -125.77 130.97 72.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.254 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.649 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.75 134.91 54.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.353 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 m -116.23 131.92 56.81 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.2 t -88.59 133.79 35.46 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.66 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.89 1.76 8.85 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.689 2.26 . . . . 0.0 112.912 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 t -106.66 -54.51 2.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.553 0.216 . . . . 0.0 111.039 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.6 p -98.15 -20.7 17.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.94 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m 65.04 43.82 3.61 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.005 0.431 . . . . 0.0 110.815 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.4 mt -96.47 -179.79 4.74 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.723 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 4' ' ' PHE . 14.1 pt -129.04 143.37 41.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.129 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.649 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.4 pt -144.38 145.22 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.018 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HB3' ' CG ' ' A' ' 7' ' ' GLU . 13.7 tptp -92.91 134.7 34.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.348 0.594 . . . . 0.0 111.421 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -108.71 113.27 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.74 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mm -91.12 134.87 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.015 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' CD2' HD22 ' A' ' 39' ' ' LEU . 17.5 p90 -152.39 179.28 8.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.221 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -81.28 99.4 8.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.456 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -60.86 -31.16 70.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.112 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -65.16 -31.28 72.39 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.993 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -95.76 -32.04 12.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.398 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -81.3 -61.96 1.8 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.643 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 65' ' ' VAL . 8.0 p -113.85 87.6 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.206 0.526 . . . . 0.0 111.776 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -154.0 39.68 0.48 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.273 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -127.08 -84.99 0.52 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.017 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -99.2 37.63 1.52 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.793 0.33 . . . . 0.0 110.983 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 69' ' ' THR . 8.9 t -85.08 107.66 17.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.995 0.426 . . . . 0.0 110.768 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.21 135.38 11.85 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.212 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.81 123.98 7.79 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.776 2.318 . . . . 0.0 112.803 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.69 ' HB3' ' CB ' ' A' ' 75' ' ' ALA . . . -171.2 150.22 2.81 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.414 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.6 110.7 2.79 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.631 2.221 . . . . 0.0 112.192 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.9 m 57.42 41.48 26.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.172 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.69 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -99.6 139.09 35.77 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.404 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -104.29 -36.61 7.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.005 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HB2' HD21 ' A' ' 79' ' ' LEU . 17.7 pttt -171.56 147.22 2.31 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.03 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.437 ' C ' HD23 ' A' ' 79' ' ' LEU . 3.3 tt0 -119.2 90.88 3.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.139 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 77' ' ' LYS . 0.8 OUTLIER -173.18 128.93 0.46 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.178 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 80' ' ' VAL . 13.4 t -107.6 38.2 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.662 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -93.87 107.85 19.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 tp -123.78 31.82 5.76 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.17 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -135.1 82.01 1.93 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.775 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.9 t60 . . . . . 0 N--CA 1.464 0.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.12 -179.76 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.474 ' HG2' HG21 ' A' ' 54' ' ' ILE . 2.8 mtt . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.7 0.286 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.92 143.57 29.62 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.025 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.5 82.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.407 ' CD1' HD12 ' A' ' 54' ' ' ILE . 4.2 m-85 -65.46 161.25 20.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.398 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -83.17 -58.95 2.63 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.869 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -157.72 162.77 38.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.273 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -110.53 134.82 52.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.575 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.701 HG11 ' CE1' ' A' ' 24' ' ' TYR . 21.5 t -134.61 140.52 45.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.212 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -67.71 139.82 56.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.102 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.509 HD11 ' CG ' ' A' ' 22' ' ' TYR . 1.3 tp -56.91 -30.17 32.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.91 -32.45 70.76 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.632 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.95 -29.92 66.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 9.5 m-85 -65.04 170.78 4.09 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.866 0.365 . . . . 0.0 111.194 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.75 109.6 21.54 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.715 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -66.28 118.73 10.39 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.769 0.319 . . . . 0.0 110.464 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.95 91.39 4.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.839 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.27 -29.06 60.63 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.176 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -48.23 -37.99 17.38 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.3 t -151.09 28.24 0.67 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 46.44 68.15 0.66 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.94 0.4 . . . . 0.0 111.748 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.4 m -137.53 155.04 49.7 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.509 ' CG ' HD11 ' A' ' 10' ' ' ILE . 35.5 m-85 -117.56 139.42 50.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.75 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -130.96 153.07 49.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.261 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.701 ' CE1' HG11 ' A' ' 8' ' ' VAL . 17.0 t80 -133.0 133.74 23.58 Favored Pre-proline 0 N--CA 1.463 0.196 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 32.4 Cg_exo -58.17 124.09 15.13 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.681 2.254 . . . . 0.0 112.479 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -99.05 143.74 26.94 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.699 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.29 -16.66 44.17 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.756 2.304 . . . . 0.0 113.029 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.9 p -77.16 -33.0 56.64 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.494 0.187 . . . . 0.0 111.214 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.17 -47.65 0.63 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.361 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -80.24 -168.89 1.84 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.282 0.233 . . . . 0.0 110.682 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 48.0 m-20 -135.35 141.95 45.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.666 0.269 . . . . 0.0 110.654 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.511 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 31.6 m-85 -62.68 168.58 3.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.807 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.9 p -150.27 139.34 21.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.754 0.311 . . . . 0.0 111.66 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.793 HD11 ' O ' ' A' ' 43' ' ' GLU . 9.8 tt -152.58 124.44 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.615 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 p -72.28 148.72 45.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.767 0.318 . . . . 0.0 111.469 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -59.73 -37.7 79.66 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.036 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -60.95 -38.6 86.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.983 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -57.05 -47.53 80.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.575 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.483 HD22 ' CD2' ' A' ' 59' ' ' TYR . 11.5 mt -59.87 -46.74 88.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.865 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -60.01 -27.95 67.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.645 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -88.25 -37.53 15.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.59 -4.72 3.7 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.925 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.793 ' O ' HD11 ' A' ' 34' ' ' ILE . 27.9 mm-40 -75.08 78.45 2.25 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.113 0.482 . . . . 0.0 110.156 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.1 m-20 -92.18 36.82 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.302 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -124.83 131.02 73.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.935 0.397 . . . . 0.0 111.702 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -113.0 131.85 55.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.431 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.8 m -115.7 130.36 56.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.9 t -92.75 118.55 67.98 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.154 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.01 -18.85 24.02 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.935 2.424 . . . . 0.0 113.293 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 m -82.45 -74.34 0.35 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.405 0.15 . . . . 0.0 111.405 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.536 ' HB2' HD13 ' A' ' 53' ' ' LEU . 20.1 p -76.61 -25.07 53.48 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.36 40.73 2.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.114 0.483 . . . . 0.0 110.644 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 51' ' ' CYS . 4.7 mp -95.01 -178.45 4.49 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.756 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.474 HG21 ' HG2' ' A' ' 1' ' ' MET . 15.4 pt -129.38 143.5 40.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.361 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.641 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -143.38 146.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.945 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -92.59 136.44 33.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.236 0.541 . . . . 0.0 111.401 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -109.56 112.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.957 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.8 mm -91.37 134.2 30.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.849 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.483 ' CD2' HD22 ' A' ' 39' ' ' LEU . 17.4 p90 -153.08 -177.9 6.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.664 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.13 101.29 14.01 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 110.814 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -60.29 -31.07 69.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.93 -33.74 76.75 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.956 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -82.84 -42.09 18.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.941 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -72.39 -72.93 0.21 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.15 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 65' ' ' VAL . 9.1 p -115.72 93.51 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.206 0.527 . . . . 0.0 111.507 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.77 36.84 1.84 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.448 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.74 -81.14 0.23 Allowed Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.002 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -102.81 36.22 2.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 69' ' ' THR . 12.2 t -66.59 106.43 1.79 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.024 0.44 . . . . 0.0 111.027 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 t -148.08 140.73 14.86 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.068 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.16 176.71 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.975 2.45 . . . . 0.0 112.814 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -63.73 157.59 65.89 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.691 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 49.5 Cg_endo -69.24 130.74 20.53 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.803 2.335 . . . . 0.0 112.84 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.0 39.64 0.1 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.227 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.12 -72.71 0.53 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.133 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 62.23 104.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.411 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -127.96 141.93 51.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.343 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -130.13 119.21 22.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.142 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.34 127.33 0.96 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.05 109.81 29.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.121 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -95.75 114.06 25.76 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.897 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.7 mt -113.02 123.01 49.33 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.983 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -138.18 101.07 4.3 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.941 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 . . . . . 0 N--CA 1.462 0.168 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.052 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.934 0.397 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.8 179.59 4.16 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.492 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 m -87.81 144.47 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.473 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.622 ' CD1' HD12 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 62.4 174.31 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.365 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.435 ' HB3' HG22 ' A' ' 55' ' ' ILE . 57.9 t-80 -89.48 -61.37 1.71 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.739 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.37 161.9 14.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.037 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -109.8 123.77 50.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.3 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG11 ' CE1' ' A' ' 24' ' ' TYR . 21.6 t -128.99 141.56 46.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.099 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -67.49 140.06 57.04 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.204 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.625 HD11 ' CD2' ' A' ' 22' ' ' TYR . 1.1 tp -55.51 -29.73 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.611 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.82 -31.85 68.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.647 0.26 . . . . 0.0 110.784 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -75.0 -29.08 60.77 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.023 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' HZ ' HD12 ' A' ' 55' ' ' ILE . 7.4 m-85 -64.62 173.02 2.35 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.098 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -104.7 106.59 17.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.786 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -65.48 131.3 46.06 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.49 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -113.29 89.78 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.623 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -57.57 -26.83 62.02 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.609 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.92 -50.67 34.14 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.632 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.33 28.44 1.67 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.596 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 50.48 70.37 0.52 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.51 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -139.21 153.36 47.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.652 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.625 ' CD2' HD11 ' A' ' 10' ' ' ILE . 11.7 m-85 -121.95 139.64 53.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.615 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -128.69 151.99 48.9 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.478 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.614 ' CE1' HG11 ' A' ' 8' ' ' VAL . 12.0 t80 -129.02 136.81 29.76 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.117 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.454 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 39.6 Cg_endo -67.39 124.26 11.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.534 2.156 . . . . 0.0 112.52 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -100.66 145.15 29.84 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.844 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.9 -16.09 36.82 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.646 2.231 . . . . 0.0 112.969 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.4 p -76.64 -40.21 49.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.53 0.205 . . . . 0.0 111.111 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.12 -55.37 0.37 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.613 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.71 -174.41 2.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.579 0.228 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 65.3 m-20 -130.91 141.61 50.31 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.765 0.317 . . . . 0.0 111.232 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.509 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 34.0 m-85 -61.45 164.96 5.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.706 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 p -147.37 138.94 23.98 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 111.527 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.791 HD11 ' O ' ' A' ' 43' ' ' GLU . 4.9 tt -152.3 124.79 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.76 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.0 p -72.03 149.61 44.75 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 111.263 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.42 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -59.72 -39.16 83.77 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.898 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -60.98 -39.99 91.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.039 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.52 -47.55 79.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.633 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.543 HD13 HD13 ' A' ' 10' ' ' ILE . 6.0 mt -63.82 -40.66 97.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -64.08 -27.48 69.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.476 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -90.54 -37.32 13.93 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.99 -18.4 1.96 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 121.138 -0.554 . . . . 0.0 112.369 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.791 ' O ' HD11 ' A' ' 34' ' ' ILE . 39.7 mm-40 -66.43 80.24 0.1 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.153 0.501 . . . . 0.0 110.93 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 57' ' ' VAL . 8.4 p30 -96.66 39.94 1.15 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.515 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.79 129.97 72.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.365 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.614 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -112.97 132.35 55.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.476 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.4 m -112.59 131.52 55.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.3 t -92.4 115.88 65.51 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.535 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.14 -19.23 20.06 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.737 2.291 . . . . 0.0 113.311 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -83.41 -75.11 0.34 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.528 ' SG ' HD12 ' A' ' 53' ' ' LEU . 28.2 p -76.14 -26.9 56.77 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.35 41.24 1.04 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.074 0.464 . . . . 0.0 110.816 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.528 HD12 ' SG ' ' A' ' 51' ' ' CYS . 6.8 mt -94.99 -179.95 5.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.647 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 4' ' ' PHE . 11.6 pt -126.39 143.56 39.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.057 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -143.66 143.13 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.775 0.321 . . . . 0.0 111.167 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -91.52 133.64 35.34 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.421 0.629 . . . . 0.0 111.41 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.723 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -108.05 113.53 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.985 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.0 mm -91.34 134.71 29.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.076 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CD2' HD22 ' A' ' 39' ' ' LEU . 18.9 p90 -154.98 179.54 9.03 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.899 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -84.78 99.79 11.11 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.501 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -60.86 -29.6 69.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.34 -33.15 75.28 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.632 0.253 . . . . 0.0 110.911 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -93.56 -40.72 10.15 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.143 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -74.26 -58.59 3.2 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.724 0.297 . . . . 0.0 111.047 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 t -78.79 82.69 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.168 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 99.5 p -93.28 92.25 7.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.911 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.17 -95.85 0.13 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.327 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.8 33.25 2.6 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 111.227 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -139.37 128.46 23.79 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.73 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 19.3 t -99.11 140.66 21.86 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.038 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 70' ' ' VAL . 32.4 Cg_exo -57.87 175.5 0.44 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.835 2.356 . . . . 0.0 112.686 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.62 151.12 53.0 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.854 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.21 150.73 65.88 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.984 2.456 . . . . 0.0 112.58 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.0 m -151.31 157.91 43.12 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.363 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.27 145.6 31.41 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.297 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -127.21 36.8 4.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.015 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -123.54 37.6 4.38 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.053 179.591 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -88.1 95.56 10.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.038 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -129.44 36.43 4.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.75 107.61 19.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.076 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.5 tttp 62.53 88.51 0.09 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.337 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.57 144.67 30.2 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.054 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -146.6 170.1 17.61 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.955 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.921 -179.986 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.778 0.323 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.8 -171.58 0.22 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 3' ' ' VAL . 26.4 t 69.37 57.58 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.09 0.471 . . . . 0.0 110.382 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.4 ' CD1' HD12 ' A' ' 54' ' ' ILE . 1.5 m-85 57.42 -176.05 0.07 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.074 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -103.47 -59.54 1.7 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.799 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -167.35 158.43 11.71 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.814 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -100.23 135.0 42.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.543 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.659 HG11 ' CZ ' ' A' ' 24' ' ' TYR . 23.9 t -136.22 139.96 44.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.749 0.309 . . . . 0.0 111.198 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -72.87 139.87 47.19 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.98 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.668 HD11 ' CG ' ' A' ' 22' ' ' TYR . 1.1 tp -57.19 -29.82 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.765 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -58.68 -32.49 69.18 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.714 0.292 . . . . 0.0 110.875 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.87 -30.5 64.02 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.198 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.45 ' CZ ' HG13 ' A' ' 57' ' ' VAL . 14.2 m-85 -64.3 157.28 26.46 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.201 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -96.34 87.9 4.6 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.49 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.432 ' HB2' ' CE2' ' A' ' 22' ' ' TYR . 76.5 t80 -66.47 152.36 45.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.63 101.71 3.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.535 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -52.04 -30.24 24.67 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.098 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -51.61 -47.79 63.49 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.223 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.3 m -108.33 -17.63 13.95 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.068 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 64.25 44.53 4.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.053 0.454 . . . . 0.0 110.651 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.449 HG23 ' C ' ' A' ' 34' ' ' ILE . 22.5 m -140.3 149.8 43.23 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.746 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.668 ' CG ' HD11 ' A' ' 10' ' ' ILE . 67.4 m-85 -105.42 141.19 37.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.888 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -129.08 157.67 41.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.481 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.659 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 3.2 t80 -139.28 138.0 19.99 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.461 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 37.0 Cg_endo -65.6 124.03 12.24 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.59 2.193 . . . . 0.0 112.551 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -97.84 144.42 27.98 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.807 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 43.3 Cg_endo -67.88 -17.22 46.75 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.705 2.27 . . . . 0.0 112.884 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.1 p -76.54 -38.18 55.47 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.559 0.219 . . . . 0.0 111.105 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.45 -49.41 0.49 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.681 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.98 -171.18 2.51 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.595 0.236 . . . . 0.0 110.763 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 61.1 m-20 -132.42 141.76 48.99 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.643 0.259 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.434 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 24.9 m-85 -63.97 168.36 5.29 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 p -151.39 139.43 20.09 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.786 0.327 . . . . 0.0 111.565 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.836 HD11 ' O ' ' A' ' 43' ' ' GLU . 2.1 tt -151.89 124.07 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.522 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 p -71.88 148.62 45.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.857 0.36 . . . . 0.0 111.416 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -59.51 -38.99 82.38 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.078 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.03 -37.82 83.95 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.102 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.403 ' CB ' ' HB2' ' A' ' 43' ' ' GLU . 2.1 m-20 -58.28 -47.86 82.3 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.716 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.577 HD13 HD13 ' A' ' 10' ' ' ILE . 9.0 mt -61.75 -44.23 97.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.863 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -62.14 -32.14 72.7 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -83.41 -38.48 21.89 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.678 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.18 -16.13 2.32 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.483 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.836 ' O ' HD11 ' A' ' 34' ' ' ILE . 23.3 mm-40 -68.59 81.41 0.27 Allowed 'General case' 0 C--N 1.341 0.211 0 CA-C-O 121.25 0.548 . . . . 0.0 110.938 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.407 ' HB3' ' HE2' ' A' ' 59' ' ' TYR . 7.8 p30 -97.24 41.29 1.12 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.484 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.5 p -127.87 132.01 69.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.287 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.67 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.82 134.36 54.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.278 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.5 m -117.76 132.05 56.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.781 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 t -88.64 133.59 35.78 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.681 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.03 -8.48 23.68 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.588 2.192 . . . . 0.0 113.255 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.1 m -99.43 -71.84 0.68 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.272 0.101 . . . . 0.0 111.272 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.5 p -74.94 -27.96 60.4 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.05 42.93 1.72 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.019 0.437 . . . . 0.0 110.804 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mp -95.19 -175.14 3.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.749 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.4 HD12 ' CD1' ' A' ' 4' ' ' PHE . 14.8 pt -131.4 143.58 40.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.384 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.67 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 4.2 pt -144.68 144.31 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.969 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -91.05 134.7 34.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.225 0.536 . . . . 0.0 111.607 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.726 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -108.81 113.34 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.852 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.0 mm -91.14 135.61 26.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.789 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.495 ' CD2' HD22 ' A' ' 39' ' ' LEU . 21.7 p90 -152.72 179.35 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 9.9 t0 -85.64 96.36 9.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.588 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -60.24 -33.8 72.79 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.077 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.94 -33.07 75.16 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 121.168 -0.213 . . . . 0.0 110.707 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 0.9 OUTLIER -85.98 -36.74 19.62 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.859 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -74.29 -66.11 0.77 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.399 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 65' ' ' VAL . 7.8 p -112.8 94.69 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.244 0.545 . . . . 0.0 111.318 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.4 t -107.49 33.97 3.76 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.163 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.88 -49.51 5.04 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.257 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.07 33.02 4.01 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.796 0.331 . . . . 0.0 111.121 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.5 m -133.95 143.37 48.14 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.687 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 70' ' ' VAL . 9.8 p -84.42 114.44 54.93 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.4 126.88 23.78 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.758 2.306 . . . . 0.0 112.484 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.87 149.74 71.5 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.663 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.04 169.12 21.29 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.869 2.379 . . . . 0.0 112.638 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.77 108.13 0.88 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.17 109.16 8.71 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.05 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.444 ' HB2' HD21 ' A' ' 79' ' ' LEU . 20.1 p-10 -71.17 116.6 11.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.9 138.22 30.05 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.338 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 63.84 66.26 0.67 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.354 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 76' ' ' ASN . 1.5 pp -164.25 33.96 0.08 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.377 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 p -75.28 124.16 32.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.043 0.449 . . . . 0.0 111.443 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -121.39 108.58 13.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.857 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.8 mp -68.15 163.43 22.63 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -151.67 174.6 13.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.289 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.9 m80 . . . . . 0 C--O 1.232 0.157 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.004 179.958 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.531 0.205 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.3 -50.26 0.93 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.368 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 m -127.99 111.52 24.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.036 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.621 ' CD1' HD12 ' A' ' 54' ' ' ILE . 0.7 OUTLIER 60.23 175.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.372 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -91.01 -63.51 1.26 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.486 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -170.51 137.28 1.37 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.681 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -85.47 132.66 34.17 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.506 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.743 HG11 ' CE1' ' A' ' 24' ' ' TYR . 18.6 t -131.33 141.43 45.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.832 0.348 . . . . 0.0 111.25 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -67.0 139.99 57.7 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.253 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.503 HD11 ' CD2' ' A' ' 22' ' ' TYR . 1.1 tp -56.69 -29.06 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.612 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -59.01 -32.64 69.89 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.675 0.274 . . . . 0.0 110.682 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -73.07 -33.04 65.41 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CE1' HG13 ' A' ' 57' ' ' VAL . 8.3 m-85 -61.61 172.35 1.25 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.431 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.45 107.65 16.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.91 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -65.26 134.6 53.99 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.703 0.287 . . . . 0.0 110.636 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -110.56 98.54 7.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.493 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.04 -26.58 64.7 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.755 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -48.68 -50.95 30.96 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.3 t -149.11 32.75 0.74 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.41 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 50.25 73.49 0.26 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.936 0.398 . . . . 0.0 111.726 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.9 m -138.21 145.26 41.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.747 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.503 ' CD2' HD11 ' A' ' 10' ' ' ILE . 53.3 m-85 -113.15 140.25 48.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.554 0.216 . . . . 0.0 110.645 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -129.31 151.69 49.68 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.62 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.743 ' CE1' HG11 ' A' ' 8' ' ' VAL . 15.5 t80 -127.71 136.93 29.72 Favored Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.252 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 42.8 Cg_endo -67.89 124.07 11.43 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.56 2.173 . . . . 0.0 112.576 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.26 142.06 24.08 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.31 -17.08 44.6 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.649 2.233 . . . . 0.0 112.833 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.7 p -69.38 -32.01 70.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.518 0.199 . . . . 0.0 111.208 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.37 -39.77 1.28 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.738 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.08 -170.17 2.58 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.687 0.279 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -134.68 137.0 43.19 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.012 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.619 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 31.6 m-85 -60.14 164.33 4.18 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.734 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -147.0 139.12 24.56 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.773 0.32 . . . . 0.0 111.691 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.81 HD11 ' O ' ' A' ' 43' ' ' GLU . 13.3 tt -152.08 124.8 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.895 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -72.12 150.39 43.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.464 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -59.93 -38.23 81.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.837 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.94 -37.8 83.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.6 -47.83 81.09 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.622 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.463 HD22 ' CD1' ' A' ' 59' ' ' TYR . 5.8 mt -64.79 -36.22 83.61 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -65.49 -28.82 69.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.43 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -91.7 -35.21 14.3 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.31 -13.52 2.77 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.683 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.81 ' O ' HD11 ' A' ' 34' ' ' ILE . 60.8 mm-40 -67.85 79.22 0.21 Allowed 'General case' 0 C--N 1.34 0.184 0 CA-C-O 120.995 0.426 . . . . 0.0 110.616 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.7 p30 -96.34 39.39 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.565 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.6 p -126.82 133.62 68.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.143 0.497 . . . . 0.0 111.447 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.731 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.87 135.71 53.32 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.407 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.37 132.21 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -87.71 137.32 32.0 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.644 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.29 -5.0 16.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.573 2.182 . . . . 0.0 113.145 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.6 m -109.84 -68.03 0.95 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.914 -0.13 . . . . 0.0 111.111 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.53 ' SG ' HD12 ' A' ' 53' ' ' LEU . 30.3 p -73.85 -27.29 61.01 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.0 m 65.04 40.72 4.98 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.873 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.53 HD12 ' SG ' ' A' ' 51' ' ' CYS . 10.2 mt -93.55 -179.53 5.06 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.737 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 4' ' ' PHE . 11.6 pt -129.5 143.26 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.02 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.731 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 6.7 pt -143.69 143.62 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -91.42 135.99 33.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.361 0.601 . . . . 0.0 111.547 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.576 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -109.58 114.53 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.869 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.1 mm -92.79 135.36 27.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.706 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CD1' HD22 ' A' ' 39' ' ' LEU . 19.9 p90 -157.3 177.93 10.9 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.124 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 5.3 t0 -90.79 104.33 16.93 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -60.29 -32.09 70.87 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.788 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.04 -35.16 80.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.661 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 1.7 mm100 -79.63 -47.0 16.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -63.52 -42.76 98.44 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.345 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.5 t -84.53 83.05 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.918 0.389 . . . . 0.0 110.218 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -113.51 93.73 4.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.89 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.01 -61.91 3.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.822 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -124.63 35.54 4.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 111.347 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.7 m -140.2 103.35 4.58 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.753 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 70' ' ' VAL . 11.1 p -86.2 116.08 64.45 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.123 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.9 174.83 1.13 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.01 2.473 . . . . 0.0 112.812 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.73 155.84 62.62 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.043 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.08 154.26 62.48 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.238 2.625 . . . . 0.0 112.848 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 m -148.25 90.76 1.84 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 62.35 -179.72 0.13 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.629 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -133.59 154.89 50.52 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.114 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.48 127.44 37.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.127 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -132.67 85.02 2.19 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.67 33.79 3.73 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.99 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.86 82.59 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.973 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -141.86 35.11 1.58 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.989 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tt -92.64 99.41 12.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.97 141.4 36.24 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.6 p80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.907 179.784 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.52 -58.6 1.25 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.525 0.203 . . . . 0.0 111.513 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.515 ' O ' HD11 ' A' ' 54' ' ' ILE . 15.8 m -64.1 140.06 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 111.408 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.426 ' CD1' HD12 ' A' ' 54' ' ' ILE . 5.6 m-85 -76.36 139.82 41.15 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -62.86 -67.63 0.41 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.711 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -161.4 141.38 10.61 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.702 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -87.51 135.12 33.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.572 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.533 HG11 ' CE1' ' A' ' 24' ' ' TYR . 21.2 t -129.97 141.54 46.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.288 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.81 139.92 57.8 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.821 HD11 ' CD2' ' A' ' 22' ' ' TYR . 8.9 tp -56.92 -28.26 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.468 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.02 -33.74 69.29 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.617 0.246 . . . . 0.0 110.797 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.62 -29.55 62.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.042 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.457 ' HZ ' HD12 ' A' ' 55' ' ' ILE . 13.9 m-85 -64.31 173.99 1.82 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.186 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -116.0 111.85 20.96 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.771 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -65.71 122.08 16.45 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.846 0.355 . . . . 0.0 110.647 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -100.19 92.08 5.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.94 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.23 -27.29 54.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.675 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -47.15 -52.2 16.13 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.488 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.8 m -142.87 27.73 1.62 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.692 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 52.29 67.8 0.92 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.882 0.373 . . . . 0.0 111.473 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.8 m -138.27 150.05 46.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.563 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.821 ' CD2' HD11 ' A' ' 10' ' ' ILE . 20.3 m-85 -114.46 139.3 49.64 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.619 0.247 . . . . 0.0 110.655 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -126.6 153.93 44.62 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.549 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' CE1' HG11 ' A' ' 8' ' ' VAL . 22.5 t80 -132.12 131.47 22.5 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.029 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 32.0 Cg_exo -58.92 124.34 15.49 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.77 2.313 . . . . 0.0 112.514 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -106.67 141.37 22.69 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.02 -17.67 51.31 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.681 2.254 . . . . 0.0 112.92 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.3 p -69.16 -32.87 72.5 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.544 0.211 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.78 -41.55 1.12 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.315 -0.469 . . . . 0.0 112.356 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.8 -166.42 1.58 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 110.845 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -137.21 137.93 39.63 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.609 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 19.3 m-85 -60.02 165.54 3.26 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.984 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.7 p -147.57 139.0 23.79 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.795 0.331 . . . . 0.0 111.694 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.824 HD11 ' O ' ' A' ' 43' ' ' GLU . 7.8 tt -152.07 124.93 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.63 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.6 p -71.88 149.02 45.56 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.868 0.366 . . . . 0.0 111.246 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.57 83.9 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.045 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.96 -37.99 84.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.809 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 43' ' ' GLU . 4.5 m-20 -56.42 -42.27 77.75 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.401 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.665 HD22 ' CE2' ' A' ' 59' ' ' TYR . 24.6 mt -61.2 -46.84 88.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.776 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.92 -26.04 63.99 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -90.68 -37.34 13.8 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.42 -1.94 4.13 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.063 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.824 ' O ' HD11 ' A' ' 34' ' ' ILE . 18.1 mm-40 -75.5 76.68 2.54 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-O 121.103 0.478 . . . . 0.0 110.705 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.5 m-20 -89.66 35.83 0.84 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.443 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.03 133.18 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.087 0.47 . . . . 0.0 111.927 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.715 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.83 140.48 47.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.529 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.6 m -122.06 132.32 54.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.778 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.99 138.02 32.98 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.575 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.84 -4.82 15.98 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.636 2.224 . . . . 0.0 113.134 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.3 p -110.47 -69.05 0.89 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.41 0.148 . . . . 0.0 111.189 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 53' ' ' LEU . 31.6 p -72.4 -27.88 62.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.8 t 63.91 42.7 5.77 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.09 0.471 . . . . 0.0 110.811 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.547 HD12 ' SG ' ' A' ' 51' ' ' CYS . 5.0 mt -96.11 -178.03 4.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.586 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.515 HD11 ' O ' ' A' ' 3' ' ' VAL . 26.2 pt -129.0 143.47 41.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.208 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.715 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.7 pt -142.47 144.35 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.0 135.21 34.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.238 0.542 . . . . 0.0 111.375 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.805 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -108.08 113.31 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.201 -179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 mm -94.09 135.36 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.665 ' CE2' HD22 ' A' ' 39' ' ' LEU . 32.9 p90 -159.35 -177.32 6.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.575 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -87.91 94.41 9.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.747 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 4.3 mtpm? -58.46 -29.42 66.17 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.068 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.81 -36.82 85.57 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.61 0.243 . . . . 0.0 110.671 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -79.02 -35.11 43.28 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.315 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -74.91 -44.0 51.11 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.67 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 61' ' ' LYS . 32.7 t -80.53 81.0 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.097 0.475 . . . . 0.0 111.007 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 t -130.16 30.59 4.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.144 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.94 -41.33 61.87 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.48 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -99.81 31.81 3.11 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 111.207 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -139.73 104.63 4.95 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.763 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' HD2' ' A' ' 71' ' ' PRO . 87.3 t 67.55 141.88 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.746 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.508 ' HD2' HG13 ' A' ' 70' ' ' VAL . 35.4 Cg_exo -57.78 154.99 34.49 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.924 2.416 . . . . 0.0 112.739 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.01 151.15 13.13 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.64 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.72 159.11 54.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.728 2.285 . . . . 0.0 112.335 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 51.1 m -98.61 73.53 2.07 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.973 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 67.58 160.27 0.16 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.709 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -114.91 146.91 40.64 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.224 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 89.83 3.0 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.023 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -150.7 117.0 5.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.935 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.79 34.7 0.61 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.3 p -109.42 128.34 65.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.193 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp 59.73 85.44 0.1 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.051 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.77 127.51 41.86 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -104.75 170.5 7.84 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 . . . . . 0 C--O 1.232 0.156 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.003 179.866 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 mtp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.781 0.324 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.81 37.0 27.76 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.457 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.53 154.83 40.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.755 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.696 ' CD1' HD12 ' A' ' 54' ' ' ILE . 4.3 m-85 -62.09 138.78 58.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.962 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.434 ' HB3' HG22 ' A' ' 55' ' ' ILE . 45.4 t60 -58.4 -64.46 0.91 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.974 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -162.14 160.4 27.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -104.63 134.08 48.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.408 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.509 HG11 ' CZ ' ' A' ' 24' ' ' TYR . 19.2 t -138.75 141.5 36.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.83 0.348 . . . . 0.0 111.313 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.72 139.92 57.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.939 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.661 HD11 ' CG ' ' A' ' 22' ' ' TYR . 1.1 tp -55.26 -30.04 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.794 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -58.8 -33.34 70.25 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.588 0.232 . . . . 0.0 110.78 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -71.61 -30.52 65.89 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.999 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 16.1 m-85 -65.16 171.66 3.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 111.21 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.22 104.45 14.36 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.841 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -66.48 150.17 49.35 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.722 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 3.4 t0 -125.46 144.75 50.39 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.344 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.97 -29.01 14.39 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.276 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -49.26 -53.14 23.11 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.3 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -148.83 28.23 0.86 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.639 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 3.0 mt-10 53.74 82.28 0.08 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.891 0.377 . . . . 0.0 111.337 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 m -137.6 143.33 41.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.661 ' CG ' HD11 ' A' ' 10' ' ' ILE . 82.2 m-85 -109.92 134.87 51.62 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.895 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -123.99 159.83 28.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.257 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.509 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 4.5 t80 -143.04 139.34 16.67 Favored Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.156 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 24' ' ' TYR . 50.7 Cg_endo -69.27 124.01 10.84 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.594 2.196 . . . . 0.0 112.494 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.419 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.37 144.46 28.14 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 39.9 Cg_endo -67.06 -18.23 51.44 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.658 2.239 . . . . 0.0 112.928 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p -76.55 -38.75 54.55 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.605 0.24 . . . . 0.0 111.188 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.82 -42.57 0.78 Allowed Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.668 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -176.69 4.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.506 0.193 . . . . 0.0 110.672 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -130.24 135.1 47.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.246 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.419 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 21.0 m-85 -63.39 164.36 9.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.738 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 p -150.6 139.2 20.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.872 0.368 . . . . 0.0 111.581 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.821 HD11 ' O ' ' A' ' 43' ' ' GLU . 2.5 tt -151.6 125.43 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.7 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 p -73.07 148.45 44.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.431 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -60.58 -38.06 83.36 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.775 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.09 -37.15 81.7 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.134 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.79 -47.49 80.07 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.629 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.539 HD22 ' CD1' ' A' ' 59' ' ' TYR . 14.9 mt -60.16 -45.89 91.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.885 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.03 -32.44 70.91 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.144 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -83.19 -37.81 23.16 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.694 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.81 -13.0 2.9 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.566 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.821 ' O ' HD11 ' A' ' 34' ' ' ILE . 8.7 mt-10 -70.31 80.26 0.54 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.069 0.461 . . . . 0.0 111.054 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -97.33 41.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.497 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -132.37 135.05 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.163 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.719 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.87 137.04 51.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.481 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.4 m -117.09 132.03 56.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.841 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.9 t -96.54 115.72 65.78 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.389 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.13 -19.77 21.81 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.713 2.276 . . . . 0.0 113.74 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.02 -75.39 0.32 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.505 0.193 . . . . 0.0 111.341 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.528 ' HB2' HD13 ' A' ' 53' ' ' LEU . 29.0 p -74.45 -22.93 58.87 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m 63.89 45.74 4.2 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.073 0.464 . . . . 0.0 110.817 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 51' ' ' CYS . 3.9 mp -101.49 179.57 4.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.823 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.696 HD12 ' CD1' ' A' ' 4' ' ' PHE . 18.0 pt -126.9 143.58 39.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.352 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.719 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 7.2 pt -138.62 158.21 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.95 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -102.76 132.22 49.08 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.359 0.6 . . . . 0.0 111.502 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.714 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -109.08 113.36 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.972 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 mm -94.58 135.22 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.539 ' CD1' HD22 ' A' ' 39' ' ' LEU . 17.3 p90 -154.69 178.58 9.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.501 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -91.35 99.61 12.55 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.809 0.338 . . . . 0.0 110.95 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -58.97 -30.04 67.62 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.244 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.63 -38.94 90.8 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.946 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -74.18 -42.32 60.05 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.831 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -67.84 -44.61 76.8 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.037 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.7 t -100.93 82.25 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.699 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -113.27 91.46 3.66 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.151 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.03 -46.99 1.8 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.697 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.36 32.61 4.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.721 0.296 . . . . 0.0 111.598 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -151.39 127.54 10.5 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.867 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.99 138.35 19.63 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -85.82 51.67 2.88 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.883 2.388 . . . . 0.0 112.48 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.17 120.96 28.89 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.256 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.94 172.38 1.67 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.176 2.584 . . . . 0.0 112.959 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -70.09 -36.08 74.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.428 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.47 128.87 45.22 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.634 0.254 . . . . 0.0 111.159 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -66.97 148.42 51.98 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.174 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -106.78 152.5 23.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.437 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.416 ' C ' HD23 ' A' ' 79' ' ' LEU . 20.7 mt-10 -147.02 98.48 3.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.213 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 78' ' ' GLU . 0.9 OUTLIER -172.85 128.57 0.49 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.151 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.12 90.3 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.688 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -108.17 103.63 12.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.011 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.9 mt -129.89 36.36 4.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.171 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.29 175.34 9.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.996 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 . . . . . 0 C--O 1.232 0.149 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.975 179.875 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.706 0.289 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.47 -70.43 0.59 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.771 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.497 ' O ' HD11 ' A' ' 54' ' ' ILE . 18.0 m -146.51 26.36 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.496 ' CD1' HD12 ' A' ' 54' ' ' ILE . 3.8 m-85 -73.99 145.38 44.64 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 111.354 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -64.19 -64.12 0.97 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.446 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -163.26 145.53 10.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.781 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -91.74 134.39 34.76 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.411 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.565 HG21 ' CZ ' ' A' ' 24' ' ' TYR . 20.3 t -133.06 141.58 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.151 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.77 140.16 57.83 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.17 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.573 HD11 ' CD2' ' A' ' 22' ' ' TYR . 1.1 tp -56.25 -28.19 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.416 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.28 -32.71 68.67 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.575 0.226 . . . . 0.0 110.858 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.49 -27.78 58.95 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.153 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.479 ' HZ ' HD12 ' A' ' 55' ' ' ILE . 13.0 m-85 -65.48 173.02 2.88 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.824 0.345 . . . . 0.0 111.19 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -111.37 113.8 26.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -65.67 125.67 26.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.56 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -104.72 90.39 3.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.602 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.7 -27.87 43.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.336 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.44 -49.1 9.94 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.353 0.408 . . . . 0.0 111.456 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.8 m -151.44 32.39 0.58 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.534 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 51.65 70.49 0.54 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.911 0.386 . . . . 0.0 111.559 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.7 m -137.6 153.2 49.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.815 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.573 ' CD2' HD11 ' A' ' 10' ' ' ILE . 35.3 m-85 -120.47 131.18 54.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.8 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 33' ' ' SER . 13.5 m-85 -118.89 152.76 35.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 111.392 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CZ ' HG21 ' A' ' 8' ' ' VAL . 18.7 t80 -128.6 136.64 29.43 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.974 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 24' ' ' TYR . 32.0 Cg_exo -58.37 123.75 14.32 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.599 2.199 . . . . 0.0 112.493 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -113.66 147.24 37.16 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.405 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 51.6 Cg_exo -54.48 -30.76 65.81 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.918 2.412 . . . . 0.0 112.854 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.8 p -73.28 -42.39 62.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.282 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.6 -22.44 6.94 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.272 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -63.79 -35.73 81.55 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.921 0.36 . . . . 0.0 111.295 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 30' ' ' ASP . 66.7 m-20 73.37 131.5 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.116 0.484 . . . . 0.0 111.761 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 61.7 m-85 -61.06 163.57 5.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.916 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.445 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 81.6 p -148.15 139.23 23.29 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 111.374 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.908 HD13 HG21 ' A' ' 57' ' ' VAL . 6.2 tt -150.5 124.31 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.591 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.89 148.19 46.35 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -60.64 -38.52 85.08 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.026 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -60.95 -38.47 85.98 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.107 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.53 -47.59 79.05 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.775 0.322 . . . . 0.0 110.688 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 36' ' ' LYS . 4.8 mt -61.26 -42.45 98.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.976 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -60.13 -31.65 70.28 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.336 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -86.81 -36.9 18.26 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.9 -14.14 2.63 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.551 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.789 ' O ' HD11 ' A' ' 34' ' ' ILE . 58.7 mm-40 -68.02 80.22 0.22 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.037 0.446 . . . . 0.0 111.145 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.9 p30 -95.05 38.72 1.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.767 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.99 131.67 70.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.236 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -113.01 127.15 56.15 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.97 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.8 m -111.67 122.74 48.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.796 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -70.79 141.13 86.92 Favored Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.744 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.6 36.62 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.956 2.437 . . . . 0.0 113.444 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 t -155.51 -64.11 0.12 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.709 0.29 . . . . 0.0 110.531 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.616 ' SG ' HD12 ' A' ' 53' ' ' LEU . 29.3 p -77.16 -24.73 51.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.358 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.7 m 65.87 41.39 3.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.962 0.41 . . . . 0.0 110.79 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.616 HD12 ' SG ' ' A' ' 51' ' ' CYS . 2.7 mt -88.97 -179.59 5.97 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.9 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.497 HD11 ' O ' ' A' ' 3' ' ' VAL . 10.9 pt -136.02 143.47 36.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.402 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 ' HB3' ' A' ' 46' ' ' ALA . 3.1 pt -146.57 144.68 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.834 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.32 136.36 33.66 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.284 0.564 . . . . 0.0 111.165 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.908 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -109.3 114.53 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.981 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.4 mm -93.24 134.66 30.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.741 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.468 ' CE2' ' HE3' ' A' ' 61' ' ' LYS . 19.0 p90 -156.95 178.35 10.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.049 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 31.5 t0 -88.56 91.28 8.75 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.25 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.487 ' O ' HG12 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -58.45 -34.5 70.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.913 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.05 -34.36 78.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.79 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 3.6 mm-40 -85.99 -35.46 20.38 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.001 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 59' ' ' TYR . 4.2 m-85 -59.9 -55.01 39.45 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.48 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 65' ' ' VAL . 7.3 p -101.83 90.43 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 121.33 0.586 . . . . 0.0 111.076 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.7 p -141.36 28.36 1.85 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.449 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.82 -78.55 1.27 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.38 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.36 80.08 8.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.817 0.341 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 69' ' ' THR . 6.2 t -131.73 102.59 5.94 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.674 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.2 t -132.92 140.32 37.27 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.115 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -57.85 172.3 1.22 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.944 2.43 . . . . 0.0 112.918 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.29 150.07 74.49 Favored Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.987 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.69 -177.31 2.11 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.084 2.523 . . . . 0.0 112.691 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m -79.5 123.22 27.35 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.503 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 66.59 100.72 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.544 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -95.0 38.71 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.202 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.31 105.15 4.35 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.889 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.86 114.35 25.97 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.704 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.84 63.67 0.65 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 111.418 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.4 t -141.15 122.69 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.342 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.0 mttm 60.71 92.54 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.358 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.0 mt -87.48 104.05 16.1 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.6 -35.39 9.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.31 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 57.1 m80 . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.824 -179.482 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtm . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.605 0.241 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.34 -43.66 6.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.332 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.405 ' O ' HD11 ' A' ' 54' ' ' ILE . 23.9 m -64.83 159.61 3.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.917 0.389 . . . . 0.0 111.452 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -71.91 163.4 27.91 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.233 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.608 ' CD2' HD21 ' A' ' 53' ' ' LEU . 9.9 t-80 -89.88 -67.54 0.84 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -145.87 162.78 36.96 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.769 0.318 . . . . 0.0 111.288 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -114.03 134.03 55.13 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.671 HG11 ' CE1' ' A' ' 24' ' ' TYR . 17.0 t -132.76 140.79 46.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.178 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -66.73 139.65 57.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.021 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.767 HD11 ' CG ' ' A' ' 22' ' ' TYR . 5.9 tp -56.95 -30.4 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.657 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.32 -32.27 71.07 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.669 0.271 . . . . 0.0 110.806 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -72.88 -28.97 62.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.336 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.461 ' CZ ' HG13 ' A' ' 57' ' ' VAL . 12.8 m-85 -62.75 160.48 14.26 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.991 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -96.39 82.53 3.41 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.586 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.461 ' HB2' ' CE2' ' A' ' 22' ' ' TYR . 87.2 t80 -68.26 153.35 43.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -144.55 122.93 12.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.549 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -65.93 -28.7 69.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.101 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.7 -60.81 3.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.658 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 m -94.19 -20.63 19.68 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.855 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 64.87 47.51 2.63 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.013 0.435 . . . . 0.0 110.776 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.501 HG23 ' C ' ' A' ' 34' ' ' ILE . 87.3 m -139.63 145.86 39.01 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.496 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.767 ' CG ' HD11 ' A' ' 10' ' ' ILE . 77.5 m-85 -98.25 141.03 31.67 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.751 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -127.3 157.0 41.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.766 0.317 . . . . 0.0 111.592 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.671 ' CE1' HG11 ' A' ' 8' ' ' VAL . 27.7 t80 -140.15 136.8 17.32 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.99 124.58 12.42 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.682 2.254 . . . . 0.0 112.627 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -97.43 144.04 27.23 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.906 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.05 -15.29 35.97 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.716 2.277 . . . . 0.0 112.942 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.4 p -77.86 -38.87 45.08 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.506 0.193 . . . . 0.0 111.081 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.87 -49.16 0.45 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.791 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -167.25 1.13 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.542 0.211 . . . . 0.0 111.046 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -135.6 140.13 44.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.633 0.254 . . . . 0.0 111.079 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.438 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 50.1 m-85 -63.54 165.27 8.21 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.826 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 p -150.39 139.13 20.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.447 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.842 HD11 ' O ' ' A' ' 43' ' ' GLU . 2.4 tt -151.95 124.77 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 p -71.49 148.72 46.51 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.909 0.385 . . . . 0.0 111.423 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -38.2 87.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.21 -37.93 84.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.966 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -56.34 -46.98 79.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.531 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.517 HD12 ' CE2' ' A' ' 64' ' ' PHE . 35.2 mt -60.0 -45.45 92.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.964 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -59.45 -33.53 71.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.036 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -82.14 -38.19 25.1 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.48 -12.42 2.98 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.574 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.842 ' O ' HD11 ' A' ' 34' ' ' ILE . 5.2 mt-10 -70.06 80.34 0.49 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.146 0.498 . . . . 0.0 111.026 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -97.66 41.78 1.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.478 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.442 ' O ' HD12 ' A' ' 34' ' ' ILE . 10.4 p -129.01 132.36 67.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.329 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.85 134.69 54.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.773 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.5 m -116.7 132.59 56.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.9 t -91.4 134.12 30.16 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.524 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.02 1.77 8.87 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.583 2.188 . . . . 0.0 113.246 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.18 -51.39 2.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.615 0.245 . . . . 0.0 111.008 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.5 p -101.81 -24.22 14.08 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 69.17 41.05 1.44 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.059 0.457 . . . . 0.0 110.961 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.608 HD21 ' CD2' ' A' ' 5' ' ' HIS . 15.2 tp -95.18 163.34 13.32 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.809 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.405 HD11 ' O ' ' A' ' 3' ' ' VAL . 29.2 pt -113.55 143.26 23.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.168 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.748 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -142.51 144.43 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.052 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -91.28 134.57 34.47 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.221 0.534 . . . . 0.0 111.67 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.792 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -108.04 113.22 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.006 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 mm -92.99 134.07 32.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.045 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.415 ' CE1' HD22 ' A' ' 39' ' ' LEU . 26.5 p90 -156.44 177.12 11.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.823 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -90.26 104.53 17.1 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.858 0.361 . . . . 0.0 110.905 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -30.6 69.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.078 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -64.94 -39.15 93.06 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.686 0.279 . . . . 0.0 110.661 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.97 -47.86 19.64 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.23 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.517 ' CE2' HD12 ' A' ' 39' ' ' LEU . 16.1 m-85 -59.96 -43.63 94.91 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.191 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.95 83.88 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.787 0.327 . . . . 0.0 110.526 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.79 89.49 2.83 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.17 -37.96 6.96 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.603 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -101.96 37.74 1.79 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.742 0.306 . . . . 0.0 111.269 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.0 t -91.07 171.3 9.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.065 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.422 HG23 ' HD2' ' A' ' 71' ' ' PRO . 9.7 p -131.17 135.95 28.02 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.474 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.422 ' HD2' HG23 ' A' ' 70' ' ' VAL . 73.3 Cg_endo -75.88 -175.19 2.36 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.781 2.321 . . . . 0.0 112.461 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.09 152.12 57.43 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.649 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.68 142.34 61.63 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.149 2.566 . . . . 0.0 112.714 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.9 135.25 8.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.012 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.44 113.82 27.56 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -83.51 105.29 14.33 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.9 0.381 . . . . 0.0 110.825 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -66.7 141.71 57.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.214 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' C ' HD23 ' A' ' 79' ' ' LEU . 3.2 tt0 -155.8 101.99 2.16 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.281 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 78' ' ' GLU . 0.5 OUTLIER -163.35 40.59 0.1 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.991 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -77.24 117.32 22.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.135 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -145.7 25.79 1.3 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.569 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 83' ' ' GLU . 0.7 OUTLIER 69.0 152.36 0.09 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.837 0.351 . . . . 0.0 111.337 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.481 ' N ' HD23 ' A' ' 82' ' ' LEU . 2.6 mt-10 -67.61 147.18 53.07 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.11 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.067 -179.903 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 ttp . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.625 0.25 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.96 -66.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.892 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.1 m -134.98 24.82 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.397 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' CD1' HD12 ' A' ' 54' ' ' ILE . 1.2 m-85 60.35 -179.95 0.1 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 111.22 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.557 ' CG ' HD21 ' A' ' 53' ' ' LEU . 53.8 t60 -97.28 -61.63 1.37 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.728 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -165.65 160.17 17.17 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.748 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -107.29 120.38 41.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.459 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.64 141.54 45.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -66.5 139.81 57.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.064 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.661 HD11 ' CG ' ' A' ' 22' ' ' TYR . 8.2 tp -56.87 -28.99 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.441 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.96 -35.84 71.72 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.731 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.25 -28.87 63.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.293 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 15.6 m-85 -63.93 161.43 15.69 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 111.307 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.13 99.03 11.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.544 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.42 136.58 53.5 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.925 0.393 . . . . 0.0 110.745 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -119.42 89.99 3.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.518 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -55.85 -29.29 59.62 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.24 -44.21 22.6 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.9 m -138.68 24.37 2.64 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 47.09 59.73 3.85 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.06 0.457 . . . . 0.0 111.783 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.7 m -138.15 144.07 40.6 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.987 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.661 ' CG ' HD11 ' A' ' 10' ' ' ILE . 44.1 m-85 -106.15 141.13 38.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.94 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 76.7 m-85 -124.18 161.11 26.38 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.331 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.454 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 7.7 t80 -148.53 137.45 11.96 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.01 126.34 13.04 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.456 2.104 . . . . 0.0 112.706 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.437 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 1.6 t -101.87 143.57 26.86 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 46.5 Cg_exo -56.25 -26.16 59.79 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.907 2.405 . . . . 0.0 113.043 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -69.19 -38.31 78.58 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.466 0.174 . . . . 0.0 111.463 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.63 -39.95 1.18 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.464 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.98 -176.23 2.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.682 0.277 . . . . 0.0 110.885 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -130.44 133.06 46.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.693 0.283 . . . . 0.0 111.416 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.599 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 47.3 m-85 -63.06 162.86 10.84 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.709 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 p -146.93 139.34 24.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 111.558 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.781 HD11 ' O ' ' A' ' 43' ' ' GLU . 2.3 tt -151.82 122.06 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.759 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.6 p -72.17 149.44 44.68 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.103 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -60.05 -37.17 79.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.708 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.56 -38.34 84.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.933 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.3 -47.16 79.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.617 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.508 HD22 ' CE1' ' A' ' 59' ' ' TYR . 13.4 mt -61.7 -46.11 91.07 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.18 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.39 -31.04 69.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.851 -0.159 . . . . 0.0 111.284 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -83.88 -36.59 23.28 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.55 -12.8 3.21 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.722 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.781 ' O ' HD11 ' A' ' 34' ' ' ILE . 8.1 mt-10 -71.65 81.28 0.84 Allowed 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.186 0.517 . . . . 0.0 110.849 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -97.44 41.79 1.11 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.469 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.02 137.3 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.54 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.724 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.71 131.51 55.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.788 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.3 m -112.56 132.39 55.14 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.145 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.26 138.43 39.24 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.26 2.46 8.45 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.546 2.164 . . . . 0.0 113.421 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.4 -64.22 1.33 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.452 0.168 . . . . 0.0 111.152 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.0 p -85.05 -20.68 30.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.6 m 65.56 38.69 5.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.872 0.368 . . . . 0.0 111.131 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.557 HD21 ' CG ' ' A' ' 5' ' ' HIS . 57.9 tp -84.14 158.76 21.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.734 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 4' ' ' PHE . 20.0 pt -112.83 142.91 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.794 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.724 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.3 pt -144.82 144.76 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.027 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -91.17 134.46 34.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.391 0.615 . . . . 0.0 111.614 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -108.24 113.24 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.744 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.47 135.03 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.805 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.508 ' CE1' HD22 ' A' ' 39' ' ' LEU . 20.1 p90 -155.92 168.23 27.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.804 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -85.68 97.77 10.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.814 0.34 . . . . 0.0 110.675 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -58.46 -30.03 66.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.109 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.78 -36.77 85.38 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.529 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -38.1 37.3 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.022 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -61.68 -60.11 4.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.11 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 65' ' ' VAL . 7.8 p -111.47 95.16 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.246 0.546 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -96.05 86.92 4.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.081 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.02 -45.9 90.73 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.649 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.49 83.59 2.06 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.947 0.403 . . . . 0.0 110.834 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -128.19 161.3 29.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.268 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 16.9 t -107.44 138.65 20.0 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.428 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 48.4 Cg_exo -55.96 124.75 17.03 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.973 2.449 . . . . 0.0 112.827 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . 72.25 158.1 0.16 Allowed Pre-proline 0 N--CA 1.468 0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.707 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 65.8 Cg_endo -72.92 165.93 31.41 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.683 2.256 . . . . 0.0 112.772 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.5 m -147.63 -59.28 0.26 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.148 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.25 171.68 8.05 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.42 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -145.49 37.29 1.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -135.92 36.01 2.84 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.247 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.01 94.07 0.62 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.894 0.378 . . . . 0.0 110.382 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.67 -146.86 0.37 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.456 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.9 t -94.59 102.28 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.696 0.284 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.7 tttm 61.06 79.02 0.26 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.43 156.87 48.0 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 73.21 -64.69 0.39 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.296 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.8 t60 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.85 0.357 . . . . 0.0 110.719 179.871 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 ttm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.38 152.58 50.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.66 0.267 . . . . 0.0 111.663 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.424 HG23 HD11 ' A' ' 54' ' ' ILE . 16.0 m -103.48 30.9 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.305 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CD1' HD12 ' A' ' 54' ' ' ILE . 3.9 m-85 -75.71 173.5 11.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 111.279 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -94.52 -65.75 0.96 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.633 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.64 138.41 7.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.14 133.71 34.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.537 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.433 HG11 ' CE1' ' A' ' 24' ' ' TYR . 19.1 t -136.78 141.69 40.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.836 0.351 . . . . 0.0 111.485 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . 8.7 mt-10 -66.68 140.16 57.89 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.06 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.669 HD11 ' CG ' ' A' ' 22' ' ' TYR . 1.0 OUTLIER -55.73 -27.68 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.692 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -58.98 -32.93 70.12 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.659 0.266 . . . . 0.0 110.689 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.88 -28.57 61.63 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 11.0 m-85 -66.77 170.86 5.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 111.364 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -105.23 109.37 21.34 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.874 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -66.74 110.95 3.45 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.747 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -88.69 95.4 10.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.833 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -25.58 64.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.552 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -49.18 -51.53 32.08 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.736 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.9 m -143.1 28.45 1.53 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 51.98 68.03 0.88 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.874 0.368 . . . . 0.0 111.544 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.4 m -137.88 149.89 46.65 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.67 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.669 ' CG ' HD11 ' A' ' 10' ' ' ILE . 39.1 m-85 -114.09 138.7 50.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.655 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -126.89 157.14 40.16 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.777 0.322 . . . . 0.0 111.788 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 10.3 t80 -135.87 136.61 23.6 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.327 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.409 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 37.8 Cg_endo -65.92 124.64 12.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.805 2.337 . . . . 0.0 112.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.407 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -100.84 144.9 29.43 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.34 -17.48 44.42 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.647 2.232 . . . . 0.0 112.898 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.2 p -75.99 -36.24 59.3 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.152 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.99 -49.55 0.55 Allowed Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.763 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.3 -168.21 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.51 0.195 . . . . 0.0 110.928 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -137.87 138.65 39.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.687 0.28 . . . . 0.0 111.261 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CE2' ' SG ' ' A' ' 26' ' ' CYS . 28.6 m-85 -61.07 163.22 6.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.787 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.7 p -147.18 139.28 24.46 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.86 0.362 . . . . 0.0 111.568 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.794 HD11 ' O ' ' A' ' 43' ' ' GLU . 2.1 tt -151.96 124.8 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.618 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.9 p -71.96 149.2 45.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 111.315 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -38.46 86.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -61.56 -38.11 86.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.93 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.46 -47.76 78.5 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.616 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.563 HD13 HD13 ' A' ' 10' ' ' ILE . 7.5 mt -62.5 -41.21 98.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -62.67 -31.04 71.85 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.449 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -86.62 -36.45 18.81 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.78 -15.04 2.65 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.443 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.794 ' O ' HD11 ' A' ' 34' ' ' ILE . 7.9 mt-10 -68.8 80.76 0.29 Allowed 'General case' 0 C--N 1.34 0.165 0 CA-C-O 121.203 0.525 . . . . 0.0 110.561 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -98.49 41.9 1.12 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.282 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.36 131.9 65.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.095 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.693 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -113.5 137.0 52.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.421 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 m -118.57 131.71 56.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.652 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 49.4 t -92.03 117.19 67.58 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.43 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.87 -19.1 24.06 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.758 2.305 . . . . 0.0 113.402 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.1 m -83.21 -73.85 0.39 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.539 ' SG ' HD12 ' A' ' 53' ' ' LEU . 26.3 p -76.86 -24.94 52.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.21 38.77 2.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.048 0.452 . . . . 0.0 110.722 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.539 HD12 ' SG ' ' A' ' 51' ' ' CYS . 5.3 mt -92.06 178.06 5.99 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.732 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.489 HD12 ' CD1' ' A' ' 4' ' ' PHE . 16.9 pt -125.68 143.5 39.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.4 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.693 HD11 ' HB3' ' A' ' 46' ' ' ALA . 4.5 pt -140.6 159.19 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.979 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.37 133.98 49.24 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.273 0.558 . . . . 0.0 111.409 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.752 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -109.7 113.28 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.082 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 27.3 mm -92.61 135.42 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.986 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' CD2' HD22 ' A' ' 39' ' ' LEU . 30.5 p90 -151.67 178.21 9.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -87.08 99.8 12.18 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.622 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -61.17 -31.92 71.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.01 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.22 -35.12 80.07 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.66 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -80.82 -42.16 22.09 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.94 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -72.4 -72.2 0.25 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.28 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 65' ' ' VAL . 7.5 p -114.81 92.04 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 121.276 0.56 . . . . 0.0 111.662 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 p -78.03 88.54 4.17 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.344 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -99.39 0.04 OUTLIER Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.368 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.55 32.33 4.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 t -81.82 125.72 31.01 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.9 t -97.12 139.62 21.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.493 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.11 86.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.795 2.33 . . . . 0.0 112.53 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -174.71 148.2 1.17 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.86 135.28 21.17 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.869 2.379 . . . . 0.0 112.84 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -163.99 -54.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.143 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.47 -42.64 92.51 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.774 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -158.67 163.11 37.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.664 0.268 . . . . 0.0 111.09 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -146.71 80.57 1.55 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.155 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -134.92 95.7 3.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.282 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -150.17 31.14 0.69 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.348 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.42 113.13 43.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.658 0.266 . . . . 0.0 111.455 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -170.85 101.75 0.23 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.949 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.17 152.38 34.86 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.099 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -152.92 167.14 30.13 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.427 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 15.6 m80 . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.746 179.654 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.456 0.17 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.86 -72.21 0.65 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.259 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.4 m -151.54 76.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 111.265 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -71.09 162.89 28.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.375 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -92.81 -64.43 1.1 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.681 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -160.79 136.31 7.99 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.963 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.21 134.57 34.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.595 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 24' ' ' TYR . 20.2 t -137.09 141.5 40.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.244 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . 55.1 mt-10 -66.82 140.04 57.8 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.041 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.743 HD11 ' CG ' ' A' ' 22' ' ' TYR . 1.2 tp -55.34 -28.58 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.732 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.49 -31.34 67.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.6 0.238 . . . . 0.0 110.982 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.51 -31.11 60.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.964 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.41 ' HZ ' HD12 ' A' ' 55' ' ' ILE . 8.2 m-85 -63.68 168.68 4.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.146 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -101.95 110.52 22.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -65.73 127.23 31.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.751 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -102.36 97.72 7.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.559 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -59.54 -26.11 65.08 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.554 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -49.15 -50.87 35.62 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.73 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 t -152.93 34.77 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.569 0.223 . . . . 0.0 111.583 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 52.11 77.03 0.16 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.897 0.379 . . . . 0.0 111.863 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.8 m -137.92 151.48 48.04 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.685 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.743 ' CG ' HD11 ' A' ' 10' ' ' ILE . 78.4 m-85 -122.02 139.87 53.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.769 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -130.6 157.35 42.96 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.626 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.436 ' CE1' HG11 ' A' ' 8' ' ' VAL . 7.7 t80 -135.74 137.28 25.23 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.23 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 43.6 Cg_endo -68.16 124.61 11.94 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.611 2.208 . . . . 0.0 112.557 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.23 142.99 25.76 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.55 -17.7 48.54 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.644 2.229 . . . . 0.0 112.864 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.1 p -71.34 -31.75 67.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.578 0.227 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.48 -40.18 1.35 Allowed Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.38 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.3 -171.99 3.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.679 0.276 . . . . 0.0 110.897 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -136.17 133.39 37.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -59.62 163.14 4.46 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.4 p -147.56 139.22 23.97 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.85 0.357 . . . . 0.0 111.627 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.841 HD11 ' O ' ' A' ' 43' ' ' GLU . 2.6 tt -152.32 124.57 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.777 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.7 p -71.82 149.56 45.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 111.263 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -37.18 82.95 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -60.96 -39.34 89.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.789 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.24 -47.91 77.55 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.691 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 10' ' ' ILE . 9.8 mt -62.14 -43.97 97.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.067 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.413 ' O ' HG22 ' A' ' 65' ' ' VAL . 54.5 mt-10 -60.69 -28.94 69.0 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.353 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -88.1 -36.87 16.66 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.35 -14.51 2.52 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.649 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.841 ' O ' HD11 ' A' ' 34' ' ' ILE . 10.0 mt-10 -69.74 80.47 0.44 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.191 0.519 . . . . 0.0 111.125 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.412 ' HB3' ' HE1' ' A' ' 59' ' ' TYR . 1.6 p30 -96.71 40.14 1.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.502 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -127.78 134.23 65.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.371 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.745 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -113.1 139.42 48.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.178 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.5 m -118.8 132.12 56.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.746 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -91.69 135.86 27.17 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.794 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.84 -2.06 12.2 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.566 2.177 . . . . 0.0 113.239 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.58 -65.51 1.14 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.455 0.169 . . . . 0.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.581 ' SG ' HD12 ' A' ' 53' ' ' LEU . 31.3 p -79.61 -24.65 41.82 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.94 39.67 5.71 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 111.093 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.581 HD12 ' SG ' ' A' ' 51' ' ' CYS . 11.6 mt -95.86 -179.59 4.76 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.5 pt -128.83 143.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.224 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.745 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 6.1 pt -139.99 143.68 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -91.62 132.76 36.11 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.347 0.594 . . . . 0.0 111.493 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.738 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -106.77 116.03 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.854 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 24.7 mm -94.06 135.56 28.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.785 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CD1' HD22 ' A' ' 39' ' ' LEU . 16.0 p90 -154.82 178.04 10.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.916 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.87 99.79 12.39 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.565 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -60.39 -30.39 69.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.068 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -65.23 -33.57 76.31 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.709 0.29 . . . . 0.0 110.851 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -88.96 -45.52 9.6 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.013 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -66.97 -55.65 13.57 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.248 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 40' ' ' GLU . 18.5 t -81.01 82.74 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.93 0.395 . . . . 0.0 110.693 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -95.81 88.82 5.07 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.074 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.67 -60.17 0.94 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.785 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.24 22.63 10.25 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.9 m -153.13 117.86 5.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.655 0.264 . . . . 0.0 110.949 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 71' ' ' PRO . 11.2 p -134.36 135.65 24.35 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.416 ' HD2' HG23 ' A' ' 70' ' ' VAL . 74.5 Cg_endo -75.92 168.23 24.59 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.002 2.468 . . . . 0.0 112.818 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.16 150.83 19.16 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.725 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.7 135.75 70.95 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.474 2.783 . . . . 0.0 113.346 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.6 m -147.42 87.43 1.65 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.18 155.87 37.73 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.364 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 25.05 15.06 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.63 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.96 74.5 0.15 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.826 0.346 . . . . 0.0 111.147 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -145.09 87.38 1.82 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.801 0.334 . . . . 0.0 111.101 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.422 ' N ' HD23 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -133.5 34.1 3.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 80' ' ' VAL . 10.1 p -99.43 24.49 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.06 0.457 . . . . 0.0 111.36 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.469 ' CE ' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -127.75 31.3 5.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 tp -122.48 32.02 5.91 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 110.978 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -88.83 -56.33 3.34 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.876 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.462 0.133 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.049 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.7 mtt . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 120.609 0.242 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.87 150.2 26.63 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.315 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.27 108.29 5.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.825 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -63.65 142.59 58.34 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.043 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -68.28 -65.4 0.7 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.367 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -156.82 149.46 23.51 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.887 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.41 134.57 44.29 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.449 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 24' ' ' TYR . 19.2 t -132.9 141.52 44.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -67.17 139.99 57.46 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.02 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.664 HD11 ' CD2' ' A' ' 22' ' ' TYR . 7.9 tp -56.38 -29.92 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.513 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -58.76 -33.94 70.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.577 0.227 . . . . 0.0 110.858 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.45 -30.37 63.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.135 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.405 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 6.8 m-85 -63.02 164.49 8.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.124 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.26 110.89 23.37 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.653 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -66.86 121.3 15.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.732 0.301 . . . . 0.0 110.512 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -102.17 85.17 2.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.653 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -55.81 -29.4 59.69 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.815 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.12 -41.56 17.66 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.16 0.288 . . . . 0.0 111.324 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.93 28.95 0.83 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 48.46 66.45 1.07 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.042 0.449 . . . . 0.0 111.909 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -138.09 154.26 49.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.589 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.664 ' CD2' HD11 ' A' ' 10' ' ' ILE . 67.4 m-85 -118.88 139.33 51.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.466 0.174 . . . . 0.0 110.573 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -128.8 156.81 42.99 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.829 0.347 . . . . 0.0 111.529 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CE1' HG11 ' A' ' 8' ' ' VAL . 31.8 t80 -137.14 136.21 20.62 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.238 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 40.0 Cg_endo -66.72 124.04 11.83 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.447 2.098 . . . . 0.0 112.622 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.41 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.6 143.36 26.19 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.16 -17.62 50.58 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.692 2.261 . . . . 0.0 112.829 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.0 p -74.76 -39.37 61.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.47 0.176 . . . . 0.0 111.153 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.43 -47.94 0.52 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.539 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.58 -173.99 4.43 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.487 0.184 . . . . 0.0 110.665 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.495 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 65.6 m-20 -131.99 140.42 48.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.683 0.278 . . . . 0.0 111.084 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.517 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 27.2 m-85 -64.48 166.25 8.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.789 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -149.8 139.49 21.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 111.57 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.791 HD11 ' O ' ' A' ' 43' ' ' GLU . 12.7 tt -151.87 125.29 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.605 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.9 p -72.72 150.54 42.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.382 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 39' ' ' LEU . 8.7 tptt -59.39 -38.81 81.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.722 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -60.7 -38.09 83.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.115 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -57.82 -47.99 81.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.375 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' A' ' 59' ' ' TYR . 4.3 mt -64.06 -38.34 90.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -65.03 -29.02 69.9 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.497 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.26 -36.98 14.41 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.17 -15.23 2.33 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.647 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.791 ' O ' HD11 ' A' ' 34' ' ' ILE . 20.9 mm-40 -68.22 80.6 0.24 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-O 121.146 0.498 . . . . 0.0 110.619 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.2 p30 -96.7 38.88 1.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.421 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.12 134.93 64.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.253 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.726 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.67 138.52 49.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.153 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.3 m -117.05 131.16 57.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.636 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.2 t -99.48 114.23 65.44 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.264 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.0 -18.53 28.68 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.706 2.271 . . . . 0.0 113.34 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 m -81.11 -73.76 0.36 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 53' ' ' LEU . 27.4 p -79.8 -24.29 41.51 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.4 m 69.28 42.46 1.2 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.978 0.418 . . . . 0.0 111.03 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.584 HD13 ' SG ' ' A' ' 51' ' ' CYS . 5.0 mp -98.69 -179.75 4.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 pt -129.55 143.41 41.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.176 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.726 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 17.2 pt -140.18 143.09 30.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.76 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -91.75 134.26 34.89 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.335 0.588 . . . . 0.0 111.426 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -108.37 114.78 47.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.834 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 mm -93.61 134.49 31.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.679 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.465 ' CD2' HD22 ' A' ' 39' ' ' LEU . 19.9 p90 -154.42 177.97 10.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.207 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.44 102.49 14.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.448 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -60.39 -30.68 69.74 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.296 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -64.83 -33.67 76.56 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.619 0.247 . . . . 0.0 111.04 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -87.16 -41.55 13.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.995 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -71.55 -34.72 70.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.42 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.23 93.61 2.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.905 0.383 . . . . 0.0 110.691 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.8 t 61.06 74.9 0.43 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.823 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.89 -55.11 0.02 OUTLIER Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.186 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -117.59 41.7 2.78 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.796 0.332 . . . . 0.0 111.139 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.7 t -66.77 154.44 40.77 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.472 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 14.3 p -78.79 137.33 58.15 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.406 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 50.6 Cg_exo -53.84 127.52 25.9 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 123.009 2.473 . . . . 0.0 112.548 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 71' ' ' PRO . . . 72.85 153.17 0.15 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.187 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.58 81.1 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.371 2.047 . . . . 0.0 112.071 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.84 113.82 26.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.253 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.0 37.28 0.35 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -103.29 126.79 50.63 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.9 pttt -137.58 76.88 1.6 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.289 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -106.9 38.43 2.09 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.762 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -82.71 70.85 9.78 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.092 0.472 . . . . 0.0 111.04 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.1 t -129.04 108.38 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.991 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -73.67 109.32 7.08 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.801 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 83' ' ' GLU . 0.6 OUTLIER 70.28 150.31 0.09 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' N ' HD23 ' A' ' 82' ' ' LEU . 1.5 tt0 -158.61 -62.26 0.08 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.321 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 82.1 t60 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.948 0.404 . . . . 0.0 110.853 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.0 177.07 9.04 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.621 0.248 . . . . 0.0 111.631 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.0 m -75.4 80.4 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.154 0.502 . . . . 0.0 111.214 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.437 ' CE2' HG23 ' A' ' 45' ' ' VAL . 8.4 m-85 -77.28 160.32 28.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.418 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -76.44 -62.16 1.71 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.614 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -157.96 141.24 15.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.988 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -94.68 132.66 39.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.471 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.734 HG11 ' CE1' ' A' ' 24' ' ' TYR . 20.7 t -130.96 141.57 45.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.214 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -69.52 140.14 53.9 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.203 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.551 HD13 HD13 ' A' ' 39' ' ' LEU . 1.1 tp -55.64 -29.01 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.537 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.97 -32.41 69.61 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.638 0.256 . . . . 0.0 110.809 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.28 -30.6 62.17 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.88 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.466 ' HZ ' HD12 ' A' ' 55' ' ' ILE . 11.9 m-85 -64.08 171.32 3.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.3 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -109.35 112.65 24.9 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -65.85 124.1 21.58 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.386 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -100.38 93.82 5.85 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.81 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.49 -26.45 54.28 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.67 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -47.77 -52.97 16.76 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.521 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.9 m -145.27 29.91 1.15 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.73 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.96 70.3 0.57 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.958 0.409 . . . . 0.0 111.458 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.3 m -138.35 154.87 48.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.595 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.53 ' CG ' HD11 ' A' ' 10' ' ' ILE . 51.7 m-85 -119.93 140.37 51.01 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.6 0.238 . . . . 0.0 110.583 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -131.37 153.72 49.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.602 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.734 ' CE1' HG11 ' A' ' 8' ' ' VAL . 7.4 t80 -129.55 137.13 30.28 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.25 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 54.6 Cg_endo -69.93 124.17 10.76 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.605 2.203 . . . . 0.0 112.665 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.43 143.47 26.59 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.929 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.08 -17.08 45.75 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.759 2.306 . . . . 0.0 112.851 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.9 p -74.35 -41.16 61.5 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.422 0.153 . . . . 0.0 111.168 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.63 -52.57 0.4 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.917 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.56 -169.59 1.76 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.67 0.235 . . . . 0.0 111.231 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 5.3 m-80 -136.37 142.36 43.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 112.068 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -64.1 162.03 15.05 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.153 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.82 138.89 25.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.774 0.321 . . . . 0.0 111.83 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.804 HD11 ' O ' ' A' ' 43' ' ' GLU . 3.5 tt -152.01 124.39 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.992 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.0 p -72.81 148.84 44.14 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.572 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HA ' HD12 ' A' ' 39' ' ' LEU . 8.5 tptt -58.71 -39.62 81.34 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.768 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -61.11 -39.16 88.96 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.134 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -57.06 -47.98 79.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.692 0.282 . . . . 0.0 110.49 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.551 HD13 HD13 ' A' ' 10' ' ' ILE . 3.9 mt -64.49 -39.15 93.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.876 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.474 ' O ' HG22 ' A' ' 65' ' ' VAL . 52.9 mt-10 -64.51 -26.4 68.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.579 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -92.97 -36.57 12.68 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.67 -17.2 2.02 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.634 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.804 ' O ' HD11 ' A' ' 34' ' ' ILE . 8.7 mt-10 -67.61 81.13 0.17 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-O 121.219 0.533 . . . . 0.0 110.875 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.3 p30 -95.64 39.43 1.13 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.519 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG23 ' CE2' ' A' ' 4' ' ' PHE . 8.1 p -126.17 130.85 72.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.074 0.464 . . . . 0.0 111.501 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -114.8 135.08 54.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.714 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 m -111.0 125.87 54.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.562 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 49.4 t -78.63 133.92 62.17 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.812 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.34 45.95 2.11 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.955 2.437 . . . . 0.0 113.328 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.77 -67.93 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.348 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 53' ' ' LEU . 30.0 p -80.5 -24.96 39.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.484 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.86 37.86 2.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.853 0.359 . . . . 0.0 110.981 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.547 HD12 ' SG ' ' A' ' 51' ' ' CYS . 10.9 mt -88.66 -179.82 6.1 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.713 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.1 pt -128.57 143.36 41.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.863 0.363 . . . . 0.0 111.291 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 46' ' ' ALA . 4.0 pt -142.56 141.27 27.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.975 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.18 135.64 33.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.207 0.527 . . . . 0.0 111.324 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.769 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -109.36 113.35 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.033 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 mm -90.51 134.85 28.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.428 ' CZ ' ' HE2' ' A' ' 61' ' ' LYS . 22.5 p90 -154.86 174.3 15.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.795 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.37 102.48 12.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.622 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HE2' ' CZ ' ' A' ' 59' ' ' TYR . 8.8 mmtp -59.82 -30.49 68.97 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.5 -40.31 89.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.831 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -78.14 -44.2 26.67 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.934 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -68.02 -38.97 83.22 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.442 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 40' ' ' GLU . 21.2 t -114.73 91.33 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.651 0.263 . . . . 0.0 111.558 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.58 79.13 0.36 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.114 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -104.86 -50.18 0.97 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.379 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.65 33.77 2.86 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.641 0.258 . . . . 0.0 111.226 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.0 t -133.04 154.77 50.23 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.686 0.279 . . . . 0.0 111.133 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.9 t -139.76 141.33 27.39 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.411 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.14 175.81 0.61 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.015 2.477 . . . . 0.0 112.675 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.06 114.85 8.48 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.801 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.89 98.21 0.6 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.625 2.216 . . . . 0.0 111.802 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.7 m 58.41 37.05 25.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.042 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.51 172.3 13.76 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -134.74 161.33 35.47 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.009 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -87.67 103.83 15.96 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.455 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -140.85 37.94 1.8 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.9 35.43 4.11 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.984 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.54 138.52 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.08 115.35 23.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.832 0.348 . . . . 0.0 111.18 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.5 tp -130.61 34.73 4.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.072 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.31 -52.02 0.95 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.904 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 . . . . . 0 C--O 1.231 0.12 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.54 0.21 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.8 157.47 27.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.341 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.514 ' O ' HD11 ' A' ' 54' ' ' ILE . 7.1 t -120.99 31.59 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.426 ' CE2' HG23 ' A' ' 45' ' ' VAL . 3.2 m-85 -110.36 175.46 5.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.74 -62.07 1.67 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.832 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -165.42 139.57 4.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.969 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.33 133.07 35.21 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.662 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.506 HG11 ' CE1' ' A' ' 24' ' ' TYR . 21.2 t -134.12 141.51 43.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.179 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -67.19 139.9 57.44 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.965 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.625 HD11 ' CG ' ' A' ' 22' ' ' TYR . 6.7 tp -54.15 -31.16 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.606 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -59.28 -34.14 71.92 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.709 0.29 . . . . 0.0 110.822 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.2 -28.52 62.24 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.136 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 27.4 m-85 -66.12 169.21 7.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.875 0.369 . . . . 0.0 110.974 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -103.32 109.02 20.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -65.75 128.01 34.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.644 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -103.96 94.99 5.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.0 -26.28 59.98 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.357 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.52 -51.66 19.99 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.679 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -152.0 33.61 0.53 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.667 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 52.53 74.32 0.29 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.812 0.339 . . . . 0.0 111.838 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 m -138.48 151.17 47.15 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.791 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.625 ' CG ' HD11 ' A' ' 10' ' ' ILE . 54.0 m-85 -122.02 137.69 54.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.724 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -130.19 156.94 43.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.482 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.506 ' CE1' HG11 ' A' ' 8' ' ' VAL . 24.8 t80 -141.09 134.33 14.56 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.043 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 24' ' ' TYR . 32.1 Cg_exo -58.19 127.47 25.01 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.903 2.402 . . . . 0.0 113.03 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.433 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 2.0 t -102.74 138.04 19.49 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.433 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 60.4 Cg_endo -73.11 60.78 3.9 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.665 2.243 . . . . 0.0 112.64 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.1 p -157.16 -47.57 0.07 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.971 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.59 -52.15 0.19 Allowed Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.645 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.46 -179.38 6.07 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.642 0.258 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -127.43 142.41 51.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.722 0.296 . . . . 0.0 111.455 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.416 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 89.0 m-85 -58.91 166.86 1.79 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.295 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.1 p -150.97 139.02 20.06 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.611 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.878 HD13 HG21 ' A' ' 57' ' ' VAL . 1.7 tt -152.22 124.6 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.828 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.0 p -72.1 149.48 44.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 111.347 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -39.3 87.31 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.952 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -61.25 -37.88 84.71 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.236 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 43' ' ' GLU . 4.8 m-20 -56.41 -43.95 79.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.413 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.605 HD22 ' CE2' ' A' ' 59' ' ' TYR . 29.0 mt -61.7 -41.77 98.04 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.874 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.57 -28.12 67.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.597 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -85.85 -39.63 16.83 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.22 -13.38 2.55 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.534 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.823 ' O ' HD11 ' A' ' 34' ' ' ILE . 32.0 mm-40 -71.13 81.31 0.7 Allowed 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.088 0.471 . . . . 0.0 110.866 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -96.6 39.95 1.15 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 4' ' ' PHE . 7.8 p -130.33 128.9 64.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.324 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.62 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.92 140.93 47.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 52' ' ' SER . 1.0 OUTLIER -119.32 132.89 55.94 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.0 t -74.25 133.5 77.93 Favored Pre-proline 0 C--O 1.234 0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.857 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.28 52.93 4.49 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.874 2.382 . . . . 0.0 112.93 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.0 t -164.64 -56.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.445 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.742 ' SG ' HD13 ' A' ' 53' ' ' LEU . 29.2 p -98.01 -22.83 16.06 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.61 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.579 ' HA ' HG22 ' A' ' 47' ' ' THR . 1.9 t 71.95 41.87 0.64 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 110.444 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.742 HD13 ' SG ' ' A' ' 51' ' ' CYS . 1.4 mp -77.31 -175.44 3.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.665 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.514 HD11 ' O ' ' A' ' 3' ' ' VAL . 8.4 pt -139.1 143.66 31.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.893 0.377 . . . . 0.0 111.557 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.62 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 12.0 pt -147.09 147.8 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.908 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -93.2 133.56 36.27 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.252 0.548 . . . . 0.0 111.229 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.878 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -107.25 113.95 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.948 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.7 mm -95.41 135.04 30.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.84 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.605 ' CE2' HD22 ' A' ' 39' ' ' LEU . 15.9 p90 -156.22 178.42 10.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.984 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 10.9 t0 -80.55 98.04 7.43 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.394 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -61.89 -29.9 70.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.695 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 66' ' ' SER . 1.0 OUTLIER -69.18 -32.6 72.03 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.761 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 17.7 mm-40 -82.92 -45.41 14.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.742 0.306 . . . . 0.0 110.848 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -72.46 -42.57 64.82 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.468 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.6 t -105.5 84.18 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.923 0.392 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 7.4 t -168.47 43.83 0.04 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.766 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -141.31 -50.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.275 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -103.76 33.23 3.49 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.687 0.28 . . . . 0.0 111.308 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.6 m -112.24 80.08 1.29 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.819 0.343 . . . . 0.0 110.487 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.406 HG23 ' HD2' ' A' ' 71' ' ' PRO . 9.1 p -168.99 135.87 1.51 Allowed Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 70' ' ' VAL . 74.3 Cg_endo -75.76 151.02 35.75 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.641 2.227 . . . . 0.0 112.601 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.58 150.46 88.98 Favored Pre-proline 0 C--O 1.231 0.104 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.886 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.16 88.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.94 2.427 . . . . 0.0 112.764 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.6 m 63.38 100.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.815 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.13 154.95 31.27 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.582 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m120 64.93 -179.33 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.618 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -132.62 121.07 22.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.903 0.383 . . . . 0.0 111.291 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -137.12 92.83 2.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.734 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.92 68.29 1.2 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.071 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.8 t -118.13 86.82 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 95.5 10.07 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -70.04 132.44 45.89 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.132 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.422 ' N ' HD13 ' A' ' 82' ' ' LEU . 1.6 tm-20 -62.72 152.13 36.47 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.297 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.9 t60 . . . . . 0 C--O 1.232 0.145 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.735 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.611 0.243 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.09 -66.67 0.61 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.138 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.3 m -63.28 122.77 14.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.967 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.414 ' CD1' HD12 ' A' ' 54' ' ' ILE . 5.2 m-85 -67.33 146.42 54.11 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -64.96 -61.39 2.19 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.692 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -166.95 156.51 10.9 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.73 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.92 136.06 39.45 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.528 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG21 ' CZ ' ' A' ' 24' ' ' TYR . 19.7 t -136.66 141.3 41.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.195 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.63 139.91 57.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.084 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.571 HD11 ' CD2' ' A' ' 22' ' ' TYR . 1.0 OUTLIER -55.45 -28.84 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.378 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -57.18 -32.05 66.06 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.898 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -76.16 -29.38 57.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.114 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' HZ ' HD12 ' A' ' 55' ' ' ILE . 7.6 m-85 -63.92 174.99 1.29 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.026 0.441 . . . . 0.0 111.251 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -113.95 111.78 22.23 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -64.9 124.91 23.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.655 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -107.36 88.73 2.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.897 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -55.34 -28.21 52.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.267 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.2 -44.56 11.07 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.611 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.1 p -146.51 25.47 1.2 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 50.8 62.89 2.47 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.098 0.475 . . . . 0.0 111.563 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.1 m -138.52 153.29 48.74 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.673 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.571 ' CD2' HD11 ' A' ' 10' ' ' ILE . 27.1 m-85 -113.51 138.76 49.66 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.61 0.243 . . . . 0.0 110.679 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 7.9 m-85 -122.36 149.58 43.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.375 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.454 ' HB2' ' CE2' ' A' ' 13' ' ' PHE . 40.8 t80 -127.45 131.56 23.9 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.794 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.15 123.94 14.79 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.717 2.278 . . . . 0.0 112.626 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -108.36 146.07 32.85 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.601 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 26' ' ' CYS . 44.3 Cg_exo -56.29 -28.27 70.95 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.005 2.47 . . . . 0.0 112.847 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -72.88 -39.25 66.59 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.045 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.31 21.01 6.37 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.193 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 -32.47 9.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.932 0.366 . . . . 0.0 111.399 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 73.89 122.01 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.128 0.49 . . . . 0.0 111.944 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.695 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 68.7 m-85 -62.65 165.2 6.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.423 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -143.17 139.39 30.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.819 0.343 . . . . 0.0 111.561 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.773 HD11 ' O ' ' A' ' 43' ' ' GLU . 6.0 tt -151.73 122.92 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.705 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 p -71.63 148.56 46.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.379 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HA ' HD12 ' A' ' 39' ' ' LEU . 19.3 tptm -58.94 -39.54 81.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.985 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -60.88 -38.07 84.33 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.6 -47.49 81.99 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.638 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.508 HD13 HD13 ' A' ' 10' ' ' ILE . 4.2 mt -65.0 -36.13 83.42 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.863 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.596 ' O ' HG22 ' A' ' 65' ' ' VAL . 57.4 mt-10 -67.85 -24.77 65.3 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.499 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -94.83 -35.82 11.91 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.91 -16.32 2.38 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.46 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.773 ' O ' HD11 ' A' ' 34' ' ' ILE . 20.6 mm-40 -67.63 81.8 0.18 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-O 121.036 0.445 . . . . 0.0 110.606 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.6 p30 -96.64 38.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.749 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.48 132.61 70.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.946 0.403 . . . . 0.0 111.278 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.695 ' HB1' ' HB3' ' A' ' 32' ' ' PHE . . . -112.74 130.3 56.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.962 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.2 132.91 56.46 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.046 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.96 143.65 53.75 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.629 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -79.42 1.83 8.86 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.621 2.214 . . . . 0.0 113.277 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.1 t -120.36 -68.75 0.89 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.395 0.14 . . . . 0.0 111.038 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.497 ' SG ' HD12 ' A' ' 53' ' ' LEU . 31.9 p -75.0 -24.98 58.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.381 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 m 64.67 40.69 5.7 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 110.851 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.497 HD12 ' SG ' ' A' ' 51' ' ' CYS . 3.4 mt -81.05 -178.68 7.0 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.768 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.414 HD12 ' CD1' ' A' ' 4' ' ' PHE . 14.4 pt -135.82 143.19 37.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.351 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.641 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.7 pt -147.62 144.91 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.902 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -92.74 133.97 35.5 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.293 0.568 . . . . 0.0 111.477 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.738 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -108.62 113.94 45.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.158 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.0 mm -92.55 134.9 29.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.668 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.433 ' CD2' HD22 ' A' ' 39' ' ' LEU . 17.9 p90 -153.44 178.63 9.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.477 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -86.5 105.89 17.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.893 0.377 . . . . 0.0 110.7 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -60.28 -29.33 68.74 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.093 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -68.15 -41.76 81.09 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.91 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -76.28 -47.93 21.97 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.238 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -69.99 -35.36 74.34 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.321 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 40' ' ' GLU . 17.8 t -125.12 93.33 2.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.94 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 t -95.47 42.66 1.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.944 0.402 . . . . 0.0 110.951 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -136.28 -58.75 0.06 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.961 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -121.31 42.51 3.06 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.734 0.302 . . . . 0.0 111.044 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 t -63.79 152.08 40.42 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.834 0.349 . . . . 0.0 110.967 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.433 HG23 ' HD2' ' A' ' 71' ' ' PRO . 9.8 p -161.07 136.29 5.66 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.41 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 70' ' ' VAL . 72.2 Cg_endo -76.1 -174.37 2.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.841 2.36 . . . . 0.0 112.322 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.73 150.03 18.82 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.534 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.17 -179.84 3.87 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.821 2.348 . . . . 0.0 112.427 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -152.32 126.67 9.3 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.13 -60.4 2.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -162.65 154.18 17.97 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.99 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -134.35 117.08 15.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.041 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.82 103.82 3.66 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.74 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 79' ' ' LEU . 2.3 pt? -175.91 130.11 0.24 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -112.98 137.31 46.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -78.36 114.66 17.46 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.804 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.66 119.18 20.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -138.48 35.14 2.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.067 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.905 0.383 . . . . 0.0 110.781 179.84 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mtt . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.21 93.75 1.11 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 111.135 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.23 148.35 24.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.856 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CD1' HD12 ' A' ' 54' ' ' ILE . 7.8 m-85 -61.22 125.69 24.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -59.57 -64.41 0.95 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -156.99 161.05 39.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.912 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 56' ' ' LYS . 23.4 mt-10 -99.87 135.57 41.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.488 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.592 HG11 ' CE1' ' A' ' 24' ' ' TYR . 21.4 t -130.72 140.95 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.189 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -73.86 139.8 45.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.994 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.804 HD11 ' CD2' ' A' ' 22' ' ' TYR . 9.0 tp -57.21 -28.72 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.576 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.92 -33.44 71.88 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.573 0.225 . . . . 0.0 110.681 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -74.92 -29.98 61.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.779 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 24' ' ' TYR . 6.1 m-85 -62.38 172.61 1.45 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.301 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -115.03 108.52 16.79 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -66.13 135.88 55.18 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.525 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -113.11 97.14 6.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.609 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -57.74 -26.09 61.33 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -48.16 -52.91 18.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.428 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -146.65 30.84 0.98 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.648 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 52.32 71.75 0.45 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 111.482 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 m -137.94 143.54 40.8 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.512 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.804 ' CD2' HD11 ' A' ' 10' ' ' ILE . 14.6 m-85 -113.68 138.84 49.65 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.788 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -128.71 157.05 42.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.625 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.592 ' CE1' HG11 ' A' ' 8' ' ' VAL . 22.0 t80 -138.09 135.54 18.69 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.091 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 24' ' ' TYR . 32.2 Cg_exo -58.3 124.44 15.88 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.79 2.326 . . . . 0.0 112.559 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.432 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.8 144.17 27.69 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.45 -17.14 43.88 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.612 2.208 . . . . 0.0 112.84 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.8 p -77.86 -33.15 52.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.248 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.06 -47.72 0.65 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.623 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 -163.25 0.37 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.538 0.209 . . . . 0.0 110.954 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -140.39 139.41 35.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.728 0.299 . . . . 0.0 110.848 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.493 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 22.7 m-85 -62.61 162.6 10.29 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.978 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m -144.13 139.22 28.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.793 0.33 . . . . 0.0 111.638 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.807 HD11 ' O ' ' A' ' 43' ' ' GLU . 5.8 tt -151.95 124.38 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.752 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 p -72.08 148.56 45.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.368 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -38.91 85.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.854 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -36.89 81.23 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.169 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.14 -48.0 83.21 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.532 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.427 HD22 ' CE1' ' A' ' 59' ' ' TYR . 6.7 mt -63.2 -36.61 84.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.99 -32.46 73.81 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.303 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -89.49 -34.38 16.43 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.15 -12.54 3.06 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.57 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.807 ' O ' HD11 ' A' ' 34' ' ' ILE . 20.1 mm-40 -68.05 79.17 0.23 Allowed 'General case' 0 C--N 1.343 0.283 0 CA-C-O 121.135 0.493 . . . . 0.0 110.728 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 57' ' ' VAL . 11.3 p30 -95.02 39.37 1.11 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.408 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.2 p -124.24 133.81 68.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.256 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.671 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.75 137.0 51.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.391 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 130.58 56.18 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.1 t -93.08 133.36 28.9 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.423 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.07 -4.59 15.62 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.629 2.219 . . . . 0.0 113.241 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.81 -65.92 0.96 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.528 0.204 . . . . 0.0 111.262 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 53' ' ' LEU . 31.9 p -80.45 -26.28 38.44 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m 66.81 42.92 2.45 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.935 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.543 HD12 ' SG ' ' A' ' 51' ' ' CYS . 7.9 mt -100.51 179.69 4.36 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.851 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 4' ' ' PHE . 13.5 pt -128.98 143.43 41.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.185 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.671 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 7.1 pt -141.79 147.98 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.014 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 7' ' ' GLU . 1.9 tppp? -93.17 134.58 35.2 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.334 0.588 . . . . 0.0 111.381 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.718 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -108.79 113.2 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.826 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.56 134.29 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CE1' HD22 ' A' ' 39' ' ' LEU . 12.6 p90 -155.12 178.62 9.99 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.894 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 5.6 t70 -92.42 93.82 8.79 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.73 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -57.68 -31.15 66.08 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.288 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -34.92 79.51 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.762 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 2.3 mt-30 -84.3 -36.37 22.66 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.769 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -61.75 -61.13 2.73 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.434 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 65' ' ' VAL . 9.9 p -112.17 94.61 3.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.349 0.595 . . . . 0.0 111.229 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.22 32.85 2.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.83 -92.83 1.01 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.15 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.73 78.56 1.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 0.0 111.034 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 t -97.32 97.28 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.713 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.11 138.35 19.27 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.192 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 52.0 Cg_exo -54.76 140.68 77.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.806 2.338 . . . . 0.0 112.654 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . 71.38 159.33 0.16 Allowed Pre-proline 0 N--CA 1.467 0.392 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.329 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 58.6 Cg_endo -71.54 156.23 58.24 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.429 2.086 . . . . 0.0 112.575 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.2 m -107.12 -45.76 4.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.128 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.93 138.85 32.97 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.298 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -103.14 -34.94 8.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HG2' HD21 ' A' ' 79' ' ' LEU . 9.4 ttpt -160.37 113.25 2.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.988 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -136.62 102.37 4.9 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.118 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 79' ' ' LEU . 1.4 pt? -173.44 129.17 0.44 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 80' ' ' VAL . 12.2 p -69.53 117.54 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.129 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -113.12 104.51 12.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.008 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 82' ' ' LEU . 4.2 mm? -80.67 143.77 32.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.044 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.21 117.94 17.06 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.956 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 . . . . . 0 N--CA 1.465 0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.959 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.521 ' HB3' HG22 ' A' ' 3' ' ' VAL . 1.8 mmt . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.676 0.274 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.38 33.16 3.01 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.254 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 1' ' ' MET . 11.9 m -120.32 25.49 4.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.176 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.552 ' CD1' HD12 ' A' ' 54' ' ' ILE . 1.0 OUTLIER 59.45 178.67 0.08 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.961 0.41 . . . . 0.0 111.295 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -96.77 -62.54 1.25 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -167.82 144.67 4.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.752 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -93.28 124.21 37.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.461 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.52 HG11 ' CE1' ' A' ' 24' ' ' TYR . 30.2 t -121.67 141.51 41.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.229 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -69.48 140.07 53.97 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.141 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.55 HD11 ' CD2' ' A' ' 22' ' ' TYR . 1.2 tp -56.81 -29.83 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.754 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -59.44 -34.02 71.99 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.691 0.281 . . . . 0.0 110.816 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -72.54 -34.03 67.26 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -59.04 159.49 7.16 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.433 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.71 87.62 4.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.323 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.53 ' HB2' ' CE2' ' A' ' 22' ' ' TYR . 83.9 t80 -72.64 150.04 43.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.908 0.385 . . . . 0.0 111.017 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.48 135.15 47.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.636 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.26 -31.72 26.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.554 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.22 -34.39 42.89 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.805 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.6 t -96.02 -29.5 14.1 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.875 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 61.37 39.57 15.15 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.081 0.467 . . . . 0.0 110.73 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.497 HG23 ' C ' ' A' ' 34' ' ' ILE . 48.8 m -142.04 146.11 35.12 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.418 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.55 ' CD2' HD11 ' A' ' 10' ' ' ILE . 65.0 m-85 -98.83 140.73 32.58 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.709 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -127.96 156.46 42.63 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.454 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.52 ' CE1' HG11 ' A' ' 8' ' ' VAL . 23.1 t80 -148.91 136.86 11.37 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.146 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 37.2 Cg_endo -65.47 130.73 25.89 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.656 2.237 . . . . 0.0 112.731 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.75 144.95 28.73 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.818 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.91 -25.78 63.98 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.927 2.418 . . . . 0.0 112.912 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -74.91 -40.54 60.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.31 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.27 -46.17 0.55 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.609 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.69 -178.76 2.35 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.524 0.202 . . . . 0.0 110.66 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 35.8 m-20 -127.73 138.14 52.68 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.713 0.292 . . . . 0.0 111.095 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.791 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 60.9 m-85 -65.34 169.19 6.08 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.511 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 p -152.18 139.14 19.05 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.653 HD11 ' O ' ' A' ' 43' ' ' GLU . 14.4 tt -150.99 124.5 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.28 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 p -71.72 149.36 45.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.197 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -56.29 -36.61 68.83 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.641 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.09 -39.29 89.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.287 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.409 ' CB ' ' HB2' ' A' ' 43' ' ' GLU . 5.0 m-20 -56.46 -47.82 78.37 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.76 0.314 . . . . 0.0 110.988 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.426 HD22 ' CD1' ' A' ' 59' ' ' TYR . 5.6 mt -61.73 -42.44 98.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -68.16 -30.28 69.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.275 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -82.27 -39.76 22.51 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.94 -13.99 2.62 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.64 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.653 ' O ' HD11 ' A' ' 34' ' ' ILE . 58.4 mm-40 -69.46 80.19 0.39 Allowed 'General case' 0 C--N 1.341 0.224 0 CA-C-O 120.902 0.382 . . . . 0.0 110.941 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.1 p30 -95.37 40.32 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.76 137.94 54.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.319 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.791 ' HB1' ' HB3' ' A' ' 32' ' ' PHE . . . -113.12 132.27 55.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.764 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -113.56 132.6 55.66 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.147 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.409 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . 26.1 t -89.81 134.43 32.1 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.572 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.98 0.04 10.09 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.668 2.245 . . . . 0.0 113.439 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.69 -65.28 1.1 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.512 0.196 . . . . 0.0 111.272 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.661 ' SG ' HD13 ' A' ' 53' ' ' LEU . 28.1 p -88.18 -22.86 23.8 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t 69.36 42.77 1.13 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.078 0.465 . . . . 0.0 110.784 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.661 HD13 ' SG ' ' A' ' 51' ' ' CYS . 4.7 mp -88.74 179.54 6.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.744 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.552 HD12 ' CD1' ' A' ' 4' ' ' PHE . 14.0 pt -132.24 143.31 40.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.271 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.756 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 11.0 pt -143.85 146.74 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.935 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.16 136.01 33.38 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.297 0.57 . . . . 0.0 111.248 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -110.19 114.05 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.867 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.3 mm -93.62 135.39 28.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.787 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.426 ' CD1' HD22 ' A' ' 39' ' ' LEU . 12.5 p90 -157.98 176.47 12.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.058 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 6.6 t0 -88.94 94.38 9.92 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.82 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -59.09 -33.1 70.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.822 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.09 -30.24 71.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.035 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 1.9 mm-40 -89.49 -33.41 16.79 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.636 0.255 . . . . 0.0 110.769 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.82 -64.02 0.96 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.244 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 65' ' ' VAL . 8.4 p -112.74 96.02 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.24 0.543 . . . . 0.0 111.382 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.3 t -157.34 84.44 0.92 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.634 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -149.82 -65.58 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.142 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -103.07 37.4 1.98 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.69 0.281 . . . . 0.0 110.673 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -130.68 120.7 24.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.666 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.87 140.42 93.52 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.344 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.86 171.61 1.0 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.988 2.459 . . . . 0.0 112.844 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.98 150.2 73.75 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.993 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.79 168.38 21.75 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.023 2.482 . . . . 0.0 112.643 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 12.5 p -96.41 142.64 28.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.328 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 74' ' ' SER . . . 71.83 -70.4 0.16 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.95 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -153.47 165.76 34.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.557 0.218 . . . . 0.0 110.876 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -70.24 127.9 34.37 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.652 0.263 . . . . 0.0 110.701 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.86 118.43 30.77 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.878 0.371 . . . . 0.0 111.371 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.54 33.03 0.56 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.243 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 p -116.36 129.55 72.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.012 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -108.51 73.36 0.87 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.818 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mt -148.27 167.35 25.38 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.054 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.44 -52.78 8.53 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 . . . . . 0 N--CA 1.461 0.119 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.817 179.767 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.662 0.268 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.19 153.56 24.7 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.309 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p -105.37 148.93 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.413 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -80.47 167.96 19.53 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -78.38 -60.32 2.42 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.877 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -160.63 161.12 32.37 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.002 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -110.69 132.99 53.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.466 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.621 HG11 ' CE1' ' A' ' 24' ' ' TYR . 22.1 t -138.7 141.54 36.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.12 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.13 139.71 57.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.006 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.751 HD11 ' CG ' ' A' ' 22' ' ' TYR . 8.2 tp -56.62 -29.57 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.926 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.46 -30.54 69.74 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.592 0.234 . . . . 0.0 110.991 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.43 -31.13 65.23 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.06 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 7.6 m-85 -61.93 156.73 20.21 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.977 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -92.96 83.65 4.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.414 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.45 ' HB2' ' CE2' ' A' ' 22' ' ' TYR . 76.5 t80 -67.38 153.46 43.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.966 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.82 99.18 2.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.299 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.15 -31.8 20.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.01 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -53.23 -43.1 67.03 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.066 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 t -107.22 -18.86 13.77 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 63.85 42.59 5.93 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.097 0.475 . . . . 0.0 110.524 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.469 HG23 ' C ' ' A' ' 34' ' ' ILE . 24.2 m -142.9 146.35 33.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.819 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.751 ' CG ' HD11 ' A' ' 10' ' ' ILE . 81.6 m-85 -101.46 141.15 34.76 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.739 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -127.41 149.07 50.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.388 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.621 ' CE1' HG11 ' A' ' 8' ' ' VAL . 12.6 t80 -131.52 137.13 29.77 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.175 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.78 124.24 10.04 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.639 2.226 . . . . 0.0 112.58 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.47 145.2 29.26 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.724 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.29 -18.6 50.35 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.617 2.211 . . . . 0.0 112.83 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.0 p -76.77 -33.95 58.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.183 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.25 -45.53 0.79 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.546 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 0.4 OUTLIER -74.02 -173.33 1.57 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.704 0.288 . . . . 0.0 110.876 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -139.51 133.16 30.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.675 0.274 . . . . 0.0 111.405 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.564 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 40.0 m-85 -61.16 159.06 12.63 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.847 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 p -146.33 139.21 25.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 111.603 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.655 HD11 ' O ' ' A' ' 43' ' ' GLU . 11.5 tt -152.02 125.58 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.556 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.0 p -71.53 151.95 43.42 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.274 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -57.46 -37.15 72.42 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.734 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -60.86 -38.15 84.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.034 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.17 -47.96 81.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.804 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.69 -42.04 98.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.862 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.59 -29.73 69.16 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.4 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -84.23 -40.98 17.41 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.74 -13.79 2.2 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.715 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.655 ' O ' HD11 ' A' ' 34' ' ' ILE . 51.2 mm-40 -68.68 79.2 0.29 Allowed 'General case' 0 C--N 1.343 0.297 0 CA-C-O 121.044 0.449 . . . . 0.0 110.877 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 p30 -94.07 39.47 1.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.639 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.5 p -129.58 132.07 66.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.692 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -113.16 138.63 49.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.632 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.0 m -117.57 132.1 56.58 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.3 t -89.97 133.91 32.84 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.569 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.53 -4.76 15.98 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.595 2.196 . . . . 0.0 113.385 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -104.01 -67.03 0.92 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.517 0.199 . . . . 0.0 111.149 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.56 ' SG ' HD12 ' A' ' 53' ' ' LEU . 31.3 p -80.68 -26.83 37.32 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.716 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.46 40.36 2.66 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.999 0.428 . . . . 0.0 110.902 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.56 HD12 ' SG ' ' A' ' 51' ' ' CYS . 12.4 mt -93.87 -179.84 5.11 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.707 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.9 pt -126.13 143.51 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.185 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.692 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.2 pt -141.66 144.2 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.15 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -91.68 133.82 35.24 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.282 0.563 . . . . 0.0 111.412 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.442 HG13 ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -108.32 113.18 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.908 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mm -91.22 134.46 29.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.058 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -155.19 176.55 12.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.619 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.37 99.43 12.45 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.835 0.35 . . . . 0.0 110.801 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -60.32 -29.99 69.22 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.102 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.95 -36.2 83.63 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.739 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -82.26 -44.51 16.21 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.865 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -64.16 -38.09 89.79 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.132 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.3 t -112.37 84.9 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.95 0.405 . . . . 0.0 110.983 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.1 p -108.77 40.9 1.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.994 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.32 -67.25 1.72 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.073 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -116.02 79.62 1.33 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.809 0.337 . . . . 0.0 111.487 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.0 m -153.92 126.52 8.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.049 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.48 140.39 21.27 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.022 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.03 -178.0 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.965 2.443 . . . . 0.0 112.723 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.64 144.42 13.22 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.602 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.25 51.94 4.11 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.772 2.315 . . . . 0.0 112.275 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.69 -73.15 0.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.257 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -176.03 178.88 1.38 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.027 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -99.12 -42.95 6.84 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.135 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -174.43 121.27 0.26 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.171 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -157.48 95.51 1.46 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.022 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.39 33.18 5.69 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.04 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 80' ' ' VAL . 10.6 p -105.47 23.86 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.069 0.461 . . . . 0.0 111.273 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -156.97 90.89 1.16 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.113 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 tp 65.25 106.48 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.466 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -121.39 132.9 55.02 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.999 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 m80 . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 121.11 0.481 . . . . 0.0 111.018 179.429 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.758 0.313 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.8 94.68 2.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.624 ' O ' HD11 ' A' ' 54' ' ' ILE . 15.9 m -139.04 78.44 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.054 0.455 . . . . 0.0 111.448 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -101.23 175.26 5.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.303 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.531 ' CG ' HD21 ' A' ' 53' ' ' LEU . 4.0 t60 -88.29 -62.35 1.51 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.947 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -159.53 155.57 26.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.074 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 56' ' ' LYS . 1.9 mp0 -103.09 134.76 45.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.669 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.656 HG11 ' CZ ' ' A' ' 24' ' ' TYR . 21.2 t -134.68 139.93 46.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.042 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -67.13 140.07 57.52 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.989 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.462 HD11 ' CD2' ' A' ' 22' ' ' TYR . 1.1 tp -56.76 -29.73 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.495 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -58.99 -33.24 70.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.703 0.287 . . . . 0.0 110.686 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.86 -29.6 65.76 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.156 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 11.2 m-85 -66.54 172.33 4.22 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.134 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.87 110.31 22.44 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.736 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -66.84 112.02 4.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.877 0.37 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -94.02 87.38 5.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.442 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -56.01 -28.55 57.74 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.354 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -47.23 -43.91 22.22 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.278 0.361 . . . . 0.0 111.498 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.0 m -143.93 28.06 1.43 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.647 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 46.98 62.52 2.34 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.898 0.38 . . . . 0.0 111.645 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.2 m -137.8 151.7 48.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.462 ' CD2' HD11 ' A' ' 10' ' ' ILE . 26.1 m-85 -112.97 139.54 48.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.528 0.204 . . . . 0.0 110.758 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -128.9 153.84 47.1 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.466 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.656 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 4.4 t80 -134.63 137.14 26.89 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 52.1 Cg_endo -69.38 126.58 13.74 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.573 2.182 . . . . 0.0 112.947 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.429 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -98.84 142.28 24.33 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 35.3 Cg_endo -64.97 -18.5 62.38 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.733 2.289 . . . . 0.0 113.045 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.7 p -76.36 -41.48 48.04 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.338 0.113 . . . . 0.0 111.168 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.42 -55.46 0.33 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.968 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 0.4 OUTLIER -75.93 -175.82 3.18 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.596 0.236 . . . . 0.0 111.039 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 48.7 m-20 -129.89 144.24 51.22 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.854 0.359 . . . . 0.0 111.506 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.619 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 68.4 m-85 -66.27 168.94 7.89 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.646 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.4 p -153.1 139.2 18.27 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 111.736 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.775 HD11 ' O ' ' A' ' 43' ' ' GLU . 9.6 tt -151.97 123.49 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.778 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.5 p -72.1 151.77 42.83 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 111.386 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -60.18 -38.83 84.41 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.826 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.86 -38.13 84.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.231 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -57.14 -48.05 79.63 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.684 0.278 . . . . 0.0 110.582 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.472 HD22 ' CD2' ' A' ' 59' ' ' TYR . 8.5 mt -61.4 -46.9 88.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.807 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -59.76 -27.18 66.3 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.665 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -89.98 -38.42 13.65 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.68 -4.6 3.04 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.844 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.775 ' O ' HD11 ' A' ' 34' ' ' ILE . 53.1 mm-40 -76.55 79.92 3.23 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.125 0.488 . . . . 0.0 109.788 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.0 m-20 -91.95 35.88 0.97 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.464 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -124.02 132.08 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.619 ' HB1' ' HB3' ' A' ' 32' ' ' PHE . . . -115.46 128.99 56.41 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.4 m -107.34 131.78 53.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.094 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 t -86.44 134.7 37.57 Favored Pre-proline 0 C--O 1.234 0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -82.48 40.77 1.01 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.771 2.314 . . . . 0.0 113.231 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -150.61 -59.09 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.328 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.7 p -93.38 -20.44 20.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.843 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m 67.23 37.89 3.51 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.975 0.417 . . . . 0.0 110.987 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.531 HD21 ' CG ' ' A' ' 5' ' ' HIS . 32.5 tp -89.11 160.79 16.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.959 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.624 HD11 ' O ' ' A' ' 3' ' ' VAL . 24.2 pt -114.66 143.3 24.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.826 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.526 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 21.8 pt -143.43 147.26 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.029 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.412 ' HB3' ' HG3' ' A' ' 7' ' ' GLU . 9.0 tppt? -93.19 134.75 35.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.301 0.572 . . . . 0.0 111.328 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.659 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -108.15 113.11 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.076 -179.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.5 mm -91.63 134.95 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.472 ' CD2' HD22 ' A' ' 39' ' ' LEU . 22.1 p90 -151.17 -178.63 6.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -89.88 99.94 12.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.599 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -61.23 -31.13 70.91 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.941 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.04 -34.83 79.37 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.753 0.311 . . . . 0.0 110.614 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -85.27 -46.22 11.23 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.304 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -65.62 -51.35 60.33 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.694 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.17 77.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.059 0.457 . . . . 0.0 111.068 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.25 93.36 0.13 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.763 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.46 -60.95 0.56 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.424 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -97.16 31.89 2.32 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.657 0.265 . . . . 0.0 111.321 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.1 m -139.65 118.61 12.55 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.661 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 t -105.71 139.45 20.22 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.212 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 40.2 Cg_exo -56.89 156.43 23.68 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.865 2.377 . . . . 0.0 112.542 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 71' ' ' PRO . . . 74.52 157.99 0.16 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.223 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.455 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 56.1 Cg_endo -70.17 138.49 36.63 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.462 2.108 . . . . 0.0 112.585 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.0 t -101.59 114.98 29.5 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.32 166.55 12.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.368 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -96.75 -37.62 10.22 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.522 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.55 104.76 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.58 0.352 . . . . 0.0 111.596 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -136.89 103.75 5.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.191 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -154.48 44.19 0.53 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.944 0.402 . . . . 0.0 111.027 179.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.78 152.42 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.209 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 mttt 64.77 78.28 0.29 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.046 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 tt -146.41 65.52 1.19 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 62.65 168.08 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.028 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 . . . . . 0 N--CA 1.463 0.206 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.91 179.574 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmm . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.685 0.279 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.76 93.95 0.33 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 m -92.02 143.89 10.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.173 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CD1' HD12 ' A' ' 54' ' ' ILE . 4.2 m-85 -66.6 140.9 57.97 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.967 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -68.63 -63.77 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -157.09 162.64 39.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.038 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.422 ' CG ' ' HB3' ' A' ' 56' ' ' LYS . 1.5 mp0 -112.46 134.89 53.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.743 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.795 HG11 ' CZ ' ' A' ' 24' ' ' TYR . 21.3 t -135.8 141.28 42.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 111.078 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -68.58 139.89 55.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.032 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.601 HD11 ' CG ' ' A' ' 22' ' ' TYR . 1.7 tp -54.6 -29.42 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.406 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -58.71 -32.87 69.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.637 0.256 . . . . 0.0 110.837 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.11 -30.82 63.92 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.914 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 15.0 m-85 -63.94 170.04 3.8 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.859 0.361 . . . . 0.0 111.349 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 23' ' ' PHE . 5.9 tt0 -107.02 112.98 26.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.63 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -66.02 116.44 7.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.581 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -95.02 88.49 5.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.539 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.84 -28.31 48.82 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.318 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.62 -47.08 10.41 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.33 0.394 . . . . 0.0 111.382 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 m -147.62 29.93 0.92 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.583 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 48.64 68.96 0.61 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.098 0.475 . . . . 0.0 111.485 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.4 m -138.8 157.73 45.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.86 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.601 ' CG ' HD11 ' A' ' 10' ' ' ILE . 53.2 m-85 -121.9 139.72 53.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.603 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 14' ' ' GLN . 4.4 p90 -137.08 152.06 49.59 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.43 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.795 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 1.3 t80 -127.86 139.33 35.02 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.303 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.56 124.51 12.94 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.719 2.279 . . . . 0.0 112.763 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.96 144.6 28.32 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.835 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.62 -17.38 48.07 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.632 2.221 . . . . 0.0 112.945 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.0 p -75.94 -41.11 52.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.181 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.02 -59.38 0.3 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.751 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.93 -174.0 1.73 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.782 0.325 . . . . 0.0 110.999 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -128.42 142.36 51.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.662 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.46 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 24.7 m-85 -61.76 171.9 1.46 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.576 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.0 p -154.31 139.17 17.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 111.737 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.823 HD11 ' O ' ' A' ' 43' ' ' GLU . 3.7 tt -152.07 125.06 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.684 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -72.15 148.65 45.44 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.437 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -59.58 -40.21 86.65 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -60.62 -38.35 84.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.943 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -57.33 -47.74 80.78 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.694 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD13 HD13 ' A' ' 10' ' ' ILE . 8.5 mt -63.42 -43.17 98.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.073 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.38 -28.29 69.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.572 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -88.14 -37.84 15.85 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.79 -0.186 . . . . 0.0 111.363 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.68 -15.39 2.44 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.563 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.823 ' O ' HD11 ' A' ' 34' ' ' ILE . 13.8 mt-10 -68.09 80.63 0.22 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-O 121.215 0.531 . . . . 0.0 110.616 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 57' ' ' VAL . 5.2 p30 -96.54 40.09 1.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.566 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -125.77 130.97 72.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.254 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.649 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.75 134.91 54.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.353 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 m -116.23 131.92 56.81 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.2 t -88.59 133.79 35.46 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.66 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.89 1.76 8.85 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.689 2.26 . . . . 0.0 112.912 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 t -106.66 -54.51 2.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.553 0.216 . . . . 0.0 111.039 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.6 p -98.15 -20.7 17.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.94 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m 65.04 43.82 3.61 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.005 0.431 . . . . 0.0 110.815 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.4 mt -96.47 -179.79 4.74 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.723 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 4' ' ' PHE . 14.1 pt -129.04 143.37 41.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.129 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.649 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.4 pt -144.38 145.22 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.018 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HB3' ' CG ' ' A' ' 7' ' ' GLU . 13.7 tptp -92.91 134.7 34.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.348 0.594 . . . . 0.0 111.421 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -108.71 113.27 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.74 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mm -91.12 134.87 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.015 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' CD2' HD22 ' A' ' 39' ' ' LEU . 17.5 p90 -152.39 179.28 8.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.221 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -81.28 99.4 8.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.456 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -60.86 -31.16 70.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.112 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -65.16 -31.28 72.39 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.993 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -95.76 -32.04 12.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.398 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -81.3 -61.96 1.8 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.643 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 65' ' ' VAL . 8.0 p -113.85 87.6 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.206 0.526 . . . . 0.0 111.776 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -154.0 39.68 0.48 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.273 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -127.08 -84.99 0.52 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.017 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -99.2 37.63 1.52 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.793 0.33 . . . . 0.0 110.983 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 69' ' ' THR . 8.9 t -85.08 107.66 17.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.995 0.426 . . . . 0.0 110.768 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.21 135.38 11.85 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.212 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.81 123.98 7.79 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.776 2.318 . . . . 0.0 112.803 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.69 ' HB3' ' CB ' ' A' ' 75' ' ' ALA . . . -171.2 150.22 2.81 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.414 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.6 110.7 2.79 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.631 2.221 . . . . 0.0 112.192 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.9 m 57.42 41.48 26.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.172 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.69 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -99.6 139.09 35.77 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.404 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -104.29 -36.61 7.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.005 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HB2' HD21 ' A' ' 79' ' ' LEU . 17.7 pttt -171.56 147.22 2.31 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.03 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.437 ' C ' HD23 ' A' ' 79' ' ' LEU . 3.3 tt0 -119.2 90.88 3.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.139 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 77' ' ' LYS . 0.8 OUTLIER -173.18 128.93 0.46 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.178 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 80' ' ' VAL . 13.4 t -107.6 38.2 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.662 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -93.87 107.85 19.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 tp -123.78 31.82 5.76 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.17 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -135.1 82.01 1.93 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.775 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.9 t60 . . . . . 0 N--CA 1.464 0.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.12 -179.76 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.474 ' HG2' HG21 ' A' ' 54' ' ' ILE . 2.8 mtt . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.7 0.286 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.92 143.57 29.62 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.025 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t 60.5 82.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.407 ' CD1' HD12 ' A' ' 54' ' ' ILE . 4.2 m-85 -65.46 161.25 20.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.398 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -83.17 -58.95 2.63 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.869 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -157.72 162.77 38.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.273 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -110.53 134.82 52.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.575 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.701 HG11 ' CE1' ' A' ' 24' ' ' TYR . 21.5 t -134.61 140.52 45.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.212 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -67.71 139.82 56.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.102 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.509 HD11 ' CG ' ' A' ' 22' ' ' TYR . 1.3 tp -56.91 -30.17 32.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.91 -32.45 70.76 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.632 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.95 -29.92 66.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 24' ' ' TYR . 9.5 m-85 -65.04 170.78 4.09 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.866 0.365 . . . . 0.0 111.194 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.75 109.6 21.54 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.715 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -66.28 118.73 10.39 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.769 0.319 . . . . 0.0 110.464 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.95 91.39 4.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.839 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.27 -29.06 60.63 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.176 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -48.23 -37.99 17.38 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.3 t -151.09 28.24 0.67 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 46.44 68.15 0.66 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.94 0.4 . . . . 0.0 111.748 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.4 m -137.53 155.04 49.7 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.509 ' CG ' HD11 ' A' ' 10' ' ' ILE . 35.5 m-85 -117.56 139.42 50.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.75 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -130.96 153.07 49.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.261 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.701 ' CE1' HG11 ' A' ' 8' ' ' VAL . 17.0 t80 -133.0 133.74 23.58 Favored Pre-proline 0 N--CA 1.463 0.196 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 32.4 Cg_exo -58.17 124.09 15.13 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.681 2.254 . . . . 0.0 112.479 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -99.05 143.74 26.94 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.699 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.29 -16.66 44.17 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.756 2.304 . . . . 0.0 113.029 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.9 p -77.16 -33.0 56.64 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.494 0.187 . . . . 0.0 111.214 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.17 -47.65 0.63 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.361 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -80.24 -168.89 1.84 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.282 0.233 . . . . 0.0 110.682 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 48.0 m-20 -135.35 141.95 45.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.666 0.269 . . . . 0.0 110.654 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.511 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 31.6 m-85 -62.68 168.58 3.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.807 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.9 p -150.27 139.34 21.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.754 0.311 . . . . 0.0 111.66 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.793 HD11 ' O ' ' A' ' 43' ' ' GLU . 9.8 tt -152.58 124.44 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.615 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 p -72.28 148.72 45.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.767 0.318 . . . . 0.0 111.469 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -59.73 -37.7 79.66 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.036 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -60.95 -38.6 86.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.983 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -57.05 -47.53 80.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.575 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.483 HD22 ' CD2' ' A' ' 59' ' ' TYR . 11.5 mt -59.87 -46.74 88.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.865 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -60.01 -27.95 67.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.645 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -88.25 -37.53 15.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.59 -4.72 3.7 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.925 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.793 ' O ' HD11 ' A' ' 34' ' ' ILE . 27.9 mm-40 -75.08 78.45 2.25 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.113 0.482 . . . . 0.0 110.156 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 57' ' ' VAL . 2.1 m-20 -92.18 36.82 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.302 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -124.83 131.02 73.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.935 0.397 . . . . 0.0 111.702 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -113.0 131.85 55.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.431 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.8 m -115.7 130.36 56.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.9 t -92.75 118.55 67.98 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.154 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.01 -18.85 24.02 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.935 2.424 . . . . 0.0 113.293 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 m -82.45 -74.34 0.35 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.405 0.15 . . . . 0.0 111.405 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.536 ' HB2' HD13 ' A' ' 53' ' ' LEU . 20.1 p -76.61 -25.07 53.48 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.36 40.73 2.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.114 0.483 . . . . 0.0 110.644 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 51' ' ' CYS . 4.7 mp -95.01 -178.45 4.49 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.756 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.474 HG21 ' HG2' ' A' ' 1' ' ' MET . 15.4 pt -129.38 143.5 40.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.361 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.641 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -143.38 146.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.945 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -92.59 136.44 33.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.236 0.541 . . . . 0.0 111.401 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -109.56 112.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.957 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.8 mm -91.37 134.2 30.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.849 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.483 ' CD2' HD22 ' A' ' 39' ' ' LEU . 17.4 p90 -153.08 -177.9 6.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.664 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.13 101.29 14.01 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 110.814 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -60.29 -31.07 69.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.93 -33.74 76.75 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.956 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -82.84 -42.09 18.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.941 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -72.39 -72.93 0.21 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.15 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 65' ' ' VAL . 9.1 p -115.72 93.51 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.206 0.527 . . . . 0.0 111.507 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.77 36.84 1.84 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.448 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.74 -81.14 0.23 Allowed Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.002 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -102.81 36.22 2.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 69' ' ' THR . 12.2 t -66.59 106.43 1.79 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.024 0.44 . . . . 0.0 111.027 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 t -148.08 140.73 14.86 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.068 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.16 176.71 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.975 2.45 . . . . 0.0 112.814 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -63.73 157.59 65.89 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.691 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 49.5 Cg_endo -69.24 130.74 20.53 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.803 2.335 . . . . 0.0 112.84 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.0 39.64 0.1 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.227 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.12 -72.71 0.53 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.133 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 62.23 104.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.411 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -127.96 141.93 51.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.343 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -130.13 119.21 22.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.142 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.34 127.33 0.96 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.05 109.81 29.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.121 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -95.75 114.06 25.76 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.897 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.7 mt -113.02 123.01 49.33 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.983 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -138.18 101.07 4.3 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.941 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 . . . . . 0 N--CA 1.462 0.168 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.052 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.934 0.397 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.8 179.59 4.16 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.492 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 m -87.81 144.47 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.473 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.622 ' CD1' HD12 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 62.4 174.31 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.365 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.435 ' HB3' HG22 ' A' ' 55' ' ' ILE . 57.9 t-80 -89.48 -61.37 1.71 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.739 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.37 161.9 14.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.037 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -109.8 123.77 50.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.3 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG11 ' CE1' ' A' ' 24' ' ' TYR . 21.6 t -128.99 141.56 46.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.099 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -67.49 140.06 57.04 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.204 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.625 HD11 ' CD2' ' A' ' 22' ' ' TYR . 1.1 tp -55.51 -29.73 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.611 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.82 -31.85 68.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.647 0.26 . . . . 0.0 110.784 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -75.0 -29.08 60.77 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.023 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' HZ ' HD12 ' A' ' 55' ' ' ILE . 7.4 m-85 -64.62 173.02 2.35 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.098 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -104.7 106.59 17.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.786 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -65.48 131.3 46.06 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.49 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -113.29 89.78 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.623 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -57.57 -26.83 62.02 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.609 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.92 -50.67 34.14 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.632 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.33 28.44 1.67 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.596 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 50.48 70.37 0.52 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.51 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -139.21 153.36 47.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.652 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.625 ' CD2' HD11 ' A' ' 10' ' ' ILE . 11.7 m-85 -121.95 139.64 53.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.615 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -128.69 151.99 48.9 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.478 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.614 ' CE1' HG11 ' A' ' 8' ' ' VAL . 12.0 t80 -129.02 136.81 29.76 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.117 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.454 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 39.6 Cg_endo -67.39 124.26 11.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.534 2.156 . . . . 0.0 112.52 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' SG ' ' CE2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -100.66 145.15 29.84 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.844 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.9 -16.09 36.82 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.646 2.231 . . . . 0.0 112.969 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.4 p -76.64 -40.21 49.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.53 0.205 . . . . 0.0 111.111 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.12 -55.37 0.37 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.613 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.71 -174.41 2.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.579 0.228 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 65.3 m-20 -130.91 141.61 50.31 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.765 0.317 . . . . 0.0 111.232 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.509 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 34.0 m-85 -61.45 164.96 5.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.706 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 p -147.37 138.94 23.98 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 111.527 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.791 HD11 ' O ' ' A' ' 43' ' ' GLU . 4.9 tt -152.3 124.79 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.76 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.0 p -72.03 149.61 44.75 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 111.263 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.42 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -59.72 -39.16 83.77 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.898 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -60.98 -39.99 91.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.039 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.52 -47.55 79.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.633 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.543 HD13 HD13 ' A' ' 10' ' ' ILE . 6.0 mt -63.82 -40.66 97.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -64.08 -27.48 69.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.476 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -90.54 -37.32 13.93 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.99 -18.4 1.96 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 121.138 -0.554 . . . . 0.0 112.369 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.791 ' O ' HD11 ' A' ' 34' ' ' ILE . 39.7 mm-40 -66.43 80.24 0.1 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.153 0.501 . . . . 0.0 110.93 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 57' ' ' VAL . 8.4 p30 -96.66 39.94 1.15 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.515 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.79 129.97 72.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.365 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.614 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -112.97 132.35 55.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.476 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.4 m -112.59 131.52 55.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.3 t -92.4 115.88 65.51 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.535 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.14 -19.23 20.06 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.737 2.291 . . . . 0.0 113.311 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -83.41 -75.11 0.34 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.528 ' SG ' HD12 ' A' ' 53' ' ' LEU . 28.2 p -76.14 -26.9 56.77 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.35 41.24 1.04 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.074 0.464 . . . . 0.0 110.816 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.528 HD12 ' SG ' ' A' ' 51' ' ' CYS . 6.8 mt -94.99 -179.95 5.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.647 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 4' ' ' PHE . 11.6 pt -126.39 143.56 39.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.057 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -143.66 143.13 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.775 0.321 . . . . 0.0 111.167 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -91.52 133.64 35.34 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.421 0.629 . . . . 0.0 111.41 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.723 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -108.05 113.53 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.985 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.0 mm -91.34 134.71 29.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.076 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CD2' HD22 ' A' ' 39' ' ' LEU . 18.9 p90 -154.98 179.54 9.03 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.899 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -84.78 99.79 11.11 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.501 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -60.86 -29.6 69.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.34 -33.15 75.28 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.632 0.253 . . . . 0.0 110.911 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -93.56 -40.72 10.15 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.143 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -74.26 -58.59 3.2 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.724 0.297 . . . . 0.0 111.047 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 t -78.79 82.69 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.168 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 99.5 p -93.28 92.25 7.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.911 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.17 -95.85 0.13 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.327 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.8 33.25 2.6 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 111.227 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -139.37 128.46 23.79 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.73 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 19.3 t -99.11 140.66 21.86 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.038 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 70' ' ' VAL . 32.4 Cg_exo -57.87 175.5 0.44 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.835 2.356 . . . . 0.0 112.686 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.62 151.12 53.0 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.854 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.21 150.73 65.88 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.984 2.456 . . . . 0.0 112.58 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.0 m -151.31 157.91 43.12 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.363 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.27 145.6 31.41 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.297 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -127.21 36.8 4.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.015 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -123.54 37.6 4.38 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.053 179.591 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -88.1 95.56 10.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.038 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -129.44 36.43 4.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.75 107.61 19.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.076 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.5 tttp 62.53 88.51 0.09 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.337 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.57 144.67 30.2 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.054 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -146.6 170.1 17.61 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.955 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.921 -179.986 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.778 0.323 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.8 -171.58 0.22 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 3' ' ' VAL . 26.4 t 69.37 57.58 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.09 0.471 . . . . 0.0 110.382 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.4 ' CD1' HD12 ' A' ' 54' ' ' ILE . 1.5 m-85 57.42 -176.05 0.07 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.074 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -103.47 -59.54 1.7 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.799 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -167.35 158.43 11.71 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.814 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -100.23 135.0 42.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.543 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.659 HG11 ' CZ ' ' A' ' 24' ' ' TYR . 23.9 t -136.22 139.96 44.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.749 0.309 . . . . 0.0 111.198 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -72.87 139.87 47.19 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.98 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.668 HD11 ' CG ' ' A' ' 22' ' ' TYR . 1.1 tp -57.19 -29.82 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.765 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -58.68 -32.49 69.18 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.714 0.292 . . . . 0.0 110.875 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.87 -30.5 64.02 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.198 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.45 ' CZ ' HG13 ' A' ' 57' ' ' VAL . 14.2 m-85 -64.3 157.28 26.46 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.201 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -96.34 87.9 4.6 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.49 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.432 ' HB2' ' CE2' ' A' ' 22' ' ' TYR . 76.5 t80 -66.47 152.36 45.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.63 101.71 3.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.535 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -52.04 -30.24 24.67 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.098 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -51.61 -47.79 63.49 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.223 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.3 m -108.33 -17.63 13.95 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.068 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 64.25 44.53 4.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.053 0.454 . . . . 0.0 110.651 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.449 HG23 ' C ' ' A' ' 34' ' ' ILE . 22.5 m -140.3 149.8 43.23 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.746 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.668 ' CG ' HD11 ' A' ' 10' ' ' ILE . 67.4 m-85 -105.42 141.19 37.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.888 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -129.08 157.67 41.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.481 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.659 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 3.2 t80 -139.28 138.0 19.99 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.461 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 37.0 Cg_endo -65.6 124.03 12.24 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.59 2.193 . . . . 0.0 112.551 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -97.84 144.42 27.98 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.807 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 43.3 Cg_endo -67.88 -17.22 46.75 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.705 2.27 . . . . 0.0 112.884 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.1 p -76.54 -38.18 55.47 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.559 0.219 . . . . 0.0 111.105 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.45 -49.41 0.49 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.681 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.98 -171.18 2.51 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.595 0.236 . . . . 0.0 110.763 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 61.1 m-20 -132.42 141.76 48.99 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.643 0.259 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.434 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 24.9 m-85 -63.97 168.36 5.29 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 p -151.39 139.43 20.09 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.786 0.327 . . . . 0.0 111.565 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.836 HD11 ' O ' ' A' ' 43' ' ' GLU . 2.1 tt -151.89 124.07 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.522 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 p -71.88 148.62 45.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.857 0.36 . . . . 0.0 111.416 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -59.51 -38.99 82.38 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.078 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.03 -37.82 83.95 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.102 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.403 ' CB ' ' HB2' ' A' ' 43' ' ' GLU . 2.1 m-20 -58.28 -47.86 82.3 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.716 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.577 HD13 HD13 ' A' ' 10' ' ' ILE . 9.0 mt -61.75 -44.23 97.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.863 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -62.14 -32.14 72.7 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -83.41 -38.48 21.89 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.678 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.18 -16.13 2.32 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.483 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.836 ' O ' HD11 ' A' ' 34' ' ' ILE . 23.3 mm-40 -68.59 81.41 0.27 Allowed 'General case' 0 C--N 1.341 0.211 0 CA-C-O 121.25 0.548 . . . . 0.0 110.938 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.407 ' HB3' ' HE2' ' A' ' 59' ' ' TYR . 7.8 p30 -97.24 41.29 1.12 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.484 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.5 p -127.87 132.01 69.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.287 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.67 ' HB3' ' CG1' ' A' ' 55' ' ' ILE . . . -112.82 134.36 54.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.278 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.5 m -117.76 132.05 56.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.781 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 t -88.64 133.59 35.78 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.681 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.03 -8.48 23.68 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.588 2.192 . . . . 0.0 113.255 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.1 m -99.43 -71.84 0.68 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.272 0.101 . . . . 0.0 111.272 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.5 p -74.94 -27.96 60.4 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.05 42.93 1.72 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.019 0.437 . . . . 0.0 110.804 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mp -95.19 -175.14 3.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.749 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.4 HD12 ' CD1' ' A' ' 4' ' ' PHE . 14.8 pt -131.4 143.58 40.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.384 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.67 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 4.2 pt -144.68 144.31 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.969 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -91.05 134.7 34.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.225 0.536 . . . . 0.0 111.607 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.726 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -108.81 113.34 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.852 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.0 mm -91.14 135.61 26.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.789 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.495 ' CD2' HD22 ' A' ' 39' ' ' LEU . 21.7 p90 -152.72 179.35 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 9.9 t0 -85.64 96.36 9.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.588 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -60.24 -33.8 72.79 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.077 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.94 -33.07 75.16 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 121.168 -0.213 . . . . 0.0 110.707 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 0.9 OUTLIER -85.98 -36.74 19.62 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.859 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -74.29 -66.11 0.77 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.399 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 65' ' ' VAL . 7.8 p -112.8 94.69 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.244 0.545 . . . . 0.0 111.318 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.4 t -107.49 33.97 3.76 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.163 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.88 -49.51 5.04 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.257 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.07 33.02 4.01 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.796 0.331 . . . . 0.0 111.121 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.5 m -133.95 143.37 48.14 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.687 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 70' ' ' VAL . 9.8 p -84.42 114.44 54.93 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.4 126.88 23.78 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.758 2.306 . . . . 0.0 112.484 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.87 149.74 71.5 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.663 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.04 169.12 21.29 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.869 2.379 . . . . 0.0 112.638 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.77 108.13 0.88 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.17 109.16 8.71 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.05 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.444 ' HB2' HD21 ' A' ' 79' ' ' LEU . 20.1 p-10 -71.17 116.6 11.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.9 138.22 30.05 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.338 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 63.84 66.26 0.67 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.354 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 76' ' ' ASN . 1.5 pp -164.25 33.96 0.08 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.377 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 p -75.28 124.16 32.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.043 0.449 . . . . 0.0 111.443 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -121.39 108.58 13.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.857 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.8 mp -68.15 163.43 22.63 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -151.67 174.6 13.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.289 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.9 m80 . . . . . 0 C--O 1.232 0.157 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.004 179.958 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_